Antigen presentation and immune response in the female rabbit reproductive tract to antigens delivered by recombinant Myxoma viruses by Gu, Wenyi
ANTIGEN PRESENTATION AND IMMUNE RESPONSE 
IN THE FEMALE RABBIT REPRODUCTIVE TRACT TO 
ANTIGENS DELIVERED BY RECOMBINANT 
MYXOMA VIRUSES 
Wenyi Gu 
'k thesis submitted for the degree of Doctor of Philosophy at The 
Australian National University 
Division of Biochemistry and Molecular Biology, School of Science, 
The Australian National University 
and 
Pest Animal Control Cooperative Research Centre at CSIRO Wildlife 
and Ecology 
December 2002 
. 
1 
This thesis is my original work except where acknowledged. 
Signature----~-----------------
Wenyi Gu 
.. 
11 
ACKNOWLEDGMENTS 
I would like to sincerely thank my supervisors Dr Peter Kerr, Dr Peter Janssens, Dr 
Michael Holland, and adviser Dr Robert Seamark for their consistent support and 
valuable input throughout this study. Peter (K) and Michael provided day to day 
supervision throughout the experimental period. Peter (K) and Peter (J) put a lot of 
effort into critically reading and correcting the who le thesis. Without their support and 
help I would not have completed the thesis by now. 
I would also like to thank Dr Ronald Jackson and Dr Tony Robinson for generously 
providing recombinant myxoma viruses, recombinant ZPB protein, the HA plasmid and 
information about its transfection. My thanks are also extended to Dr Sonja Best for 
kindly providing many reagents, and for her help in setting up immuno-histochemical 
and lymphocyte transformation assays; to Dr Russell Jones for his help in collecting the 
micro-puncture samples; to Dr Kenneth Beagley for the constructive discussions of 
chapter 4; and to Dr Bob Moore for the constructive discussion about chapter 5, and for 
providing references about ovary-granulosa cell communication. 
I would like to specially thank Hannah Clarke, Nigel French, and Brenda Donges for 
their help in organising the animal experiments, animal immunisations, collecting 
flushing samples and for many other forms of technical assistance. Nigel, I shall 
remember that you suffered a sore back in helping me collect washing samples and that 
your recombinant ZPB protein made ELISA work beautifully. 
I would like to express my deepest thanks to my wife Zhihong and my son Ming and 
daughter May for their support and help during the study. I am also very grateful to my 
mother-in-law who helped a great deal in looking after the kids during my PhD course. 
To my friends, Jianwei Xu, James de Jersey, Changjiang Wei, Andrew Simon, and 
Anna Butt, your help in all aspects and your friendship are greatly appreciated. 
111 
Finally, I would like to thank the VB CRC (now PAC CRC), Graduate School ANU, 
Division of Biochemistry & Molecular Biology ANU, and CSIRO Wildlife and Ecology 
(now CSIRO Sustainable Ecosystem) for offering me a PhD scholarship and financial 
support for the 11 th International Conference on Mucosal Immunology (Amsterdam, 
June 1999). 
lV 
TABLE OF CONTENTS 
L. fF. .. 1st o 1gures .................................................................................... x11 
List of Tables ..................................................................................... xv 
Common-used Abbreviations ............................................................... . xvii 
Abstract ... ........................................................................................ xix 
Chapter 1: General Introduction .................................................................................... 1 
1.1 Rabbit control in Australia: immunocontraception ............................................. 1 
1.2 Viral vectored immunocontraception for rabbits ................................................ 2 
1.2.1 The concept and target ................................................................................ 2 
1.2.2 Myxoma virus as a viral vector ................................................................... 3 
1.2.2.1 The pathogenesis and disease course of myxomatosis ............................ 4 
1.2.2.2 Viral replication and replication strategies ................... ........... .. .............. 5 
1.2.2.3 As a viral vector for delivering immunocontraceptive vaccine ................ 6 
1.3 Sperm as a target for immunocontraception ....................................................... 7 
1.3 .1 The role of antibody in blocking fertilisation ............................................... 7 
1.3 .2 Induction of an effective antibody response in the reproductive tract ........... 9 
1.4 Antibody and its transfer in the female reproductive tract ................................ 11 
1.4.1 IgG antibody in the tract and passive transfer ............................................ 11 
1.4.2 Secretory IgA and mucosa! immunity ....................................................... 12 
1.4.3 Rabbit IgA isotypes ................................................................................... 15 
1.4.4 Diversification of the antibody repertoire .................................................... 15 
1.5 Antigen presentation and induction of a mucosal antibody response in the female 
reproductive tract .......................................... ..... ..................................................... 16 
1.5.1 Antigen presentation via common mucosal inductive sites ........................ 16 
V 
1.5.2 Local antigen presentation in the female reproductive tract ....................... 18 
1.5.3 The effect of ovarian hormones on antibody levels in the reproductive tract 
fluid ............................................................................................................... 2 0 
1.6 Immunocontraception targeting oocytes in the ovary ....................................... 23 
1.6.1 Infertility achieved by immunisation with zona pellucida protein .............. 23 
1.6.2 The mechanism of infertility following ZP immunisation .......................... 24 
1.6.2.1 Antibodies blocking fertilisation .......................................................... 24 
1.6.2.2 Follicle loss, ovarian dysfunction and infertility ....... ............................ 25 
1.6.3 Antibody titers in ovarian follicles: the ovary could be more accessible to 
serum antibody .................................................................................................... 26 
1.7 The aim of this study .................. ..................................................................... 27 
Chapter 2: Materials and Methods ................................. .............................................. 28 
2.1 Biochemical reagents and solutions ................................................................. 28 
2.1.1 Recombinant myxoma viruses and antigens .............................................. 28 
2.1.1.1 Recombinant myxoma viruses .............................................................. 28 
2.1.1.2 HA and MV antigens ........................................................................... 28 
2.1.1.3 Recombinant rabbit ZPB (RC55) protein .............................................. 29 
2.1.2 Antibodies and antibody conjugates .......................................................... 29 
2.1.3 Chemicals and solutions ............................................................................ 31 
2.1.3.1 ELISA solutions: ...................................................................... ............ 31 
2.1.3.2 Tissue or section fixation and slide preparation .................................... 32 
2.1.3.3 Plasmid DNA preparation and sub-cloning solutions: ........................... 32 
2.1.3.4 In situ hybridisation ............ ....................... .................................... ...... 33 
2.2 Animal treatment and sampling ..... ............................................................... ... 34 
2.2.1 Animal housing ...................................... , ...................... ............................ 34 
2.2.2 Immunisation and induction of ovulation ............................................ ...... 35 
2.2.2.1 Immunisations ............................................................ .................. ........ 3 5 
2.2.2.2 Induction of ovulation and super-ovulation .. .. ........................ .............. 3 5 
2.2.3 Sample collection and preparation ........................... ................. ................. 36 
2.2.3.1 Seru~ reproductive tract fluids and ovarian follicular fluids .............. .. 36 
2.2.3.2 Reproductive tract tissue and other tissue samples .. ............. .............. ... 3 7 
,.., ? 3,, P . ffr . ,,7 
...,._. ..J reparation o ozen sections .................................................. .... ........ _) 
2.2.3 .4 Paraffin embedded section .................. ........................................ .. ....... 3 7 
2.3 Antibody and immunoglobulin measurement ................................................... 38 
VI 
2.3 .1 Antibody measurement ............................................................................. 3 8 
2.3.2 Total immunoglobulin measurement ......................................................... 39 
2.3.2.1 IgG and IgM ........................................................................................ 39 
2.3.2.2 Total IgA ............................................................................................. 39 
2.4 Immunofluorescence ....................................................................................... 40 
2.4.1 Indirect immunofluorescence .................................. ..... ............................. 40 
2.4.2 Immunofluorescence for detection of HA specific antibody secreting cells40 
2.4.3 Double immunofluorescence ..................................................................... 41 
2.4.4 Cell counting using confocal microscopy .................................................. 42 
2.5 Preparation of sense and anti-sense RNA probes .............................................. 42 
2.5.1 Sub-cloning IL-2 DNA ............................................................................. 42 
2.5.1.1 Mini-preparations of plasmid DNA ...................................................... 43 
2.5 .1.2 Restriction enzyme digestion for ligation ............................................. 43 
2.5 .1.3 Purification of DNA fragment .............................................................. 44 
2.5.1.4 Ligation reaction and transformation .................................................... 44 
2.5.2 Synthesising and labelling RNA probes .................................................... 45 
2.5.2.1 Preparation of sense and anti-sense DNA templates ............................. 45 
2.5.2.2 Transcription and labelling ................................................................... 46 
2.5.3 RNA probe hydrolysis: ....................................................................... ...... 47 
2. 5. 4 Concentration test ..................................................................................... 4 7 
2 6 I . h b .d. . 
. n situ y r1 1sat1on .................................................................... ..................... 48 
27 D 1 . d .. 
. ata ana ys1s an statistics ........................................................... .................... 49 
Chapter 3: Immune cells in the female rabbit reproductive tract ...... ............................ 50 
3 .1 Introduction ..... ................................................................ ................................ 5 0 
,., 2 E . 1 d . "' -'. xperrmenta es1gn .................................................................................... .... 5 _, 
3 .3 Results .............................................................. ................. .. ............................ 54 
"l ,., 1 
.) . .) . The effect of ovulation on the mucosal structure of the reproductive tract 
. ............................................................................. .. ......... 54 
3.3.2 CD45 positive leucocytes in the reproductive tract .... ........................ 59 
3.3.2.1 CD45+ cells in the normal reproductive tract .. ......... ..... ....... .......... ..... . 59 
3 .3 .2.2 CD45+ cells in the ovulated reproductive tract. ........... ...................... ... 62 
3.3.3 CD43 positive cells in the reproductive tract ....... . .................... . ....... 65 
3.3.3.1 CD43+ cells in normal reproductive tract. ........................ .................... 65 
3.3.3.2 CD43+ cells in the ovulated reproductive tract. .................................... 67 
.. 
vu 
3.3.3.3 The proportion of CD43+ cells to CD45+ cells .................................... 68 
3.3.4 KEN-5 positive cells in the repro~uctive tract ............................... 68 
3 .3 .4.1 KEN-5+ cells in normal reproductive tract. .......................................... 70 
3 .3 .4.2 KEN-5+ cells in the ovulated reproductive tract. .................................. 70 
3.3.5 Unsuccessful CD4 staining in the reproductive tract. ........................... 70 
3.3.6 MHC class II positive cells in the reproductive tract. ........................... 73 
3.3.6.1 MHC II+ cells in normal reproductive tract. ......................................... 73 
3.3.6.2 MHC II+ cells in the ovulated reproductive tract. ................................. 75 
3.3.6.3 Double labelling with MI-IC class II and KEN-5 monoclonal antibodies ... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 5 
3.3.7 lmmunoglobulin µ-chain positive B cells in the reproductive tract .... 78 
3.3.7.1 lg µ-chain positive cells in normal reproductive tract. .......................... 78 
3 .3. 7.2 lg µ-chain positive cells in the ovulated reproductive tract ................... 78 
3.3.8 IgA containing cells in the reproductive tract .................................... 78 
3 .3. 8.1 lgA containing cells in normal reproductive tract ................................. 81 
3 .3. 8.2 lgA containing cells in the ovulated reproductive tract ......................... 81 
3 .3. 9 lgG containing cells in the reproductive tract. ................................... 85 
3.3.9.1 IgG containing cells in normal reproductive tract ................................. 85 
3.3.9.2 lgG containing cells in the ovulated reproductive tract ......................... 88 
3. 3 .10 IL-2 mRN A expression in the uterus .............................................. 8 8 
3 .3 .11 A summary of results: .............................................................. 89 
3.4 Discussion ................................................................................ ..................... .. 91 
3 .4.1 Leukocytes and T cells in the reproductive tract .................. ... .......... 91 
3.4.2 The effect of ovulation on leucocyte and T cell distribution and activation 
· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ...................... . . 94 
3 .4.3 MHC class II expression in the reproductive tract. .......... . .................. 95 
3.4.4 The effect of ovulation on MHC II expression .................... . ..... . ....... 96 
3 .4.5 lgA and lgG positive cell distribution in the reproductive tract ............. 98 
3.4.6 The effect of ovulation on IgA and IgG presence in the reproductive tract 
......................................... . .................................... . .......... 99 
3.4.7 Epithelial surface IgA and IgG and the specificity of the staining ........... 100 
3.4.8 Conclusion ...................... . .............. . ...... . .. . . ... ....... . ........ . ..... . 101 
Vlll 
Chapter 4: Immune response in the female rabbit reproductive tract to a model antigen 
influenza HA delivered by a recombinant myxoma virus ....................................... ... . 103 
4.1 Introduction ................................................................................................. .. 103 
4.2 Experimental design ........................................................ ..... ..... .................. .. 106 
4.3 Results .................................................................... ................. ...................... 108 
4.3.1 Antibody response to HA following intradermal immunisation with MV-HA 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 0 8 
4.3 .2 The effect of ovulation on HA antibody titers .......................................... 110 
4.3.3 Antibody response to HA following intranasal infection with MV-HA .... 111 
4.3.4 Antibody response to HA following intra-vaginal infection with MV-HA ..... 
............................................................................................................. 113 
4.3.4.1 Replication of recombinant virus in the reproductive tract .................. 113 
4.3.4.2 HA antibodies in serum and reproductive tract flushings .................... 115 
4.3 .5 Antibody response to the vector, myxoma virus ...................................... 119 
4.3.6 Time course of antibody response after mucosal infection with MV-HA and 
intra-vaginal boo st with HA ............................................................................... 12 0 . 
4.3.6.1 HA IgG and IgA response in serum and vaginal washings .................. 120 
4.3.6.2 HA IgG and IgA in reproductive tract flushings after boost ................ 120 
4.3.6.3 MV specific IgG and IgA in vaginal washings ................................... 121 
4.3. 7 Antibody production in the reproductive tract ......................................... 122 
4.3.7.1 Total IgA titers in serum and reproductive tract fluids ........................ 122 
4.3. 7 .2 HA specific antibody producing cells in reproductive tract tissues ...... 123 
4.3.7.3 Source oflgG in reproductive tract fluids ........................................... 126 
4.3.8 Antibodies to HA in serum and ovarian follicular fluids following MV-HA 
infection ................................................................ ......... .... .............. ................. 12 8 
4.4 Discussion .............................. ......................... ...... ........................................ 130 
4.4.1 Is myxoma virus an efficient vector for inducing a mucosal antibody 
response in the female reproductive tract? ......................................................... 130 
4.4.1.1 Immunisation through intradermal inoculation .. ........................ ........ . 130 
4.4.1.2 Immunisation via mucosal routes ................................. .... .................. 132 
4.4.2 Antibody response and transfer in the reproductive tract of female rabbits ... . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 5 
4.4.2.1 IgA transfer in the reproductive tract. ................................................. 13 5 
4.4.2.2 IgG antibody transfer in the reproductive tract .......................... ......... 136 
1X 
4.4.3 Myxoma virus is an effective vector for inducing a strong IgG response in 
serum and in the ovarian follicle ........................................................................ 137 
4. 4. 4 A summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 9 
Chapter 5: Immunological and histological responses in ovary to infections of a 
recombinant myxoma virus expressing rabbit zona pellucida antigen B (ZPB) .......... 140 
5 .1 Introduction ................................................................................................... 140 
5. 2 Experimental design ........................................................................... ........... 14 2 
5.3 Results ................................................. ...... ...... .............................................. 143 
5.3.1 Serum antibody response to ZPB following infection with MV-ZPB ....... 143 
5.3.2 Antibody localisation in the ovary following MV-ZPB infection ............. 144 
5 .3 .2.1 IgG staining in the ovary .................................................................... 144 
5. 3 .2.2 IgM staining in the ovary ................................................................... 144 
5.3.2.3 IgA staining in the ovary .................................................................... 150 
5.3.3 Specificity of serum IgG antibody ........................................................... 150 
5.3.3.1 Serum antibody binding to the zona pellucida in ovarian sections ....... 150 
T cell response in the ovary after MV-ZPB infection ......................................... 153 
5.3.4.1 KEN-5 positive cells in the ovary ....................................................... 153 
5 .3 .4.2 CD43 positive cells in the ovary ......................................................... 153 
5 .3 .5 Morphological and histological changes in the ovary after MV-ZPB 
infection ......................................................................................... ................... 156 
5 .3 .5.1 Ovarian weight and pro-ovulatory follicle losses .... ............................ 156 
5.3.5.2 Follicle loss and degeneration .......... ........................ .......................... 157 
5 .3 .5.3 LPC accumulation in the infected ovaries ........................ ................... 161 
5.3.5.4 Infiltration of lymphoid cells in the tertiary follicles .............. ............. 164 
5 .3. 6 The relationship between follicle number and infertility rate ............. ...... 165 
5 .3 . 6.1 IgG antibody in serum and in the ovary of boosted rabbits ................. 165 
5.3.6.2 CD43 and KEN-5+ cells in the ovary of boosted rabbits ..................... 166 
5.3.6.3 Ovarian weight and pre-ovulatory follicles in boosted rabbits ............. 166 
Follicle loss and LPC accumulation in the ovary of boosted rabbits ............... 169 
5.3.7 Granulosa lutein cells ...... ...... .............. ... ... ............. ...... ... ... .......... ........... 169 
5. 4 Discussion ............. ... .... ............ ........... ............ ...................... ...... ............. .... . 171 
5.4.1 Immune response to ZPB in the ovary and immune tolerance to ZPB ... ... 171 
5.4.2 Follicle loss and infertility ....................................................................... 174 
X 
5.4.2.1 A potential mechanism for IgG-mediated tertiary or secondary follicle 
disruption ...................................................................................................... 174 
5 .4.2.2 Is there a relationship between fo Ilic le loss and infertility ................... 176 
5 .4.3 Accumulation of LPC in infected ovaries ................................................ 177 
5 . 4. 4 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 7 8 
Chapter 6: Final discussion ............................................................ ........................... 179 
6.1 Introduction ................................................................................................... 179 
6.2 The Immune response to antigens delivered by a recombinant MV and the 
selection of immuno-contraceptive target antigens ................................................. 180 
6.2.1 IgA antibody response ··········.·························· ........................................ 180 
6.2.2 IgG antibody response and transfer of IgG into the lumen of the 
reproductive tract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 2 
6.2.3 A model of the immune response to recombinant MV ............................. 183 
6.3 Antigen presentation and immune response to ZPB, a self-antigen ................. 185 
6.3 .1 Overcoming self-tolerance to ZPB ...................... .................................... 185 
6.3.2 A possible model for the short-lived antibody response to ZPB induced 
when rabbits were immunised with MV-ZPB .................................................... 187 
6.4 A hypothesis for the relationship between follicle losses and infertility induced 
by MV-ZPB infection ............................................................................................ 188 
6.5 Future studies ................................................................................................ 190 
6.5.1 Enhancing immunogenicity of ZP to induce a stronger antibody response ..... 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 9 0 
6.5.2 Understanding LPC and their effect on follicle development and ovarian 
function ............................................................................................................. 1 91 
6.5.3 Passive immunisation experiments with anti-ZPB IgG .............. .. ............ 191 
6.5 .4 Further studies of mucosa! immunity in the female reproductive tract ..... 192 
6.6 Conclusion .......................................... ... ....................................................... 192 
References ........................................................... . ........ . .................. . 193 
XI 
LIST OF FIGURES 
Figure 1- 1. The concept of viral vectored immunocontraception, proposed by PAC 
CRC (from PAC CRC Web site: www.pestanimal.org.auD ...................... ...... ... ..... 2 
Figure 1- 2. Compartments of the female rabbit reproductive tract and fertilisation ....... 4 
Figure 1- 3. Transfer of dimeric IgA through the plgR on epithelial cells .................... 14 
Figure 1- 4. Inductive and effector sites of common mucosal immune system ............. 17 
Figure 1- 5. The concentration change of oestrogen and progesterone during an oestrous 
cycle of mice, rats and livestock (adapted from Johnson and Everitt, 2000) ......... 21 
Figure 3- 1. 1 The mucosa! structure of the oviduct and uterus from normal and ovulated 
rabbits ................................................................................................................. 5 5 
Figure 3- 1.2 The luminal epithelium of the oviduct and uterus from normal and 
ovulated rabbits .................................................................................... 5 6 
Figure 3- 2.1 The mucosa! structure of the cervix and vagina from normal and ovulated 
rabbits ................................................................................................................. 57 
Figure 3- 2.2 The luminal epithelium of the cervix and vagina from normal and ovulated 
rabbits ................................................................................ . .............. 58 
Figure 3- 3. CD45 positive cells in the reproductive tract of normal female rabbits ..... 60 
Figure 3- 4. CD45 staining in rabbit popliteal lymph nodes ......................................... 61 
Figure 3- 5. CD45 positive cells in the reproductive tract of ovulated rabbits ............... 63 
Figure 3- 6. Sub-epithelial CD45+ cells in the cervix and CD45+ cells in the mucosa 
muscularis of the vagina after ovulation ............................................ ................... 64 
Figure 3- 7. Immunofluorescent images of CD43+ cells in the reproductive tract of 
normal and ovulated female rabbits ..................................................................... 66 
Figure 3- 8. Comparison of CD45+ and CD43+ cells in the reproductive tract of normal 
rabbits ................................................................................................................. 69 
Figure 3- 9. Immunofluorescent images of KEN-5+ cells in the female rabbit 
reproductive tract ................. ................................... ........... .... ...... .. ................ ... .. 71 
Figure 3- 10. Immunofluorescent images of KEN-5+ cells in the endometrium of 
normal and ovulated rabbits ........................................................ ......................... 72 
.. 
Xll 
Figure 3- 11. Imrnunofluorescent images of MHC-II+ cells in the female rabbit 
reproductive tract ................................................................................................ 7 4 
Figure 3- 12. Comparison of MHC-II + cells in the endometrium of normal and 
ovulated rabbits ................................................................................................... 76 
Figure 3- 13. MHC II and KEN-5 double positive cells in the reproductive tract of 
normal female rabbit ............................................................................................ 77 
Figure 3- 14. Immunoglobulin µ-chain positive cells in the female rabbit reproductive 
tract ..................................................................................................................... 79 
Figure 3- 15. lg µ chain positive cells in the popliteal lymph nodes and vagina ........... 80 
Figure 3- 16. IgA staining in the reproductive tract of normal female rabbits ............... 82 
Figure 3- 17. Positive control, IgA staining in small intestine ...................................... 83 
Figure 3- 18. IgA staining in the reproductive tract of ovulated rabbits ........................ 84 
Figure 3- 19. IgA staining in the deep muscular layer of the oviduct and in the mucosa 
muscularis of the vagina after induction of ovulation ........................................... 86 
Figure 3- 20. IgG staining in the female reproductive tract of normal and ovulated 
rabbits ................................................................................................................. 87 
Figure 3- 21. IL-2 mRNA expression in popliteal lymph nodes and the uterus of normal 
and ovulated rabbits ............................................................................................. 90 
Figure 4- 1. HA specific IgG titers in serum and reproductive tract fluids after 
intradermal infection with MV -HA .................................................................... 109 
Figure 4- 2. HA specific IgG in serum and reproductive tract fluids of rabbits infected 
with MV-HA and treated with hCG ................................................................... 110 
Figure 4- 3. HA specific IgG titers in serum, reproductive tract flushings and nasal 
washings after intranasal infection with MV -HA ............................................... 112 
Figure 4- 4. MV positive cells in the reproductive tract of rabbits intra-vaginally 
immunized with MV -HA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114 
Figure 4- 5. The location of HA positive cells in the vagina of intra-vaginally 
immunised rabbits ............................................................................................. 116 
Figure 4- 6. Myxoma virus and MHC class II double staining in the lower reproductive 
tract of intra-vaginally immunised rabbits .......................................................... 117 
Figure 4- 7. HA specific IgG titers in serum, reproductive tract flushings and nasal 
_ washings after intra-vaginal immunisation ......................................................... 118 
Figure 4- 8. HA specific IgG titers in serum and vaginal washings after mucosal 
infection with MV-HA and intra-vaginal boost with HA .................................... 121 
Xlll 
Figure 4-9. HA specific antibody secreting cells in popliteal lymph nodes and the uterus 
ofMV-HA infected rabbits ................................................................................ 125 
Figure 4- 10. HA IgG and IgM titer in serum and ovarian follicular fluids ................. 130 
Figure 5- I. IgG staining in ovaries of rabbits at day 5 post-infection with MV-ZPB and 
negative contra ls ............................................................................................... 14 5 
Figure 5- 2. IgG localization in ovaries of rabbits at 15 days post-infection with MV-
ZPB ................................................................................................................... 146 
Figure 5- 3. IgG localization in ovaries of rabbits at 30 days post-infection with MV-
ZP B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 7 
Figure 5- 4. IgG staining in ovaries of rabbits infected with MV-HA or from uninfected 
controls ............................................................................................................. 148 
Figure 5- 5. IgM staining in the ovary of rabbits infected with MV-ZPB ................... 149 
Figure 5- 6. lg µ-chain positive B cells in ovaries of rabbits infected with MV-ZPB .. 151 
Figure 5- 7. Specificity of serum IgG antibody from rabbits infected with MV-ZPB. 152 
Figure 5- 8. KEN-5+ T cell response in ovaries of some MV-ZPB infected rabbits ... 154 
Figure 5- 9. Comparison of CD43+ and KEN-5+ T cells in ovaries from MV-ZPB 
infected rabbits .................................................................................................. 15 5 
Figure 5- 10. The loss of pre-ovulatory follicles in MV-ZPB infected ovaries ........... 158 
Figure 5- 11. Reduction in follicle numbers in ovaries from MV-ZPB infected rabbits 
(1 00x) ............................................................................................................... 159 
Figure 5- 12. Follicle degeneration in ovaries from rabbits infected with recombinant 
MV(l00x) ........................................................................................................ 162 
Figure 5- 13. The pattern of LPC accumulation in ovaries from rabbits infected with 
MV-ZPB ........................................................................................................... 163 
Figure 5- 14. IgG localization in ovaries of rabbits infected with MV-ZPB and boosted 
with recombinant ZPB protein ........................................................................... 167 
Figure 5- 15. KEN-5+ and CD43+ T cells in ovaries of rabbits infected with MV-ZPB 
and boosted with recombinant ZPB protein ....................................................... 168 
Figure 5- 16. Comparison of granulosa lutein cells in ovulated follicles and LPC (1 00x) . 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 7 0 
Figure 6- 1. A model of antigen presentation and immune response to a strong antigen 
HA delivered by a recombinant myxoma virus (MV-HA) in the female rabbit ... 184 
XIV 
LIST OF TABLES 
Table 2- 1. Monoclonal antibodies used in this study ................................................... 29 
Table 2- 2. Polyclonal antibodies used in this study ..................................................... 30 
Table 2- 3. Antibody conjugates used in this study ...................................................... 30 
Table 3- 1. CD45 positive cell (leucocyte) numbers in the mucosa of the normal 
reproductive tract ................................................................................................ 5 9 
Table 3- 2. CD45 positive cell (leucocyte) number in the mucosa of the ovulated 
reproductive tract ................................................................................................ 62 
Table 3- 3. CD43+ T cell numbers in the mucosa of the normal reproductive tract ...... 65 
Table 3- 4. CD43+ T cells in the ovulated reproductive tract ....................................... 67 
Table 3- 5. The percentage of CD45+ cells that were also CD43+ in normal and 
ovulated reproductive tracts ........................................................... .. .................... 6 8 
Table 4-1. Individual MV IgG titers in seru~ reproductive tract flushings, and nasal 
washings after mucosal immunisations with MV -HA ........................................ 119 
Table 4- 2. HA specific IgG titers in serum and reproductive tract flushings after 
infection with MV -HA and 15 days after boosting with HA .............................. 121 
Table 4- 3. MV IgG titers in serum and vaginal washings in a time course after infection 
with MV -HA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122 
Table 4- 4. Total IgA titers in serum and reproductive tract fluids of control and 
intradermally immunised rabbits ........................................................................ 123 
Table 4- 5. Total IgA titers in serum and reproductive fluid samples after mucosa! 
immunisations with MV -HA ............................................................................. 124 
Table 4- 6. Total IgG titers in serum and reproductive tract flushings in intradermal 
infected and uninfected control rabbits ......................................................... ..... 127 
Table 4- 7. Total IgG titers in micropuncture samples of reproductive tract from 
intradermal infected and uninfected control rabbits ............... ...... ....................... 127 
Table 4- 8. Total _IgG titer in serum and reproductive tract flushings after mucosa! 
immunisations ... ..... .. .................. ....................................................................... 128 
xv 
Table 4- 9. The ratios of total IgG and HA-IgG in serum and reproductive tract 
flushings from rabbits immunised with MV-HA through different routes .......... 129 
Table 5- 1. IgG antibody to rabbit ZPB in serum of rabbits infected with MV-ZPB ... 143 
Table 5- 2. Fresh ovarian weight of rabbits infected with MV-ZPB or MV-HA ......... 156 
Table 5- 3. The number of pre-ovulatory follicles (>0.5 mm in diameter) in ovarian 
sections ............................................................................................................. 157 
Table 5- 4. The numbers of follicles at different stages of development. .................... 160 
Table 5- 5. The rate and intensity ofLPC accumulation in the ovary ......................... 164 
Table 5- 6. The number and ratio of tertiary follicles infiltrated with lymphoid cells in 
the ovarian sections ........................................................................................... 165 
XVl 
APC 
APS 
BALT 
BSA 
cm 
CTB 
DNA 
DC 
DEPC 
DTT 
ELISA 
FITC 
g 
GALT 
HRP 
HA 
hCG 
Ig 
IgA 
IgG 
IgM 
IEL 
INF-gamma 
IL-2 
. 
lU 
Kd 
LP 
Mab 
COMMON-USED ABBREVIATIONS 
Antigen presenting cells 
Ammonium persulpbate 
Bronchus associated lymphoid tissues 
Bovine serum albumin 
Centimetre 
Cholera toxin B 
Deoxyribonucleic acid 
Dendritic cells 
Diethy lpryocarbonate 
1, 4-dithiothreito I 
Enzyme linked immunosorbent assay 
Fluoresceinisothiocyanate 
gram 
Gut associated lymphoid tissues 
Horse radish peroxidase 
Influenza virus haemoagglutinin 
Human chorionic gonadotrophin 
Immunoglo bulin 
Immunoglobulin A 
Immuno globulin G 
Immunoglobulin M 
Intra-epithelial lymphocytes 
Interferon gamma 
Interlukin-2 
International units 
Kilo dolton 
Lamina! propria 
Monoclonal antibody 
.. 
XVll 
MAF 
mg 
MHC 
MHC-I 
MHC-II 
. 
mm 
ml 
mM 
mRNA 
MV 
MV-HA 
MV-ZPB 
NALT 
NK 
PAGE 
PBS 
PBST 
pfu 
plgR 
RC55 
RNA 
RL-5 
SC 
SDS 
SlgA 
SigM 
TEMED 
TNF-a 
TBS 
µl 
µg 
ZP 
ZPB 
Mouse ascites fluids 
Milli gram 
Major histocompatibility complex 
MHC class I 
MHC class II 
Minute 
Milli litre 
Milli Mole 
Me.ssenger RNA 
Myxoma virus 
Recombinant myxoma virus expressing HA 
Recombinant myxoma virus expressing zona pellucida protein B 
Nasal associated lymphoid tissues 
Natural killer cells 
Polyacrylamide gel electrophoresis 
Phosphate buffered saline 
Phosphate buffered saline Tween 
Plaque-forming units 
Polymeric lg receptor 
Rabbit zona pellucida protein B cDN A 
Ribonucleic acid 
Rabbit CD4+ T cell line 
Secretory component 
Sodium dodecyl sulfate 
Secretory IgA 
Secretory IgM 
T etramethylethy lenediamine 
Tumor necrosis factor-alpha 
Tris buffered saline 
Micro litre 
Microgram 
Zona pellucida 
Rabbit zona pellucida protein B 
XVlll 
ABSTRACT 
The European rabbit ( Oryctolagus cuniculus) is a major introduced vertebrate pest 
species in Australia, causing millions of dollars in economic losses each year and 
uncountable environmental damage. Current methods used to reduce the rabbit 
population are basically lethal and include shooting, trapping, poisoning, myxoma virus 
and rabbit haemorrhagic disease virus. These methods are expensive and have not been 
successful in reducing rabbit numbers to acceptable levels. An alternative, biological 
method of fertility control using a myxoma virus vectored immunocontraceptive 
vaccine, has been proposed by the Pest Animal Control CRC. For this proposal to be a 
success, an understanding of the profile of the immune response in the female rabbit 
reproductive system induced by antigens delivered in a recombinant myxoma virus and 
the selection of an effective immunocontraceptive antigen are crucial. 
This project focused on understanding the immune response in the female rabbit to 
reproductive antigens delivered by the recombinant myxoma virus and assessing the 
immunocontraceptive potential of the reproductive antigens. To understand the basic 
elements of the immune system, essential immune cells such as T cells, B cells, and 
MHC class II+ cells and immunoglobulin distribution were examined in the oviduct, 
uterus, cervix and vagina both before and after ovulation. As in most reported species, 
large numbers of T cells and MHC class II+ cells were present in the reproductive tract 
of rabbits, especially in the cervix and vagina, whereas few B cells were present. KEN-
S+ T cell and MHC class II+ cell numbers increased considerably in the uterus, but not 
in other sections of the tract, after ovulation. IgA and IgG were both present in the 
reproductive tract but there were few plasma cells. This suggested that these 
immunoglobulins were predominantly derived from serum. 
The capacity of a viral vector to induce an immune response in the reproductive tract 
was directly investigated by infecting female rabbits with recombinant myxoma virus 
expressing the influenza haemagglutinating protein, a model strong antigen (MV-HA) . 
. 
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Intradermal inoculation of MY-HA induced high IgG titers to HA in serum and a low 
level of IgG to HA in the reproductive tract fluids but failed to induce an IgA response 
in either serum or reproductive tract fluids. Immunisation of female rabbits with MY-
HA through intra-nasal or intra-vaginal mucosa! routes also induced low levels of IgG 
to HA in reproductive tract fluids compared to serum and only a very low-level IgA 
antibody response. 
In spite of the low antibody response in the reproductive tract, high titers of IgG to 
HA were always induced in serum following infections with MY-HA through any 
routes of immunisation. Although IgG antibody in reproductive tract fluids is thought to 
derive mainly from serum, the high-level of IgG antibody in serum did not transfer 
efficiently into the luminal fluids of the reproductive tract. In contrast, serum antibody 
freely entered the ovarian follicular fluids. The finding that the recombinant virus 
consistently induced a strong antibody response in serum and that the antibody freely 
entered the ovarian follicle indicates that recombinant myxoma virus could be used as a 
vector to deliver ovarian antigens for rabbit immunocontraception. 
The study then investigated immunological and histological responses in the ovary to 
infection by a recombinant myxoma virus expressing an ovarian antigen, rabbit ZPB 
(MV-ZPB). Delivery of ZPB by MV-ZPB overcame self-tolerance to ZPB in female 
rabbits and induced a specific serum IgG response to this antigen. The IgG to ZPB 
specifically bound to the ZP of oocytes and this was associated with follicle disruption 
and other ovarian pathology. 
It was concluded that if recombinant myxoma virus is to be used as a vector for 
rabbit immunocontraception, then it is more likely to be effective at inducing an 
immune response to an ovarian antigen than to an antigen located in the reproductive 
tract. The possible mechanisms underlying the immune response induced by 
recombinant myxoma virus, the implication of these results for developing a rabbit 
immunocontraceptive vaccine and future experiments are discussed in the final chapter. 
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CHAPTER 1: GENERAL INTRODUCTION 
1.1 Rabbit control in Australia: immunocontraception 
The European rabbit ( Oryctolagus cuniculus) is the major vertebrate pest species in 
Australia. It was introduced into Australia by European settlers in 1860 and then rapidly 
spread over continental Australia. It now causes hundreds of millions of dollars loss 
each year in agricultural production and untold environmental damage through land 
erosion and vegetation losses (Holland and !ackson, 1994). 
The current methods used to control the rabbit population are basically lethal 
including trapping, poisoning, shooting and inducing viral diseases. However, these 
methods have disadvantages; some are costly, some are non-species specific (Holland 
and Jackson, 1994) and all meet with only partial success. In addition, they are 
considered inhumane by the public (Tyndale-Biscoe, 1994). As an alternative to these 
lethal methods, fertility control was suggested since it was believed to have significant 
advantages over lethal methods in controlling high fertility animals like the European 
rabbit (Bradley, 1994). To achieve this, the Pest Animal Control Cooperative Research 
Centre (PAC CRC) of Australia is exploring a new biological approach of fertility 
control by developing a viral vectored immunocontraceptive vaccine for rabbit 
population control. It is believed that this vaccine will be species-specific, cheap, and 
long lasting in rabbits because it is vectored by a live and rabbit specific virus, myxoma 
virus (Tyndale-Biscoe, 1994; Holland and Jackson, 1994). 
In this chapter, the concept of viral vectored immunocontraception for rabbits will be 
introduced. Then the immune response and mechanism of blocking fertilisation in the 
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female reproductive tract will be reviewed. Next, this chapter will review and 
summarise the current antigen presentation strategies for inducing a strong antibody 
response in the female reproductive tract. And finally, as an alternative target for 
immunocontraception, immune responses in the ovary to ovarian antigens and effects of 
these on fertility will also be reviewed. 
1.2 Viral vectored immunocontraception for rabbits 
1.2.1 The concept and target 
The proposal of viral vectored immunocontraception for rabbit population control 
was first suggested by Tyndale-Biscoe (1994) and also described by Holland and 
Jackson (1994). Figure 1-1 summarizes the concept. Genes encoding immuno-
contraceptive antigens from rabbit gametes are isolated and cloned into the vector, 
myxoma virus, to make a viral vectored immunocontraceptive vaccine. When the 
recombinant virus is used to infect wild rabbits the virus would replicate in the infected 
Figure 1- 1. The concept of viral vectored immunocontraception, proposed by PAC 
CRC (from PAC CRC Web site: www.pestanimaLorg.au/) . 
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cells and synthesise both viral and gamete antigen proteins (Holland and Jackson, 
1994). The host immune system would recognise both viral and gamete antigens and 
mount both antibody and cell-mediated immune responses to them. Antibodies specific 
for the gamete antigen would enter the reproductive tract, bind to sperm or eggs and 
then block fertilisation. 
According to this proposal, antigens from both male and female gametes could be 
vectored in myxoma virus and both male and female rabbits could be targeted for 
immunocontraception (Holland and Jackson, 1994). However, as fertilisation occurs in 
females there are some advantages in targeting them. Firstly, to the female, sperm 
antigens are foreign proteins and should generate an effective immune response. 
Secondly, oocyte or ovarian antigens could also be targeted. Although these are self-
antigens, zona pellucida (ZP) proteins from heterogenous species may be used to 
overcome self-tolerance (Skinner et al. 1984; Jones et al. 1992). Finally, during 
fertilisation, both gametes are present in the female reproductive tract (Figure 1-2) 
where both can be targeted by an appropriate immune response. In particular, sperm-egg 
binding or fusion is considered to be species-specific (Holland and Jackson, 1994; 
Evans, 2000). Therefore targeting molecules involved in the interaction of sperm and 
egg increase the likelihood that a species-specific immunocontraceptive can be 
developed. This project will focus on female rabbits as targets for 
immunocontraception. 
1.2.2 Myxoma virus as a viral vector 
An ideal immunocontraceptive vaccine for wild rabbit population control should be 
self-disseminating, self-replicating and long lasting in the wild rabbit population. Above 
all it must be species-specific. During the 50 years that myxoma virus has persisted in 
the rabbit population in Australia there has been no evidence to show that the virus has 
infected other species (Tyndale-Biscoe, 1994). This is good evidence that myxoma virus 
could be used as a species-specific vector and led to its choice as a potential vector to 
deliver an immunocontraceptive vaccine (Tyndale-Biscoe, 1994; Holland and Jackson, 
1994). 
3 
Chapter 1 
Fertilisation 
Ovary • 
Sperm Oocyte 
Uterus • 
Cervix 
Vagina ---•~ 
Figure 1- 2. Compartments of the female rabbit reproductive tract and fertilisation 
The compartments of the female rabbit reproductive tract include the ovary, oviduct, uterus, 
cervix and vagina. In the rabbit, ovulation is induced by mating (Hammond and Marshall, 
1925). The sperm deposited in the vagina swim through the cervices and uteri to the oviducts, 
where they biiid to the oocytes, penetrate through the zona pellucida, fuse with the oocyte 
membrane and fertilise the egg. During this "long journey" in the female reproductive tract, 
sperm experience a series of preparations for fertilisation which include capacitation and the 
acrosome reaction which cause changes in their movement characteristics and surface 
membrane properties (Johnson and Everitt, 2000). The acrosome reaction allows the 
spermatozoa to release proteolytic enzymes from the acrosomal sac to facilitate penetration of 
the egg (Hunter, 1988). 
1.2.2.1 The pathogenesis and disease course of myxomatosis 
Myxoma virus is a poxvirus causing myxomatosis in the European rabbit. When it 
was first introduced into Australia in 1950 for rabbit population control, it killed >99% 
of infected rabbits (Fenner and Ratcliffe, 1965). However, the virus attenuated in the 
field and rabbits developed resistance to it and so the rabbit population recovered to a 
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considerable extent (Fenner and Ratcliffe, 1965). The pathogenic features of 
myxomatosis include extensive proliferative lesions at the primary sites of virus 
inoculation that are characterised by tissue degeneration and necrosis. By 7-10 days 
post-infection the virus has disseminated through the host and induces numerous 
secondary lesions, sometimes termed myxomas, that become visibly evident around the 
ears, eyelids, lips, nares, and genitalia. However, there is not sufficient histological 
damage in key organs to explain the high lethality of virulent strains of the virus. The 
accompanying dysfunction in host immunity can lead to supervening bacterial 
infections of the nasal and conjunctiva! mucosae and respiratory tract. Within 10-14 
days rabbits infected with virulent strains experience dyspnea and die (Fenner and 
Ratcliffe, 1965, Fenner, 1994; Best and Kerr, 2000). 
1.2.2.2 Viral replication and replication strategies 
The virus is transmitted on the mouthparts of mosquitoes or other biting arthropods; 
it does not replicate in these vectors (Fenner, 1994). In the laboratory, intra-dermal 
inoculation of either Uriarra or SLS strain results initially in viral replication in 
dendritic-like MHC class II positive cells in the dermis (Best et al. 2000). About 24 
hours later, the virus is found in T lymphocytes of the paracortical region in the draining 
lymph nodes of the inoculation site (Best et al. 2000). Between 4-10 days post-
infection, the virus is found in peripheral blood mononuclear cells and in the spleen and 
lung (Best and Kerr, 2000). Clearance of the virus starts 10-15 days post-infection, 
depending on the strain of the virus and the resistance of the host rabbit (Best and Kerr, 
2000). The main site of replication and transmission is in the epidermis. 
Myxoma virus has developed strategies to evade, block, or modulate key effector 
molecules of innate or acquired arms of the host immune system. For example, it 
produces soluble homologues of TNF-a and INF-y (Thl cytokine) receptors that 
interfere with cytokine networks (McFadden et al. 1995; Nash et al. 1999). It is known 
that such cytokines play important roles in immune responses such as early T cell 
activation, dendritic cell maturation and antigen presentation (Roitt, 1997). Interfering 
with these cytokines would suppress the immune response against the infection. MV 
infection also down regulates MHC class I molecules on the surfaces of infected cells 
(Nash et al. 1999, Guerin et al. 2002) which will inhibit antigen presentation to 
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cytotoxic T-lymphocytes. Moreover, myxoma virus also specifically down-regulates the 
CD4 molecules on the surface of infected lymphocytes (Barry et al. 1995). This would 
result in the inhibition of recognition of antigen peptides presented by APC or B cells 
thus affecting activation of T cells and potentially the generation of cellular and 
humoral immune responses. 
Myxoma virus also blocks migration of lymphocytes and monocytes to sites of active 
virus replication by inhibiting chemokine binding. The chemokines are small pro-
inflammatory proteins which are important 1n activating and mobilising 
monocytes/macrophages, T-lymphocytes, natural killer cells, and dendritic cells to the 
sites of infection. The binding of the secreted viral protein M-Tl to CC-chemokines can 
prevent their engagement to their receptors (Nash et al. 1999; Lalani, et al. 1999). In 
addition, the viral T7 protein binds to and inhibits CC-, CXC- and C-type cytokines 
(Nash et al. 1999). Myxoma virus also produces molecules such as M-T2, M-T4, M-T5, 
and Ml lL that can modulate apoptosis of host lymphocytes (Zuniga, 2002). These 
molecules are essential for virulence, implicating lymphocytes as a key target cell for 
myxoma virus. 
1.2.2.3 As a viral vector for delivering immunocontraceptive vaccine 
Like other poxviruses, myxoma virus has been investigated as a potential antigen 
delivery vector, in this case for rabbits (Jackson and Bults, 1992). Insertions of the E. 
coli Lacz gene into either of two intergenic sites of the virus under the control of a 
poxvirus late promoter resulted in the expression of the foreign gene but the 
recombinant virus retained the virulence of the wild type virus (Jackson et al. 1996). 
Moreover, a recombinant myxoma virus expressing a model antigen, influenza 
haemagglutinin (HA), was shown to induce a strong HA antibody response in serum 
and a detectable level of IgG antibody in vaginal washings in infected rabbits (Kerr and 
Jackson, 1995). These results encouraged the view that recombinant myxoma virus 
could be used as a vector to deliver an immunocontraceptive vaccine. 
The immune response in the reproductive tract has not been investigated in detail. 
It might be expected that the immuno-suppressive effects of myxoma virus would 
interfere with the immune response to antigens vectored by the virus. However, Kerr 
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and Jackson (1995) showed that after HA cDNA insertion the recombinant myxoma 
virus expressing HA was very attenuated. This attenuation of the recombinant virus may 
reduce the immunosuppressive effect and improve the immune response to viral or 
vectored antigens. 
1.3 Sperm as a target for immunocontraception 
1.3.1 The role of antibody in blocking fertilisation 
An advantage of using a sperm antigen for immunocontraception is that both male 
and female rabbits can be targeted simultaneously (Holland and Jackson, 1994). As 
described above, spermatozoa and some seminal proteins are antigenically foreign to 
fe1nales and so are more likely to generate an effective immune response in females 
than a female self-antigen such as an oocyte protein. Therefore, sperm antigens were 
considered as the first choice for an immunocontraceptive antigen. 
Early data from rabbits demonstrated that an antibody response to rabbit semen 
(Menge and Lieberman, 1974) or sperm-specific lactate dehydrogenase (Goldberg, 
1973) was induced in females following intra-dermal or intra-muscular immunisations 
and a block in fertilisation was achieved. Antibodies to sperm antigens of both IgG and 
IgA classes in uterine fluids were shown to block fertilisation in vitro (Menge and 
Lieberman, 1974). But serum antibody levels to sperm-specific lactate dehydrogenase 
did not correlate with the significantly low pregnancy rate (Goldberg, 1973). It was 
concluded that fertilisation can be blocked by immunisation with sperm or sperm 
components and that antibodies in the reproductive tract fluids play a principal role in 
this. 
Spermatozoa are deposited in the female reproductive tract after mating and travel 
from the vagina via the cervix and the uterus to the oviduct where they bind to and 
fertilise the eggs (Figure 1-2). Therefore for immunocontraception to be most effective, 
local antibodies are ideally required throughout the reproductive tract to attack 
spermatozoa during their "long journey". Antibodies to sperm antigens in the female 
reproductive tract could agglutinate or immobilise the sperm (Metz, 1972). 
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Antibody binding to sperm antigens could also activate complement and lead to local 
inflammatory responses that might destroy or damage the spermatozoa (Goldberg, 
1973 ). The fewer spermatozoa that arrive at the oviduct, the lower the chance of the egg 
being fertilised. More importantly, specific antibodies to sperm-oocyte binding 
molecules can also block spermatozoa attaching to oocytes and penetrating through the 
oocyte zona pellucida and so block fertilisation in a specific manner. A study in rabbits 
showed that the Fab fragment of antibody to a rabbit sperm antigen (termed RSA) could 
bind to the post-acrosomal region of the sperm and inhibit sperm-zona binding and 
penetration both in vitro and in vivo (O'Rand et al. 1988). Several monoclonal 
antibodies to rabbit sperm protein epitopes were also established and shown to be able 
to block fertilisation in vitro (Holland and Jackson, 1994). These data suggest that 
antibody to specific epitopes on sperm can effectively block fertilisation. In addition, 
antibodies to sperm penetrating enzymes such as hyaluronidase were shown to inhibit 
fertilisation in vitro and the Fab fragment of specific IgG could effectively do this, 
suggesting that agglutination and immobilisation of the sperm might not be an essential 
prerequisite for infertility of female rabbits (Dunbar et al. 1976). Another study in 
rabbits also showed that active immunisation of female rabbits with rabbit sperm 
antigen GA-I resulted in reduction of fertility although the specific antibody to this 
antigen had no effect on sperm agglutination and immobilisation (Naz et al. 1986). 
These data indicated that antibody to sperm antigens can block fertilisation by 
preventing sperm-egg interactions. 
Obviously, if an immunocontraceptive vaccine based on spermatozoon antigens 
expressed in myxoma viruses is to be successful two things are necessary. Firstly, an 
immunocontraceptive sperm antigen needs to be identified (Holland and Jackson, 1994; 
Holland, 1997), and secondly a good understanding of whether the recombinant 
myxoma virus can induce a satisfactory antibody response in the female rabbit 
reproductive tract is critical. This induction of an antibody response in the female rabbit 
reproductive tract to an antigen delivered by recombinant myxoma virus is the major 
topic of this study. 
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1.3.2 Induction of an effective antibody response in the reproductive 
tract 
Data from early studies in rabbits showed that anti-sperm antibodies and infertility 
could be achieved following immunisations with sperm antigens (section 1.3.1). 
However, to achieve these, Freund's complete adjuvant and several boosts were usually 
needed for the immunisation regimes and even then, a consistent and effective antibody 
response in the female reproductive tract was not obtained. For example, female rabbits 
immunised by intra-muscular injection with complete semen produced no antibodies in 
the reproductive tract fluids though antibodies were detected in serum (Edward, 1960). 
Similar results were also obtained following immunisation with yeast alcohol 
dehydrogenase (Shapiro et al. 1971) where only 4% of the serum antibody level to this 
antigen was present in oviduct fluids (Oliphant et al. 1977). Furthermore, rabbits 
immunised with sperm antigen LDH-C4 had only 3-4% of the serum antibody titer in 
oviductal fluids (Kille and Goldberg, 1979). Freund's adjuvant and boosting were used 
in these studies but were not effective in consistently inducing a strong immune 
response in the female reproductive tract. 
Recent studies showed that female rabbits immunised with HIV -1 C4N3 peptide 
supplemented with cholera toxin elicited specific IgG in serum and specific secretory 
IgA ( slgA) in vaginal secretions when the immunisation was delivered via Thiry-Vella 
ileal loops (Winchell et al. 1997). Similarly, specific slgA response to the peptide in 
vaginal secretions was increased when using a DNA vaccine delivered by gene gun into 
Peyer' s patches (Winchell et al. 1998). In contrast, in another study in rabbits it was 
shown that immunization through Peyer's patches with rabbit sperm antigen PH30 and 
cholera toxin B was unsuccessful in inducing a specific IgA response in vaginal 
washings though a strong specific IgG response was detected in serum (Hardy et al. 
1997). These results indicate that delivery of the antigens into a mucosa! compartment 
may be important in eliciting a good immune response at a distal mucosal site. 
However, the difference between a DNA vaccine or PH30 antigen immunisation into 
Peyer's patches in terms of the IgA response may reflect the continuing expression and 
longer persistence of the DNA plasmid compared with the PH30 protein. 
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Immunisation routes play an important role in inducing a mucosal immune response. 
Local, but not systemic, immunisation of female rabbits with a model antigen, 
horseradish peroxidase (HRP), induced a detectable IgA response in reproductive tract 
fluids (McAnulty and Morton, 1978). Moreover, it was shown that intranasal 
immunisation of rabbits with HIV- I C4N3 peptide elicited a better serum IgG and 
vaginal sigA response than immunisations via systemic or other mucosal routes 
(Zinckgraf et al. 1999). In the mouse, the initial route of immunisation was important in 
determining the type of immune response (Kelly et al. 1996). For example, mice 
immunised via the intra-nasal, oral, and vaginal routes with live MoPn (mouse 
pneumonitis biovar of Chlamydia trachomatis) developed a dominant Thl-type cytokine 
profile with the ratio of gamma interferon-secreting cells to IL-4-secreting cells greater 
than 10 in lymph nodes and spleen. In contrast, mice subcutaneously injected with 
MoPn produced a Th2-type profile with a gamma interferon /IL-4 ratio of only 0. 7. 
These mice also had significantly higher anti-MoPn IgG 1 serum titres, confirming a 
Th2-type cytokine profile (Kelly et al. 1996). Furthermore, a previous study showed 
that dendritic cells (DC) within different tissues have individual microenvironments and 
induce different cytokines. For example, DC in spleen mainly induce Thl cytokines 
while DC in Peyer' s patches predominantly induce Th2 cytokines (Everson et al. 1996). 
These data collectively suggest that the use of appropriate antigen presentation 
strategies such as using DNA plasmid vectors or viruses to deliver antigens and mucosal 
immunisation routes are likely to be very important in induction of an effective antibody 
response in the female reproductive tract. 
The use of recombinant virus to deliver antigen results in replication of the antigen 
and penetration through mucosal surfaces when administered at mucosa! sites, both of 
which are considered to be important for inducing a mucosa! antibody response (Parr 
and Parr, 1994; 1996). In the mouse, recombinant adenovirus was able to deliver a 
herpes simplex virus type 1 (HSV-1) antigen and induce effective mucosal antibody 
(Gallichan et al. 1993, Gallichan and Rosenthal, 1995) and cell-mediated immune 
responses (Gallichan and Rosenthal, 1996) in the female reproductive tract. But in 
rabbits, it was unknown whether a recombinant myxoma virus could achieve this. 
However, it is necessary for the virus to do this if it is to be used to deliver 
immunocontraceptive antigens that induce immune responses within the reproductive 
tract sufficient to block fertilisation. Understanding this is a major aim of this project. 
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1.4 Antibody and its transfer in the female reproductive tract 
1.4.1 lgG antibody in the tract and passive transfer 
Although antibodies of IgG, IgA and IgM classes are all present, IgG is the dominant 
antibody class in the female reproductive tract fluids for most species (Parr and Parr, 
1996). This is different to other mucosa! sites such as the intestinal and respiratory tract 
where IgA is the dominant antibody class in the luminal secretions (Brandtzaeg, 1995, 
1997). In rabbits, early data showed that IgG was the dominant lg in the uterine and 
vaginal fluids with IgA being only detected in some instances in the vaginal fluids 
(Symons and Herbert, 1971), though IgG, IgA and IgM were all present in the oviductal 
fluids (Oliphant et al. 1977). IgG was also the only antibody class detected in 
reproductive tract fluids of female rabbits intramuscularly immunised with a model 
antigen, HRP (McAnulty and Morton, 1978). Similar results were reported in rabbits 
following . immunisation with sperm antigen (Kille and Goldberg, 1979; Menge and 
Lieberman, 1974) or infection with a recombinant myxoma virus expressing influenza 
HA (Kerr and Jackson, 1995). In humans (Mestecky and Fultz, 1999) and mice (Su et 
al. 1995), IgG was also demonstrated to be the dominant antibody class in the female 
reproductive tract fluids. 
The IgG present in the reproductive tract fluid is considered to be mainly derived 
from serum and IgG can passively cross the epithelium of the reproductive tract into the 
luminal fluids by means of intercellular diffusion or intra-cellular vascular transport 
across epithelial cells (Parr and Parr, 1994, 1996). However, in most cases, epithelium 
acts as a boundary between tissue and lumen so that the concentration of lg in luminal 
fluids is much lower than that in the tissue or circulation. Compared with serum, female 
rabbit reproductive tract fluids contained only 20% of the IgA and less than 10% of the 
IgG and IgM (Oliphant et al. 1977). This implies that high levels of serum IgG are 
likely to be important for achieving a level of IgG antibody in reproductive tract fluids 
that would be satisfactory for achieving infertility. Recombinant myxoma virus 
expressing influenza HA induced a strong antibody response to HA in serum (Kerr and 
Jackson, 1995) and this could provide a source for transfer of antibody into the 
reproductive tract fluids. 
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Although serum transudation is the main source of IgG present in the reproductive 
tract, local IgG antibody production may also be possible in the murine reproductive 
tract. This is suggested by the finding of many IgG plasma cells in the murine vagina 
after infection with HSV-2 (Parr and Parr, 1997). In addition, IgG plasma cells were 
also reported in the mucosa of the rabbit vagina (Symons and Herbert, 1971). These 
plasma cells may contribute to local IgG production and provide a source of IgG for 
transfer into the reproductive tract fluids. Thus, IgG present in the lumens of some 
compartments of the reproductive tract may derive from both serum and local 
production. 
1.4.2 Secretory IgA and mucosal immunity 
The female reproductive tract is considered to be a part of the common mucosa! 
immune system (Parr and Parr, 1994, 1996; Brandtzaeg, 1997). It is characteristic of 
mucosa! immunity that secretory IgA and IgM ( slgM) are present in mucosa! secretions. 
The general function of secretory immunoglobulins is to perform immune exclusion, 
which excludes pathogens or other toxic materials from the body and perhaps returns 
antigens, which have penetrated epithelial cells, to the lumen (Parr and Parr, 1996; 
Brandtzaeg, 1997). Adequate levels of IgG, slgA, and slgM in the reproductive tract are 
essential for protecting the tract from infection; low levels of these Igs in the uterus 
have been linked to the occurrence of endometritis (Aknazarov, 1988). Besides the 
general function of secretory lg in local immunity, slgA antibody could also neutralise 
antigens such as viruses in the epithelial cells and in the lamina propria (Kaetzel et al. 
1991; Mazanec et al. 1992, 1993). Because slgM concentration in reproductive tract 
fluids is usually much lower than slgA and is more easily degraded in mucosa! 
secretions than slgA (Brandtzaeg, 1997), sigA antibody is thought to provide a major 
and lasting immunity in the reproductive tract. In addition, it was suggested that the 
sigA antibody could be more effective than IgG antibody in neutralising antigens 
because it has more antigen binding sites and so can form a bigger antigen-antibody 
complex to be cleared (Parr and Parr, 1996). Therefore, from this point of view, an ideal 
antibody response for immunocontraception would include both IgA and IgG in the 
female reproductive tract. However, it is not clear if sigA would be more effective than 
IgG in blocking fertilisation. 
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Rather than being derived from serum, slgA present in the luminal fluids is believed 
to be mainly derived from local production by IgA plasma cells in the reproductive tract 
tissue (Parr and Parr, 1996; Brandtzaeg, 1997). This is supported by the presence of a 
greater number of IgA plasma cells compared to other plasma cells in the female 
reproductive tract in several species (Rachman et al. 1983; Parr and Parr, 1996; 
Brandtzaeg, 1997). In mice, it was shown that numerous IgA plasma cells were present 
in the uterus at pro-oestrus and oestrus with very few IgG plasma cells found at any 
stage of the oestrous cycle. Moreover, lgG was present throughout the stroma, 
suggesting that IgA may be sourced mainly from local production while IgG may be 
derived mainly from serum (Rachman et al. 1983). IgA and IgG plasma cells were 
present in the uterine glands and in the gland lumen in the horns and body of the mouse 
uterus with the ratio of cells containing IgA to cells containing lgG being 3 or 4: 1 at all 
stages (Parr and Parr, 1985). Predominant IgA with less frequent IgG plasma cells were 
also reported in the human fallopian tube (Kutteh et al. 1990). In the sow, although all 
three types of immunoglobulin secreting cells were distributed in all regions of the 
reproductive tract, IgA secreting cells were dominant (Hussein et al. 1983). Because of 
the dominant distribution of lgA plasma cells in the reproductive tract and their 
production of dimeric IgA, these cells are believed to be the prime source of slgA 
present in the luminal fluids. For the rabbit, limited information showed that there were 
some IgA plasma cells in the endometrium whereas IgG and IgM positive cells were not 
found (Otsuki et al. 1990), suggesting that local IgA production could occur. However, 
information regarding the distribution of IgA plasma cells in other regions of the female 
rabbit reproductive tract and IgA production or transport in the tract is not available. 
Although, as described above, there is good evidence for local production of IgA in 
the reproductive tract, there is also evidence that transudation from serum may also be 
important. For example, in rats, IgA plasma cells were not found in any regions of the 
female reproductive tract at any stage of the oestrous cycle, suggesting that the IgA 
present in the rat reproductive tract fluids must mainly be derived from serum (Parr and 
Parr, 1989) and in human, monomeric or dimeric IgA in serum also provides a source 
for IgA in cervical secretions (Parr and Parr, 1996; Mestecky and Fultz, 1999). In 
rabbits, it is not clear whether serum IgA would contribute to IgA present in 
reproductive tract fluids. 
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Unlike IgG, the transfer of dimeric IgA produced by local plasma cells into luminal 
fluids is a selective process, which requires the polymeric lg receptor (plgR) on the 
basal membrane of epithelial cells. The detailed transfer process is shown in Figure 1-3. 
After transfer across the epithelial cells the dimeric IgA contains an extra secretory 
component (SC) from plgR (Figure 1-3), which protects the antibody from cleavage by 
proteolytic enzymes in secretions. The transfer of dimeric IgA derived from serum into 
luminal fluids is conducted by the same process as local dimeric IgA but serum 
monomeric IgA is transferred by the same passive mechanisms as IgG (Parr and Parr, 
1996). The transfer of IgM across the epithelial cells is generally thought to also need 
the plgR (Brandtzaeg, 1997). However, plgR may be not required for rabbit IgM 
transfer because this receptor may not bind to IgM (Underdown et al. 1992). 
plgR 
• 
slgA 
Plasma cell Epithelial cell 
Figure 1- 3. Transfer of dimeric IgA through the plgR on epithelial cells 
Locally produced dimeric IgA, dlgA, consists of two monomeric lgA (mlgA) molecules linked 
together by a J chain. The dlgA binds to the polyimmunoglobulin receptor (plgR) on the basal 
membrane of epithelial cells. The antibody/receptor complexes are taken into the epithelial cells 
by endocytosis. The dimeric IgA is cleaved from the receptor in the vesicles of the epithelial 
cell after which secretory IgA (sigA: secretory component, SC together with dlgA) is released 
into luminal fluids by exocytosis. (Adapted from McGhee et al. 1999). 
Clearly, to be able to induce an effective IgA response in the reproductive tract, an 
antigen presentation strategy that could induce more IgA plasma cells to be present in 
the tract is important. A previous study showed that mucosa! immunisation resulted in 
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99% of specific antibody-secreting cells (ASC) bearing the homing receptor a4~ 7 
integrin which targets the cells to mucosa! effector sites whereas systemic immunisation 
only induced 58% ASC cells bearing the same receptor (Kentale et al. 1997). This 
suggests that immunisation through mucosa! sites induces more ASC that home back to 
mucosa! sites. Furthermore, it is now generally agreed that antigen primed B cells 
mostly home back to where they were primed (Brandtzaeg, 1997). This also suggests 
that mucosa! immunisation needs to be considered to induce an effective IgA plasma 
cell response that homes to the reproductive tract. 
1.4.3 Rabbit lgA isotypes 
One important difference between rabbit IgA and IgA of other species is the rabbit 
has the potential to produce as many as 13 IgA isotypes, Cal-13 (Spieker-Polet et al. 
1993). Most of these IgA isotypes are expressed although some (Ca4, Ca5, Ca6, Ca9, 
Cal0, Ca12, and Ca13) are expressed at high levels and others (Cal, Ca2, Ca7, and 
Ca 11) are expressed at low levels. Ca3 and Ca8 are not expressed because of 
mutations in the promoters (Spieker-Polet et al. 2002). In addition, it was shown in 
rabbits that different tissues express different IgA isotypes. For instance, Cal, 6, 9, 10 
and 12 are expressed in small intestine, mammary gland, salivary gland and appendix 
whereas Ca4 is only expressed in lung and spleen (Spieker-Polet et al. 1993). It is 
unknown how many isotypes are expressed in the reproductive tract of female rabbits. 
However, these findings suggest that induction of an IgA antibody response in the rabbit 
reproductive tract may be complex and depend upon the site of antigen presentation and 
the microenvironment in which the B cells differentiate. 
1.4.4 Diversification of the antibody repertoire 
There are also some characteristic features of rabbits compared to the standard 
human and mouse models regarding the development of the antibody repertoire. 
Somatic diversification of lg genes is an important step in this process. In mice and 
humans, it occurs as a part of the T-cell dependent immune response in peripheral 
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lymphoid tissues in response to antigen stimulation (Knight and Winstead, 1997). In 
rabbits and some other species such as chicken, sheep, and cattle, somatic 
diversification is responsible for the primary antibody repertoire and it occurs in gut-
associated lymphoid tissue (GALT, Vajdy et al. 1998). In chicken and sheep, 
diversification occurs entirely during fetal development and is independent of 
exogenous antigen (Knight and Winstead, 1997). But in rabbits, somatic diversification 
occurs post-natally and nearly all lg VDJ genes are somatically diversified by about 2 
months of age (V ajdy et al. 1998). An interaction with specific but currently 
unidentified intestinal microflora is essential for the diversification (Lanning, et al. 
2000). In addition, the rabbit is one of a few vertebrates that make a limited use of 
combinatorial joining of multiple VH, DH, and JH gene segments during lg heavy chain 
gene rearrangements. The first 3' VH gene segment, VHl, is utilised at a rate of80-90% 
though there are 100 genes available (Knight, 1992). Thus, the rabbit has a very limited 
capacity to use combinatorial joining in generating a diverse primary repertoire of 
antibody (reviewed in Knight and Crane, 1994). Rather than using combinatorial 
joining, the rabbit uses somatic gene conversion to generate antibody diversity. This 
character may influence the antibody response in rabbits and thus the antibody response 
in the reproductive tract to antigens delivered by recombinant myxoma viruses. 
1.5 Antigen presentation and induction of a mucosal antibody 
response in the female reproductive tract 
1.5.1 Antigen presentation via common mucosal inductive sites 
The female reproductive tract is considered to be a compartment of the common 
mucosa! immune system. After immunisation through a common mucosa! inductive 
site, lymphocytes including IgA plasma cells are expected to home back to the effector 
site including the female reproductive tract (McGhee et al. 1999). The general concept 
of the common mucosa! immune system is summarized in Figure 1-4. In this system, 
the antigen presenting cells (APC), M cells, in the inductive site play an important role 
in transporting antigen and presenting antigen peptides to T cells in the local lymphoid 
tissues. B cells can also be activated by antigens in the local environment or by intact 
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Inductive sites Blood strea1n Effector sites 
Lamina Propria of 
Nasal • BALT 
• Respiratory tract 
11,,,._ 
•Gastrointestinal tract 
JP"' 
• Reproductive tract 
slgA+ B, 
Peyer's CD4+ T 
Oral • 
Patches cell home 
\ 4 Other mucosal sites 
MLN eg. Mammary gland 
Figure 1- 4. Inductive and effector sites of common mucosal immune system 
Antigens administrated through nasal or oral routes are exposed to common mucosal inductive 
sites such as BALT (bronchus associated lymphoid tissues) and Peyer's patches (also GALT, 
gut associated lymphoid tissues). The antigens are taken up and transported by APC (M cells) to 
local lymphocytes in these lymphoid tissu~s (McGpijf e( a{. l 999). Th~ l3 and T lymphocytes in 
the inductive sites that are reactive with the antigen can then be activated and differentiate. In 
the respiratory tract the antigen-primed lymphocytes may directly move into the blood stream. 
In the intestine, the antigen primed T or B lymphocytes migrate to local lymph nodes (MLN, 
mesenteric lymph nodes) for further differentiation, which may involve expression of homing 
receptors, and then enter the blood stream. Some of the antigen specific slgA bearing cells or 
CD4+ T cells would home back to effector sites such as the lamina propria of the 
gastrointestinal, respiratory and reproductive tract. The slgA + cells would then contribute to 
local IgA production at this site. 
antigens on the cell membrane of APC together with co-stimulation signals ( eg. 
cytokines or cell-cell interaction) from activated CD4+ T helper cells (Roitt, 1997). 
After activation, the primed B cells will express homing receptors such as a4P7 during 
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their differentiation, which will lead these cells to home back to mucosal effector sites 
including the female reproductive tract (McGhee et al. 1999). These plasma cells would 
produce specific IgA, which would then be transferred into the lumen as described in 
section 1.4.2. 
In the rabbit, immunisation through both nasal and intestinal inductive sites is 
capable of inducing a mucosal antibody response in the female reproductive tract 
(section 1.3.2). Compared with the intestinal route, the nasal route of immunisation was 
more effective in inducing a remote specific IgA response in the female reproductive 
tract of rabbits (Zinckgraf et al. 1999, section 1.3 .2). In the mouse, intra-nasal 
immunisation was also more efficient than other routes in inducing mucosal immune 
responses in the female reproductive tract (Gallichan and Rosenthal, 1995; de Haan et 
al. 1995; Johansson et al. 1998; Xiang et al. 1999). For example, intranasal 
immunization with recombinant adenovirus expressing HSV -1 glycoprotein B was 
superior to the intra-vaginal route in inducing specific IgA responses in serum and 
vaginal secretions (Gallichan et al. 1993; Gallichan and Rosenthal, 1995). Specific 
antibody-secreting cells were also shown to home back to the reproductive tract after 
intra-nasal immunization with the same recombinant virus (Gallichan and Rosenthal, 
1998). At the start of this study, it was unknown if mucosal immunisations of rabbits 
with a recombinant virus could induce an IgA antibody response in the female 
reproductive tract. 
1.5.2 Local antigen presentation in the female reproductive tract 
The ability of immune cells in the female reproductive tract to present antigen and 
mount a local immune response is important for developing immunocontraceptive 
vaccines and vaccines against sexually transmitted diseases. That this can occur is 
demonstrated by the achievement of local immunity in the reproductive tract to viral 
infection of herpes simplex virus-2 (HSV-2, McDermott et al. 1989; Parr and Parr, 
1997). However, unlike other mucosal sites such as the intestine and respiratory tract, 
the female reproductive tract lacks antigen processing cells (M cells) and organised 
lymphoid tissues such as lymph nodes and lymphoid nodules (Parr and Parr 1996). This 
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suggests that antigen presentation in the reproductive tract, if it occurs, would be 
different to other mucosa! sites. 
APC such as macrophages, dendritic cells and Langerhans' cells are present in the 
female reproductive tract of rats (Kaushic et al. 1998), mice (Parr and Parr, 1991) and 
humans (Morris et al. 1985; Givan et al. 1997; White et al. 1997) based on 
immunohistochemical or flow cytometric analysis with monoclonal antibodies to 
specific markers for these cells. MHC class II positive cells were also reported in the 
female reproductive tract of human (Ljunggren and Anderson, 1998; Johansson et al. 
1999) and rats (Kaushic et al. 1998). Based on the observation that many APC are 
present in the lower reproductive tract but the reproductive tract lacks organised 
lymphoid tissues, the pathway of antigen presentation and immune response in the 
female reproductive tract is probably through the draining lymph nodes (Parr and Parr, 
1991; McGhee et al. 1994). According to this pathway, local APC are responsible for 
picking up and transporting antigens present at the mucosal surface of the vagina to the 
draining lymph nodes of the genital tract. The APC will also process the antigen and 
present antigenic peptides on MHC class II molecules to CD4+ T lymphocytes in the 
draining lymph nodes to activate these T cells. B cells in the draining lymph nodes 
could also be activated by intact antigens transported by these APC together with the 
signals from activated T cells as described in 1.5.1 or by direct interaction with antigens 
on dendritic cells (Wykes, et al. 1998). The antigen-specific lymphocytes, including 
committed specific IgA producing B cells, would move into the blood stream and home 
back to the reproductive tract and other mucosal sites. These specific IgA producing 
cells would then produce IgA that would be transferred into the lumen as previously 
described in section 1.4.2. 
There is some evidence supporting this pathway. Intra-vaginal vaccination of mice 
with an attenuated strain of HSV-2 rapidly induced immunity to a lethal intra-vaginal 
challenge with wild type HSV-2. This resistance was transferable to syngeneic mice 
with genital lymph node cells but not with cells from other lymphoid tissues 
(McDermott et al. 1989). HSV-2-activated T cells in the genital lymph node were 
essential for resistance to genital infection by HSV-2 (McDermott et al. 1989). 
Similarly, macaques immunised orally followed by vaginally or vaginally followed by 
orally with a recombinant particulate simian immunodeficiency virus (SIV) antigen 
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linked to cholera toxin B elicited a specific CD4+ T cell response to the antigen in the 
genital lymph nodes and the spleen but not in unrelated lymph nodes. B cells, together 
with appropriate help from CD4+ T cells and macrophages from the genital lymph 
nodes produced specific IgA and to a lesser extent, IgG antibodies. However, intra-
muscular immunisation induced splenic but not genital lymph node cells and stimulated 
CD4+ T cell proliferation and predominantly B cell IgG antibody synthesis (Lehner et 
al. 1995). Furthermore, in the mouse, ASC to cholera toxin B or cholera toxin B 
conjugated with human gamma globulin were found in the genital lymph node 
following intra-vaginal immunisations (Johansson et al. 1998). These data support the 
model that specific T cell and B cell responses can be induced in the local draining 
lymph nodes of the reproductive tract following intra-vaginal immunisation. 
Various studies have demonstrated that local immunisation in the female 
reproductive tract was an effective way to stimulate a local IgA response. In the rabbit, 
a detectable specific IgA response was induced in reproductive tract secretions 
following intra-vaginal or intra-uterine immunization followed by intra-vaginally 
boosting with HRP (McAnulty and Motton, 1978). Similarly, macaques immunised 
vaginally and boosted orally with recombinant SIV antigen produced specific IgA and 
IgG antibodies in vaginal fluid and in serum (Lehner et al. 1992). Intra-vaginal 
immunization was also an effective way to induce local mucosa! immune responses in 
the female genital tract of mice (Johansson et al. 1998; Kato et al. 2000), rats (Menge et 
al. 1993), and humans (Kozlowski et al. 1997). A neutralising IgA and IgG antibody 
response to HIV -1 envelope protein was also elicited in mouse vaginal secretions after 
intra-vaginal immunization with a DNA vaccine (Wang et al. 1997). These data 
collectively suggest that an IgA antibody response can be achieved following local 
immunisation in the reproductive tract. 
1.5.3 The effect of ovarian hormones on antibody levels in the 
reproductive tract fluid 
Variations in lg levels in the reproductive tract luminal fluids during the oestrous 
cycle have been observed in several species including rats, mice, horses and cattle. In 
these species, the concentrations of oestrogen and progesterone in blood change 
20 
Chapter 1 
cyclically with oestrogen being dominant before ovulation and progesterone being 
dominant after ovulation (Figure 1-5). The effect of ovarian hormones on IgA and IgG 
oestrus dioestrus proestrus 
progesterone 
Time 
Figure 1- 5. The concentration change of oestrogen and progesterone during an 
oestrous cycle of mice, rats and livestock (adapted from Johnson and Everitt, 2000). 
This diagram shows the concentrations of ovarian hormones in blood during an oestrous cycle 
of mice, rat and most livestock. At oestrus, oestrogen is the dominant hormone until ovulation. 
After ovulation, progesterone starts to increase in concentration and, during dioestrous, 
progesterone is the dominant hormone. At pro-oestrus, the progesterone level declines to a low 
level whereas the oestrogen level elevates in preparation for ovulation. 
movement in the female reproductive tract has been well documented in the rat (Wira 
and Sandoe, 1978, 1980, 1987; Wira et al. 1984; Sullivan and Wira, 1984) where IgG 
and IgA levels in uterine sections increased during pro-estrus. IgA continued to increase 
at oestrus while IgG dropped. At dioestrus, both IgA and IgG were low (Wira and 
Sandoe, 1980). Oestradiol injection was followed by a transient increase in IgG levels 
shortly after the injection but a sustained increase in IgA levels in uterine tissues and 
secretions (Sullivan and Wira, 1984). This increase in IgA levels in the uterine fluids 
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has three possible sources: 1) an increase in the amount of IgA formed in the tissue and 
the infiltration of IgA-positive B cells into the endometrium or myometrium; 2) an 
increase in the rate of movement of IgA from the tissue into the uterine lumen; and 3) 
an increase in the amount of secretory component in the uterus (Wira and Sullivan, 
1981 ). In the mouse, by contrast, IgA and IgG concentrations in uterine sections were 
highest at pro-oestrus, lower at oestrus, and were very low at dioestrus (Rachman et al. 
1983). In addition, the levels of specific IgA antibody increased in female genital tract 
secretions after oestradiol treatment (Wang et al. 1996) or were significantly higher at 
oestrus than at other stages of the cycle (Gallichan and Rosenthal, 1996). 
In contrast, specific IgG to HSV-1 in mouse vaginal washes was significantly higher 
after progesterone administration or at dioestrus (Gallichan and Rosenthal, 1996). In 
mares, the ratio of IgA to total protein in uterine secretions was significantly higher at 
oestrus than at dioestrus (Widders et al, 1985) and IgG concentrations in uterine fluids 
increased at di oestrous or after progesterone treatment (Mitchell et al. 1982, Johnson et 
al. 1994). A similar result was reported in cows (Whitmore and Archbald, 1977). There 
is, therefore, broad evidence that IgA levels in the reproductive tract are driven by 
oestrogen and are at their highest at those stages of the cycle when oestrogen levels are 
also high. In contrast, IgG levels appear to correlate with progesterone levels. 
Unlike the species described above, the rabbit is an induced ovulator (Hammond and 
Marshall, 1925) with oestrogen being the dominant ovarian hormone until mating 
occurs. It is not clear how this will affect antibody levels in the reproductive tract fluids. 
Although a previous study showed that the total lg level in the female rabbit 
reproductive tract fluids was slightly elevated after induction of ovulation (Oliphant et 
al. 1977), the effect of ovulation on specific antibody levels in the rabbit reproductive 
tract fluids has not been reported. 
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1.6 Immunocontraception targeting oocytes in the ovary 
1.6.1 Infertility achieved by immunisation with zona pellucida protein 
As mentioned in section 1.2.1, an advantage of targeting female rabbits for 
immunocontraception is that oocytes can provide alternative immunocontraceptive 
antigens. The zona pellucida (ZP) is a glycoprotein matrix that surrounds the oocyte and 
is the site of initial sperm binding to the ovulated oocyte. ZP proteins of oocytes are 
currently the most common oocyte antigens used for immunocontraception because of 
the special roles they play in oocyte development and fertilisation (Epifano and Dean, 
1994). High infertility rates have been achieved in several species following 
immunisation with zona pellucida proteins (Sacco, 1987; Henderson et al. 1988; 
Skinner et al. 1996; Gupta et al. 1997). ZP proteins from both heterogenous and 
homogenous sources can be used for immunocontraception. Thus, porcine ZPC-a, the 
ZP protein that is considered to be the sperm receptor in the pig (Dunbar et al. 1994; 
Skinner et al. 1996), has been used as an immunocontraceptive antigen in monkeys in 
which high infertility rates were obtained (Sacco et al. 1987; Bagavant et al. 1994). 
Equally, immunisation of female mice with homogenous mouse ZP3 expressed in a 
recombinant virus also achieved a high infertility rate (Jackson et al. 1998; Chambers et 
al. 1999). 
In female rabbits, immunisation with porcine ZP antigens resulted in a high rate of 
infertility (Jones et al. 1992), follicle loss (Skinner et al. 1984; Jones et al. 1992) and 
ovarian dysfunction (Skinner et al. 1984). But female rabbits immunised with native 
rabbit ZP protein showed no or a very low antibody response and there were very 
limited effects on fertility (Wood et al. 1981; Skinner et al. 1987). This suggested that 
immune tolerance existed to the self-antigen. Prasad et al. (1995) compared 
recombinant rabbit ZPB expressed in bacteria or in a baculovirus expression system and 
showed that eukaryotic-expressed, but not bacteria-expressed, ZP protein stimulated a 
strong antibody response in rabbits. A study conducted during my PhD course further 
demonstrated that subcutaneous immunisation with recombinant rabbit ZPB expressed 
in a rabbit cell line elicited a high-level antibody response in serum and resulted in an 
infertility rate of 75% in immunised rabbits (Kerr et al. 1999). Moreover, in this study it 
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was shown that rabbit ZPB delivered by a recombinant myxoma virus (MV-ZPB) was 
able to overcome self-tolerance to ZPB and induce an antibody response to this ZP 
antigen. However, the antibody response was transient and only 25% of rabbits were 
infertile (Kerr et al. 1999). On the other hand, immunisation of female mice with a 
recombinant ectromelia virus expressing mouse ZPC elicited a persistent antibody 
response to the antigen and resulted in a high infertility rate (Jackson et al. 1998). These 
results suggest that the glycosylation of the recombinant ZP protein is essential to 
enhance the immunogenicity of self-ZP antigen and that the recombinant virus delivery 
system provides a prospective way to overcome self-tolerance and achieve a high-level 
of infertility. 
1.6.2 The mechanism of infertility following ZP immunisation 
1.6.2.1 Antibodies blockingfertilisation 
After immunisation with ZP, antibodies to ZP proteins could play an important role 
in blocking fertilisation by preventing sperm binding to oocytes. Antibodies to hamster 
ZP inhibited sperm attaching to and penetrating the zona pellucida (Shivers et al. 1972) 
and monoclonal antibodies against recombinant bonnet monkey ZPB inhibited the 
binding of human spermatozoa to human ZP in a hemizona assay (Govind et al. 2000), 
suggesting that antibody to certain epitopes of ZP can effectively prevent spermatozoa 
from interacting with ZP and so block fertilisation. 
In theory then, antibodies to ZP in the oviduct can bind to ovulated oocytes and 
prevent fertilisation. However, in female rabbits immunised with sperm antigens, the 
antibody levels in the oviduct were not high (section 1.3.2). So how effective antibodies 
in the oviduct will be in blocking fertilisation is unclear. On the other hand, ZP 
antibodies in the ovary may be much more effective in binding to the oocyte and 
preventing sperm fertilising the eggs. Specific antibodies are able to bind to the surfaces 
of oocytes in ovarian follicles following immunisation with ZP antigens in mice (Tung 
et al. 1994; Jackson et al. 1998) and rabbits (Kerr, et al. 1999). Furthermore, passively 
injected 1251 labeled specific IgG to hamster ovarian antigens persisted in the ovary at a 
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high level and induced infertility but was not detectable in other tissues (Y anagimachi et 
al. 1976). These results collectively suggest that antibodies in the ovarian follicles could 
play a more important role than antibodies in oviductal fluids in blocking fertilisation. 
However, antibodies in the oviduct and the uterus could also play an important role in 
blocking embryo implantation. 
1.6.2.2 Follicle loss, ovarian dysfunction and infertility 
Immunisation with ZP antigens often induces follicle loss and ovarian dysfunction 
(Sacco, 1987; Henderson et al. 1988; Skinner et al. 1996). In the rabbit (Wood et al. 
1981; Skinner et al. 1984; Jones et al. 1992; Kerr et al. 1999) and some other species, 
follicle disruption and ovarian dysfunction were closely related to infertility (mice, 
Jackson et al. 1998; marmoset monkey, Aitken et al. 1996; bonnet monkeys, Bamezai et 
al. 1986, and hamster, Hasegawa et al. 1992). However, oophoritis was not correlated to 
the infertility rate in mice and a specific T cell response to mouse ZPC was compatible 
with normal ovarian function (Bagavant et al. 1999). Thus, the relationship between 
follicle loss, ovarian dysfunction and infertility is still unclear. 
The factors responsible for the ovarian pathology following ZP immunisation are 
still not fully understood. Studies in rabbits showed that antibody could play a principal 
role in follicle loss or ovarian pathology (Skinner et al. 1984; Kerr et al. 1999). 
Antibody binding to ZP of oocytes in follicles was suggested as the main cause of 
follicle disruption and ovarian dysfunction by interfering with the oocyte or follicle 
development (Skinner et al. 1984). However, how antibody could do this remains 
unclear. On the other hand, T cell responses could also play an important role in ovarian 
pathology. Immunisation of an inbred mouse strain with a mouse ZP3 peptide induced a 
specific CD4+ T cell response and these CD4+ cells alone could cause oophoritis, as 
demonstrated by a passive transfer experiment in which CD4+ but not CDS+ T cells 
were able to induce oophoritis in the recipients (Tung and Teuscher, 1995; Tung et al. 
2001; Garza, et al. 1998). This result suggested that under some circumstances T cell 
responses might play a role in ovarian pathology following ZP immunisation. However, 
the oophoritis was transient and, following recovery, could not be reinduced by 
boosting. 
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Immunocontraception that induces ovanan pathology is not suitable for human 
application and efforts in human immunocontraception are concentrated on finding B 
cell epitopes that could induce infertility without ovarian pathology (Govind et al. 
2000). However, for control of a pest animal such as the European rabbit in Australia, 
infertility resulting from ovarian pathology following ZP immunisation may be an 
acceptable and long-lasting approach. 
1.6.3 Antibody titers in ovarian follicles: the ovary could be more 
accessible to serum antibody 
Clearly, if a ZP antigen is to be vectored for immunocontraception for rabbits, 
induction of a high level immune response in the ovary or oviduct is important. Whether 
recombinant myxoma virus can deliver a strong immune response in the ovary has not 
been determined. However, it seems probable that the ovary is more accessible to serum 
antibody than the mucosa! compartment of the reproductive tract. Early studies in 
rabbits showed that the -IgG concentration (Symons and Herbert, 1971) and the specific 
IgG titer to sperm antigen LDH-C4 (Kille and Goldberg, 1979) in serum was 
comparable to that in ovarian follicle fluids. In humans, anti-sperm IgG and IgA levels 
in follicular fluids were also similar to those in serum although IgM levels were lower 
(Clarke et al. 1984, Kay et al. 1985). Antibody levels in bovine ovarian follicle fluids 
were also shown to parallel those in serum (Whitemore and Archbald, 1977). In support 
of the idea that antibody titres in serum are important to ovarian pathology and 
infertility, studies in the rabbit showed that infertility rates were correlated with serum 
antibody titers (Skinner et al. 1984; Kerr et al. 1999). Serum antibody levels also 
correlated with ovarian dysfunction in squirrel monkeys (Sacco, 1987), follicle 
disruption and infertility in mice (Jackson et al. 1998) and infertility in bonnet monkeys 
(Bamezai, 1986). However, whether antibody titers in the follicles or reproductive tract 
are the underlying cause of infertility has not been determined. 
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1. 7 The aim of this study 
An effective immunocontraceptive vaccine for European rabbit population control 
needs both effective vectors and effective immunocontraceptive antigens. Myxoma 
virus has been chosen as a potential viral vector because of its species-specificity, well-
known genetic background and transmission characteristics (Tyndale-Biscoe, 1994; 
Holland and Jackson. 1994; Kerr and Jackson, 1995). For the viral vector to be 
successful, it is vital that it can deliver a sufficiently strong immune response in the 
appropriate tissues ( the mucosa! compartment of the reproductive tract or the ovarian 
follicular fluid) so that fertilisation is blocked. An investigation of whether the 
recombinant myxoma virus could achieve this is a crucial step for developing viral 
vectored immunocontraception in rabbits. The selection of the immunocontraceptive 
antigen is also dependent on the nature of the immune response induced by the vector. If 
the virus can induce a strong antibody response in the mucosa! part of the female 
reproductive tract then sperm antigens can potentially be used for 
immunocontraception. However, if the virus is not able to do this, then induction of a 
strong immune response in the ovarian follicles could be more important and this will 
require an oocyte or follicular antigen. In this study, the following investigations of the 
immune response in the female rabbits are described. 
1). An examination of the distribution of immune cells in the female rabbit reproductive 
tract and response to ovulation. 
2). A determination of the antibody response in the rabbit reproductive tract following 
immunisations by intradermal, intranasal and intra-vaginal routes with a recombinant 
myxoma virus expressing the model HA antigen. 
3). An examination of the mechanism of the immune response in the rabbit ovary 
following immunisation with myxoma virus expressing the rabbit ZP B glycoprotein. 
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2.1 Biochemical reagents and solutions 
2.1.1 Recombinant myxoma viruses and antigens 
2.1.1.1 Recombinant myxoma viruses 
Recombinant myxoma virus expressing influenza haemagglutinin (HA) (MV-HA) 
was described previously (Kerr and Jackso~ 1995). The recombinant virus is derived 
from the Uriarra strain of myxoma virus and is extremely attenuated causing minimal 
disease in immunised rabbits. The HA cDNA is expressed under the control of a 
vaccinia virus late promoter, P 11. 
Recombinant myxoma virus encoding rabbit ~ona Qellucida protein B (MV-ZPB) 
was described previously (Kerr et al. 1999). The RC55 cDNA (rabbit zona pellucida 
protein B gene) was cloned into the exact same site as HA. Similarly to the MV-HA 
recombinant virus the MV-ZPB virus is highly attenuated. 
2.1.1.2 HA and MV antigens 
A preparation of whole influenza virus (strain A/PR/8/34; supplied by Dr. Sonja 
Best, CSIRO Wildlife and Ecology) was used as antigen to measure specific IgG, IgM, 
and IgA antibody response to the HA antigen. This preparation was also used for intra-
vaginal boosting and as the antigen for immuno-histochemical analysis of frozen tissue 
sections to quantify the number of cells producing anti-HA antibody. 
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A preparation of whole myxoma virus of Lausanne strain (gift from Louise Silver, 
CSIRO Wildlife and Ecology) concentrated from cell culture was used as antigen in 
ELISA to measure specific antibodies against myxoma virus. 
2.1.1.3 Recombinant rabbit ZPB (RC55) protein 
Rabbit ZPB protein was expressed in rabbit RK13 cells infected with vaccinia ZPB 
(Kerr et al. 1999). The ZPB protein was purified by affinity column chromatography 
using monoclonal antibody IG7El 1 (supplied by Nigel French and Hannah Clarke, 
CSIRO Wildlife and Ecology). 
2.1.2 Antibodies and antibody conjugates 
The monoclonal antibodies, polyclonal antibodies and antibody conjugates used in 
this study are listed in the tables below (Table2-1, Table 2-2, and Table 2-3). Their 
specificities and manufacturers or references are also listed in the tables. Antibodies 
were aliquoted and stored according to the supplier's instruction. 
Table 2- 1. Monoclonal antibodies used in this study 
Monoclonal antibody Specificity Manufacturer or reference 
Anti-MY Myxoma virus Fountain et al. 1997 
( clone 3B6E4) 
Anti-rabbit Ig µ chain B.cells SeroTec 
Anti-rabbit CD4 T cell subset SeroTec 
Anti-rabbit KEN-5 T cells Sero Tee, (Kotani et al. 
1993; Mage, 1998) 
Anti-rabbit CD43 Leukosialin, mainly T SeroTec, (Jackson et al. 
cells, weak monocytes 1983, Wilkinson et al. 1992) 
Anti-rabbit CD45 Pan leucocyte SeroTec, (Jackson et al. 
1983) 
Anti-rabbit MHC class II MHC IIR-DQ SeroTec, (Lobel et al. 1984) 
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Table 2- 2. Polyclonal antibodies used in this study 
Polyclonal antibodies Specificity Manufacturer 
Goat anti-rabbit IgA lg a chain Fe fragment Nordic 
specific 
Goat anti~rabbit IgG lg y chain specific Nordic 
Goat anti-rabbit IgM lg µ chain Fe fragment Nordic 
specific 
Rat anti-HA sera Influenza virus Supplied by Dr. Sonja Best 
Sheep anti-mouse IgG Mouse IgG Boehringer Mannheim 
sera 
Table 2- 3. Antibody conjugates used in this study 
Conjugates Specificity Manufacturer 
Goat anti-rabbit IgA lg a chain F c fragment Nordic 
conjugated with HRPa specific 
Goat anti-rabbit IgG lg y chain specific Southern Biotechnology 
conjugated with HRP Associates, Inc. 
Goat anti-rabbit lgM lg µ chain F c fragment Nordic 
conjugated with HRP specific 
Goat anti-rat lgG conjugated Rat IgG (mouse Silenus 
with FlTCb adsorbed) 
Goat anti-rat lgG conjugated Rat IgG (H+L) Molecular Pro bes 
with Texas Red 
Rabbit anti-goat lg conjugated Goat lg Nordic 
with FITC 
Sheep anti-mouse IgG Mouse IgG Silenus 
conjugated with FITC 
Sheep anti-mouse IgG Mouse IgG Silenus 
conjugated with rhodamine 
Sheep anti-rat IgG conjugated Rat IgG Silenus 
with FITC 
a: HRP: horse radish peroxidase; b: FITC: fluorescein isothiocyanate. 
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These antibodies or antibody conjugates were used to measure specific antibodies to 
HA, MV and ZPB or total immunoglobulins in serum and reproductive tract fluid 
samples. They were also used to label immunocyte surface markers in frozen sections of 
the reproductive tract tissues and ovary, and identify rabbit IgG, IgA and IgM in ovary. 
2.1.3 Chemicals and solutions 
Chemicals used in this study were purchased from Sigma or BDH Merck Pty, 
Australia and were all at or above analytic grade. For RNA work, freshly purchased 
chemicals or specialised RNA chemicals were purchased and stored for this purpose. 
All aqueous solutions were prepared in de-ionised or Milli-Q water. The commonly 
used solutions in this study and their components are listed below. 
2.1.3.1 ELISA solutions: 
PBS stock: 136 mM NaCl 
2.68 mMKCl 
Carbonate coating buffer: 
Colour reaction buffer: 
8.09 mM Na2HPO4· 
2.93 mM KH2PO4 
pH=7 .2, prepared as a 1 Ox concentrate, autoclaved 
and stored at room temperature. 1 x PBS was used 
as washing or coating buffer. 
14.1 mMNa2C0J 
34.9 mM NaHCO3 
Stored at 4°C 
18 mM ABTS (2, 2, . b. ..., -azino- 1s-.J-
ethylbenzthiazoline-6-sulfonic acid, Sigma), 0.5 M 
citric acid, 0.6 M Na2HPO4, and 21 mM H2O2 
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2.1.3.2 Tissue or section fixation and slide preparation 
Bouin's fixation solution: 
Formalin-calcium: 
Poly-L-lysine solution: 
0.9% picric acid (w/v) 
9% formaldehyde ( v /v) 
5% acetic acid (v/v) 
0.1 M CaCh 
1.33 M formaldehyde 
stored at 4 °C 
100 mg poly-L-lysine (hydro bromide, Sigma) 
dissolved in 10 ml H20 (w/v), stored in 2 ml 
aliquots at -20°C. Slide coating solution: 2 ml 
diluted into 20 ml H20. 
2.1.3.3 Plasmid DNA preparation and sub-cloning solutions: 
LB medium: 
Sx TBE: 
Solution I: 
1 % tryptone (w/v) 
0.5% yeast extract (w/v) 
0.17 MNaCl 
pH=7.2-7.4, autoclaved and stored at 4°C 
0.45 M Tris 
0.44 M H3B03 (boric acid) 
0.1 M EDTA 
pH=8.0 
50 mM D-glucose 
25 mM Tris 
l0mMEDTA 
pH=8.0 
Autoclaved and stored at room temperature 
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Solution III: 
Hydrolysis carbonate buffer: 
0.2MNaOH 
1 % SDS (Sodium dodecyl sulphate) 
Fresh made for use 
3 M potassium acetate 
11.5 % acetic acid 
Store at 4°C 
60 mMNa2CO3 
40 mM Na2HCO3 
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pH = 10.2, in diethyl pyrocarbonate (DEPC) 
treated H2O 
1 Ox Hydrolysis neutralisation buffer: 2 M sodium acetate 
10% acetic acid 
pH=6.0, in DEPC H2O 
20x SSC: 
TE buffer 
T 4 DNA ligase diluent: 
2.1. 3. 4 In situ hybridisation 
50x Denhardt's: 
150 mMNaCl 
15mM sodium citrate 
10 mM Tris-HCI, pH=8.0 
1 mMEDTA 
20 mM Tris-HCI, pH=7.6 
60 mM KCl 
5 mM DTT (1,4-dithiothreitol) 
0.05% BSA (Bovine serum albumin; w/v) 
50% glycerol (v/v) 
1 % ficoll (v/v) 
1 % polyvinylpyrrolidone (PVP, w/v) 
.,, .,, 
.).) 
Buffer 1: 
Buffer 2: 
Buffer 3: 
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1% BSA (w/v) 
filtered and aliquoted 50 ml, stored at -20°C 
0 .1 M maleic acid 
0.15 M NaCl 
pH=7.5 with NaOH 
autoclaved and stored at room temperature 
10% blocking reagent (RNA Labelling and 
Detection Kit, Boehringer Mannheim) in Buffer 1, 
autoclaved and aliquoted for storage in a freezer. 
100 mM Tris 
100 mMNaCl 
5 mMMgCl2 
pH=9.5 
2.2 Animal treatment and sampling 
2.2.1 Animal housing 
Female New Zealand White rabbits aged 7-13 months old were used in this study. 
The animals were bred and housed in the animal house at CSIRO Wildlife and Ecology, 
Australia. Animal immunisations and other treatments were approved by the CSIRO 
Wildlife and Ecology animal ethics committee under NHMRC/CSIRO guidelines. 
Animal experiments related to recombinant myxoma virus were carried out in the PC2 
facility within the animal house. 
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2.2.2 Immunisation and induction of ovulation 
2.2.2.1 Immunisations 
Intra-dermal immunisation with recombinant viruses and injections of rabbit ZPB 
protein for boosting were carried out by injection into the shaved skin of the rear leg. A 
total volume of 0.15 ml containing lxl06 plaque-forming units (pfu) of myxoma 
recombinant virus MV-HA (Kerr and Jackson, 1995) or lxl03 pfu of MV-ZPB (Kerr et 
al. 1999) was administered to each rabbit. For ZPB boosting, 100 mg purified 
recombinant ZPB protein in Freund's incomplete adjuvant (Sigma) in a total volume of 
0.2 ml was similarly injected subcutaneously in two or three spots (Kerr et al. 1999). 
Intra-nasal and intra-vaginal immunisations and intra-vaginal boosts were 
administered after the rabbits were anaesthetised by intra-muscular injection of Xylaze 
(5 mg xylazine/kg, Parnell Laboratory Pty Ltd, NSW Australia) followed by 
intravenous injection of Zoletil-100 (15 mg/kg, containing Tiletamine and Zolazepam at 
the concentration of 100 mg/ml, Virbac Pty, Ltd, Peakhurst, NSW Australia) 5 minutes 
later. At these doses animals remained anaesthetised for 1-2 hours. For intra-nasal 
immunisation, a total volume of 0.25 ml containing lxl06 pfu MV-HA was given in 
small drops one by one into one nostril of the nose by pipette. For intra-vaginal 
immunization with MV-HA and intra-vaginal boost with influenza virus (HA), the 
rabbit was put on its side, a soft plastic transfer pipette (Sarstedt, Germany) containing 
the volume of virus was gently inserted into the vagina. When the tip reached the 
cervix, the dose was expelled. For immunisation, lxl06 pfu MV-HA in a total volume 
of 0.25 ml was administrated. For intra-vaginal boost, 5000 influenza virus HA units 
/rabbit (diluted from a stock of l.6x 108 HA units/ml) in incomplete Freund's adjuvant 
was administered. 
2.2.2.2 Induction of ovulation and super-ovulation 
Ovulation was induced in rabbits by intravenous injection of 150 international units 
(i.u) human Chorionic Gonadotrophin (hCG, Chorulon ® Chorionic Gonadotrophin, 
Intervet Pty, Ltd NSW, Australia) 12 hours before sampling (Otsuki et al. 1990). Super-
ovulation was induced by intra-muscular injection of 150 i.u/rabbit of PMSG 
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(PREGNECOL Injection Serum Gonadotrophin, Heriot, Agvet Pty, Ltd, Rowville Vic, 
Australia) 72 hours before sampling and intravenous injection of 125 i.u/rabbit hCG 12 
hours before sampling. 
2.2.3 Sample collection and preparation 
2.2.3.1 Serum, reproductive tract fluids and ovarian follicular fluids 
Blood samples were taken from a marginal ear-vein and allowed to clot at room 
temperature for 0.5-1 hour for preparation of serum. Serum was separated by 
centrifuging in a microcentrifuge at 15000 rpm for 5 minutes and was stored at -20°C 
for analysis. 
Reproductive tract fluids were collected by two methods, micropuncture and 
flushing. For collecting free fluids, the rabbits were anaesthetised with pentobarbitone 
(Parnell Laboratory Pty Ltd, NSW Australia) and samples of the fluids in the lumen of 
oviduct, uterus and vagina were collected by Dr. Russell Jones (The University of 
Newcastle, Australia) using micropuncture with capillary tubes as previously described 
(Sujarit et al. 1990). For collection of flushing samples, rabbits were killed and the 
whole female reproductive tract was isolated. The oviduct and uterus from one side of 
the reproductive tract as well as most of the vagina were each flushed with 1 ml 
sterilised PBS and the flushing fluids were collected and stored at -20°C until analysis . 
Vaginal and nasal washings were collected by flushing the vagina with 1 ml 
sterilised PBS and flushing the nasal cavity with 0.5 ml PBS after the rabbits were 
anaesthetised. 
Ovarian follicular fluids were collected after induction of super-ovulation ( section 
2.2.2.2). The rabbits were killed and the ovaries were isolated. The follicular fluids in 
some pre-ovulatory follicles could be seen clearly with the naked eye and were 
collected directly by puncturing the follicles with capillary tubes. For some smaller 
follicles, the fluids were collected under a stereo microscope (SZ-PT, Olympus, Japan) 
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with a capillary tube and all collections from each rabbit were pooled. For each ovary, 
20-50 µl fluid could be collected. Heparin (5 µl of 2000 u/ml solution) was added to 
each fluid sample to prevent clotting. 
2.2.3.2 Reproductive tract tissue and other tissue samples 
To examine cellular responses and histological changes in the reproductive tract, 
tissue samples were collected for preparation of frozen and paraffin-embedded sections. 
Oviductal and uterine tissues were collected from the non-flushed side of the tract. 
Oviduct at the middle of ampulla and uterus at the middle of uterine body were 
collected. Whole cervix and a part of vagina 1 cm from the cervical conjunction were 
collected. Whole ovaries were collected; left side ovaries for frozen sections and right 
side ovaries for paraffin embedded sections. A part of the popliteal lymph node from 
the injected side of intra-dermally immunised rabbits and uninfected control rabbits was 
also collected for preparation of frozen sections as positive controls. 
2.2.3.3 Preparation of frozen sections 
Immediately after collection, tissue samples were embedded in Tissue-Tek, O.C.T. 
Compound (Miles Inc. Elkhart, USA) in specimen molds (Cryomold 15mm+ 15mm 
+5mm, Miles Inc. Elkhart, USA) for fixation and freezing at -70°C. When sectioning, 
the tissue was trimmed on a cryostat (Lipshaw Company, USA) until good cross 
sections could be cut. Slides used for frozen sections were pre-coated with poly-L-
lysine solution (section 2.1.3.2). Serial sections were then collected onto slides, which 
were labeled serially. Immediately after sectioning the sections were fixed in formalin-
calcium (section 2.1.3.2) and acetone-chloroform mixture (1: 1 volume) for 5 minutes 
each. The sections were washed 3 times in PBS, air dried in a fume hood, and stored at 
-70°C until staining. 
2.2.3.4 Paraffin embedded section 
Tissue samples were directly transferred into 4 ml Bouin's fixation solution (section 
2.1.3 .2) for about 4 hours. The Bouin' s fixation solution was then replaced with 4 ml 
70% alcohol, which was changed several times. Paraffin embedded sections were 
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prepared by the Department of Histology of John Curtin School of Medical Research 
(The Australian National University, Canberra, Australia) and stained with 
haematoxylin and eosin (H&E). 
2.3 Antibody and immunoglobulin measurement 
2.3.1 Antibody measurement 
ELISA was used to measure specific IgG, IgM and IgA to HA and myxoma virus. 
Antigen, either influenza virus or myxoma virus, was diluted in PBS (1 :5000 for HA 
antigen; 1 :2000 for myxoma virus antigen) and 50 µl antigen solution was transferred to 
each well of 96-well micro-plates (Greiner, Labortechnik) for coating at 37°C for 3 
hours. The plates were washed 3 times at room temperature and blocked at 4°C 
overnight with 3 % skim milk. Serum or fluid samples thawed at 4 °C were centrifuged 
in a microcentrifuge at 13500 rpm for 5 minutes and then serially diluted in PBS in a 2~ 
fold series. For serum, dilutions started at 1 :50 and for reproductive tract fluid samples 
dilutions started at 1 :5. For specific IgA measurement, the initial dilution was 1 :3. The 
diluted sample (50 µl) was added to duplicate wells. The plates were incubated at 37°C 
for 2 hours for antibody binding followed by washing 4 times with 0.1 % (v/v) Tween-
20 in PBS (PBST). Antibody binding was detected by adding 50 µl of the second 
antibody conjugate, sheep anti-rabbit IgG conjugated with HRP (1 :5000 dilution) or 
goat anti-rabbit IgA or IgM conjugated with HRP (1: 1000 dilution). After I-hour 
incubation and 6 washes with PBST, 100 µl ABTS solution (section 2.1.3 .1) was added 
to each well for the colour reaction. The plates were read at 405 nm on a Bio-Rad 
Micro-plate Reader (Bio-Rad, Model 3550). The antibody titre was determined by the 
highest dilution that gave an absorbence value more than 0.1 above the normal serum 
control (absorbence values for blank wells and negative controls were usually 0.005~ 
0.02). Positive serum from a rabbit infected with recombinant virus MV-HA and 
negative serum from a normal uninfected rabbit (supplied by Dr. Sonja Best) were used 
as positive and negative controls (1: 100 dilution). Blank controls were wells without 
antigen. 
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ELISA was also used for measuring antibody titers to rabbit ZPB as previously 
described (Kerr et al. 1999). Briefly, plates were coated with purified recombinant 
rabbit ZPB protein (2 µg/well) with carbonate coating buffer (section 2.1.3 .1 ). The 
plates were then washed and blocked with 3% skim milk/PBS. Serum samples or 
ovarian follicular fluids were serially diluted and added to the wells as described above. 
The plate washings, antibody conjugate application, colour reaction and plate reading 
were precisely as described above. 
2.3.2 Total immunoglobulin measurement 
2.3.2.1 IgGandlgM 
Direct ELISA was used to measure total IgG and IgM in serum and reproductive 
tract fluids. The samples were diluted in PBS in a 2-fold series as described in section 
2.3 .1 and 50 µl of each dilution was transferred to a micro-plate for absorption at 3 7°C 
for 2 hours and then at 4 °C overnight. The plates were washed and blocked as in section 
2.3 .1. Goat anti-rabbit IgG or IgM conjugated with HRP was diluted in 1 % skim milk 
(anti-IgG 1:4000, anti-IgM 1:1000) and 50 µl was added to each well for incubation at 
3 7°C for 1 hour. The colour reaction and plate reading were as in section 2.3 .1 . 
Negative control was 3% BSA. 
2.3.2.2 Total JgA 
Immuno-diffusion was used to measure total IgA in serum and reproductive fluids. 
Fifteen ml of 1 % agarose was poured into a 15 cm Petri dish. Rosette holes (six holes 
surrounding one central hole) were punched after the agarose was set. The central hole 
was filled with 20 µl goat-anti-rabbit IgA antibody and surrounding holes were filled 
with 20 µl samples that were diluted in PBS in a 2 fold series starting at 1 :2. The dish 
was incubated at 3 7°C for 24 hours after which precipitate bands were measured. 
Positive controls were rabbit serum or rabbit IgA or IgG standards (Sigma). Negative 
control was 3% BSA. The titer was determined by the highest dilution giving a clear 
precipitate band. 
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2.4 Immunofluorescence 
2.4.1 Indirect immunofluorescence 
Indirect immunofluorescence was used as a general method to label rabbit CD45, 
CD43, KEN-5, CD4, immunoglobulin µ-chain, MHC class II positive cells and IgG and 
IgA-containing cells in frozen sections of reproductive tract tissues, small intestine 
tissue and lymph nodes. This method was also used to localise rabbit IgG, IgM and IgA 
in frozen sections of the ovary. 
The frozen sections prepared and stored at -70°C (section 2.2.3.3) were air dried at 
room temperature for 1 hour. The sections were then blocked with 200 µl 3% BSA/PBS 
for 1 hour at room temperature in a humidity box. After 3 washes with PBS, 50 µl of 
primary antibodies diluted in 1 % BSA/PBS (1: 10 dilution for monoclonal antibodies 
and 1 :50 dilution for polyclonal antibodies) were applied to each section for an 
incubation of two hours at 3 7°C in a humidity box. After a further 4 washes with PBS, 
the second antibodies, sheep anti-mouse IgG (for monoclonal antibody as primary 
antibody) or rabbit anti-goat lg (for polyclonal antibody as primary antibody) 
conjugated with FITC (Table 2-3) were diluted 1 :50 in 1 % BSA/PBS and 50 µl was 
applied to each section. The negative control was 1: 100 mouse ascites fluid (MAP) or 
1: 100 normal goat sera (Silenus ). Positive controls were the frozen sections from 
popliteal lymph nodes or small intestine (for IgG and IgA containing cells). The 
sections were incubated at 3 7°C for one hour in a humidity box covered with aluminium 
foil to exclude light; washed 4 times with PBS and mounted with anti-fade solution 
(Molecular Probe Inc. USA). The sections were kept at 4°C covered with foil until 
confocal microscopy (Bio-Rad, MRC 1000). 
2.4.2 Immunofluorescence for detection of HA specific antibody 
secreting cells 
Frozen tissue sections were air dried and blocked as in 2.4.1. After washing in PBS, 
the sections were incubated with influenza virus (1 :2000 dilution of a stock of l .6x 108 
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HA unit/ml) for 1 hour at 3 7°C. The sections were washed 4 times in PBS and incubated 
with rat anti-HA antibody (kindly supplied by Dr. Sonja Best) at 37°C for 2 hours. After 
an additional 4 washes in PBS the sections were incubated with rabbit anti-rat IgG 
conjugated with FITC (Table 2-3) at 37°C for 1 hour in a humidity box in the dark. The 
sections were then washed in PBS and mounted with anti-fade solution as described 
above. Each slide was viewed by confocal microscopy. Frozen sections of popliteal 
lymph nodes draining the inoculation side of intradermally immunised rabbits were 
used as positive controls. Frozen sections of reproductive tract from uninfected controls 
were used as negative controls. Other controls included omitting influenza virus antigen 
or replacing primary antibody with normal rat serum. 
2.4.3 Double immunofluorescence 
Double immunofluorescence was used to label two · cell surface markers on frozen 
sections. This method was used to double-label rabbit KEN-5 and MHC class II and 
MHC class II and myxoma virus positive cells. Two antibody conjugates, one with 
FITC (green) and another with rhodamine (red) were used. 
The sections were air dried and blocked as in 2.4.1. After 3 washes in PBS, 50 µl of 
the first monoclonal antibody diluted 1: 10 in 1 % BSA/PBS ( e.g to rabbit KEN-5 or 
MHC class II) was applied to each section. The sections were incubated at 37°C for 1 
hour in a humidity box. After 4 washes in PBS, 50µ1 of the first fluorescent conjugate, 
sheep anti-mouse IgG conjugated with FITC (green, Table 2-3), diluted in 1 %BSA/PBS 
( 1 :25), was applied to each section. The sections were incubated at 3 7°C for 45 minutes 
in a humidity box in the dark. After another 4 washes in PBS (kept in the dark as much 
as possible), any unbound mouse IgG was blocked by incubation with 100 µl 1 :50 
diluted (in 1 % BSA/PBS) sheep anti-mouse IgG serum (Table 2-2) at 37°C for 1 hour; 
followed by a further 4 washes in PBS (kept in dark). The second monoclonal antibody 
( eg. to rabbit MHC class II or myxoma virus) was diluted 1: 10 in 1 % BSA/PBS and 50 
µl was applied to each section. The sections were then incubated at 3 7°C for 1 hour in a 
humidity box in the dark. After a further 4 washes in PBS (kept in the dark), 50µ1 of the 
second fluorescent conjugate, sheep anti-mouse IgG conjugated with rhodamine (red, 
Table 2-3) diluted 1: 1 O in 1 % BSA/PBS, was applied to each section. After incubation 
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at 3 7°C for 45 minutes in a humidity box in the dark, the sections were then washed in 
PBS 4 times, followed by anti-fade treatment as in 2.4.1 . 
2.4.4 Cell counting using confocal microscopy 
The immunofluorescently stained and mounted slides were viewed by confocal 
microscopy. Images were captured electronically. Constant parameters were used while 
counting the cells, e.g. zoom 2.0, iris 4.0, gain 1200, laser beam 30%, back-level 5, and 
enhancer 0. Three representative areas in each section were counted. The histogram 
function of the management software (Bio-Rad) was used to outline the areas to be 
counted and calculate the area. 
The areas for cell counting of each region of the reproductive tract was defined as: 
oviduct: whole villi, including epithelium and lamina! propria; uterus: epithelium and 
the first half of the endometrium; cervix: similar to uterus; vagina: whole mucosa area, 
including epithelium and lamina propria. 
2.5 Preparation of sense and anti-sense RNA probes 
RNA probes of rabbit IL-2 were prepared for detection of mRNA expression in 
tissue samples. Sense and anti-sense RNA probes were prepared. Anti-sense probes 
would hybridise with the RNA of interest. Sense probes were used as control probes 
that would not hybridise with the RNA of interest. 
2.5.1 Sub-cloning IL-2 DNA 
The purpose of sub-cloning was to insert the IL-2 cDNA fragment into two plasmids 
under the control of the same promoter but in opposite orientations. This allows 
transcription from the same promoter and hence synthesis of equal amounts of sense 
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and anti-sense RNA probes. Full-length rabbit IL-2 cDNA was sub-cloned into pGEM-
T (Promega) under the control of the T7 promoter or into Bluescript SK+/- (Promega) 
also under the control of the T7 promoter but in the opposite orientation. 
2.5.1.1 Mini-preparations of plasmid DNA 
Mini-preparations of plasmid DNA were made as described by Sambrook et al. 
(1989). Briefly, a single colony of TGl E. coli that contained pGEM-T-IL-2 or 
BluescriptSK +/- was inoculated into 2 ml LB medium (section 2.1.3.4) and cultured at 
3 7°C overnight on a shaker. The cells were transferred into a 1.5 ml tube and pelleted in 
a micro-centrifuge at 13500 rpm for 30 seconds. The cell pellet was resuspended in 100 
µl ice-cold Solution I (section 2.1.3.4) by vortexing and the cells were lysed by adding 
200 µl freshly made Solution II (section 2.1.3.4) with gentle mixing. After 5 minutes 
incubation on ice, 150 µl of ice-cold solution III (section 2.1.3.4) was added and the 
tube inverted twice to mix followed by incubation in an ice-bath for 5 minutes and 
centrifuging at 13500 rpm in a micro-centrifuge for 5 minutes. The supernatant was 
transferred into a new tube and an equal volume of phenol: chloroform (1: 1, v/v) was 
added and vortexed. The aqueous phase was separated by centrifuging at 13500 rpm for 
2 minutes and transferred to another tube. Two volumes of 100% ethanol were added 
and mixed and the tube was kept at room temperature for 2 minutes and then on ice for 
5 minutes. Plasmid DNA was precipitated by centrifuging at 13500 rpm for 15 minutes. 
The DNA pellet was washed with 1 ml 70% ethanol at room temperature and air dried 
for about 15 minutes and then was resuspended in 50 µl TE buffer (pH=8.0) containing 
20 µg/ml RNase A (DNase free RNase, Promega). The concentration of DNA was 
determined by reading the OD value at 260 nm on a spectrophotometer (Varian). 
2.5.1.2 Restriction enzyme digestion for ligation 
Restriction digestions were conducted to linearize the BluescriptSK +/- plasmid and 
cut IL-2 DNA fragment from the pGEM-T for ligation. Two restriction enzymes, Sac II 
and Sal I were used for both digestion reactions and the reactions were set up in a 30 µl 
volume in 1.5 ml tubes. 
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Plasmid DNA: 
H2O 
lOx Buffer 
Sac II 
4 µl 
22 µl 
3 µl 
1 µl (2 u) 
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The reactions were incubated in a 3 7°C water bath for three hours. A volume of 5 µl 
was taken for agarose gel electrophoresis. The reactions were continued by adding 2.5 
µl 1 Ox Buffer and 1 µl Sal I (2 u) to the tubes followed by incubation at 37°C for 
another 3 hours. A mini agarose gel (1 % in TBE Buffer) was used to check linearization 
of the plasmid and also for isolating the IL-2 DNA fragment from the agarose. 
2. 5.1. 3 · Purification of DNA fragment 
After agarose gel electrophoresis, the DNA bands of the correct size for the rabbit 
IL-2 DNA and the linearised BluescriptSK +/- plasmid were excised from the gel under 
UV light. The gel slices were weighed and Nucleotrap (Promega) was used to purify the 
DNA fragments from agarose following the protocol provided by the manufacturer. 
2.5.1.4 Ligation reaction and transformation 
A ligation reaction was set up to ligate the IL-2 cDNA fragment and linearized 
BluescriptSK +/- plasmid which had been digested with the same restriction enzymes. 
The reaction was set up as follows in a total volume of 20 µl. 
Plasmid DNA 3 µl 
Rabbit IL-2 cDNA fragment 3 µl 
H2O 11 µl 
Ligation buffer (1 Ox) 
T4 DNA ligase 
2 µl 
1 µl ( diluted as 2 u/µl) 
The reaction was incubated in a l 6°C water bath for 4 hours. 
After the ligation reaction, the products were transformed into E. coli strain TG 1 
competent cells (supplied by Shanshan Wu, Wildlife and Ecology, CSIRO). A volume 
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of 0.9 ml ice-cold 0.1 M CaCl2 was added to 0.1 ml competent cells. After 2 minutes on 
ice, 100 µl of the competent cells were transferred into another pre-chilled 1.5 ml tube 
and 5 µl ligation reaction mixture was added. The tube was kept on ice for 25 minutes. 
During this period, the tube was swirled several times. The cells were then heat-shocked 
by incubation at 43.5°C in a water bath for 45 seconds and then kept on ice for 2 
minutes. The cells were pelleted in a microcentrifuge for 30 seconds and resuspended in 
100 µl LB medium. The cells were spread on a LB-agar (1.5% agar in LB medium) 
plate supplemented with ampicillin (50 µg/ml). Positive colonies were chosen, based on 
ampicillin resistance conferred by the Bluescript plasmid, and cultured for mini-
preparation. The correct insertions of IL-2 DNA fragments were confirmed by 
restriction enzyme digestion and agarose gel electrophoresis. 
2.5.2 Synthesising and labelling RNA probes 
2.5.2.1 Preparation of sense and anti-sense DNA templates 
To synthesise and label specific sense and anti-sense RNA probes, a purified DNA 
template is necessary. Plasmid DNA Preparation QIA gene Kit (Promega) was used to 
prepare sense and anti-sense DNA templates. Single colonies that contained sense and 
anti-sense plasmids of IL-2 were inoculated into 30 ml LB medium supplemented with 
50 µg/ml ampicillin. The cells were cultured at 37°C overnight in a shaker and then 
pelleted by centrifuging at 5000 rpm (rotor AJ-20, Beckman) for 30 minutes. The 
manufacturer's protocol was followed to purify plasmid DNA. At the final step the 
DNA pellet was air dried and plasmid DNA was resuspended in 0.5 ml TE (pH=8.0) 
and aliquoted in small volumes for further use. 
For preparation of sense and anti-sense IL-2 DNA templates, the IL-
2/BluescriptSK +/- plasmid was digested with Sac II (sense templates) and the IL-
2/pGEM-T plasmid was digested with Sal I (anti-sense templates) that allowed 
transcription to begin with the T7 promoter and stop at the end of the IL-2 DNA 
fragment. The digestion reactions were set up as in section 2.5 .1.2 with 1 µg of plasmid 
DNA and 1 µl of the restriction enzyme (2-4 units) in a total volume of 20 µl in 1.5 ml 
tubes. The tubes were incubated at 37°C for 2 hours. After digestion, a sample (2 µl) 
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was taken from the reaction to check that digestion was complete by agarose gel 
electrophoresis. To recover the DNA template, 20 µl phenol: chloroform mixture (1: 1 
v/v) was added to the digestion reaction and vortexed thoroughly. The two phases were 
separated in a microcentrifuge at 13500 rpm for 5 minutes. The aqueous phase was 
transferred into a new tube and extracted with an equal volume of chloroform. The 
aqueous phase was again transferred to a new tube and the lid of the tube was left open 
for 5 minutes at room temperature in a fume hood to allow any remained chloroform to 
evaporate. DNA templates were recovered by adding 2 µl 3M sodium acetate and 50 µl 
100% ethanol to each tube and centrifuging in a microcentrifuge for 15 minutes. The 
pellet was washed with 50 µl 70% ethanol and air dried at room temperature for 10 
minutes. The DNA template was resuspended in 13 µl RNase free water (DEPC water) 
for transcription. 
2.5.2.2 Transcription and labelling 
A non-radioactive DIG (Digoxigenin) RNA Labelling and Detection Kit (Boehringer 
Mannheim Biochemica) was used to synthesise and label the RNA probes. The 
transcription reactions were set up as following in a total volume of 20 µI. 
Templates DNA 13 µl 
1 Ox Transcription Buffer 2 µl 
NTP labelling mixture 2 µl 
RN ase Inhibitor 1 µl 
RNA Polymerase 2 µl 
The reactions were incubated in a 3 7°C water bath overnight. After labelling, 2 µl 
RNase free DNase (Promega) was added to each reaction to digest the DNA template at 
3 7°C for 3 hours. A small volume was taken to check RNA synthesis and DNA 
template digestion by gel electrophoresis. For precipitating the RNA probe, 5 µl 4 M 
LiCl (made in DEPC water) and 75 µl 100% ethanol were added to each tube and the 
tubes were kept in a -20°C freezer for 2 hours followed by centrifugation in a 
microcentrifuge at 13500 rpm for 15 minutes. The probes were washed with 20 µl cold 
80% ethanol and dried in air for 10 minutes. 
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2.5.3 RNA probe hydrolysis: 
In order to reduce the size of the probes and thus allow better penetration into the 
cells, the RNA probes were chemically degraded by incubation in alkali at 60°C to 
reduce their size to about 50 hp. Following precipitation and air drying as above, the 
RNA pellet was resuspended in 100 µl RNase-free water. The hydrolysis reaction was 
conducted by adding 95 µl hydrolysis carbonate buffer (section 2.1.3.4) to each tube 
and incubating at 60°C for 30 minutes after which the reaction was stopped by adding 
10 µl of 1 Ox hydrolysis neutralisation buffer (section 2.1.3.4). To precipitate the RNA 
probes, 20 µl 10% acetic acid, 24 µl 3M sodium acetate, and 640 µl 100% ethanol were 
added to each tube and the tubes were placed in a -20°C freezer overnight. The RNA 
probes were precipitated by centrifuging at 13500 rpm for 15 minutes. The pellets were 
washed with 100 µl cold 80% ethanol, dried in air for 5 minutes, resuspended in 50 µl 
TE (pH8.0, RNase free) and aliquoted and stored at -20°C in pre-hybridisation solution 
(section 2.6) containing RNase inhibitor (2 µ1/ml, Promega). 
2.5.4 Concentration test 
To test the result of labelling and determine the concentration of RNA probe, a spot 
analysis was used. Each RNA probe (sense and anti-sense) was serially diluted with a 
dilution solution (mixture of DEPC H2O: 20x SSC: formaldehyde at a ratio of 5 :3 :2 
v/v/v). A sample of 2 µl from each dilution was transferred onto a nylon membrane 
(Hybond-N+, Amersham) including unlabelled controls and antibody control. The 
membrane was wetted in Buffer 1 (section 2.1.3.4) and then put in 10 ml Buffer 2 
(section 2.1.3.4) for blocking at room temperature for 30 minutes on a shaker. The 
membrane was then incubated in 10 ml anti-DIG antibody solution (From the Kit, 
1 :5000 dilution in Buffer 1) at room temperature for 30 minutes with shaking. After 3 
washes in Buffer 1 the membrane was transferred into a colour substrate solution which 
contained 10 ml buffer 3 (section 2.1.3.4), 45 µl NBT (nitroblue tetrazolium, vial No.9 
of the Kit) and 35 µl X-phosphate (vial No. 10 of the Kit), for colour reaction (about 20 
minutes) in dark. The concentration of each pro be used for in situ hybridisation was 
determined by the highest dilution that gave a dark spot. This was usually between a 1 
in 100 and a 1 in 200 dilution of the original probe. 
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2.6 In situ hybridisation 
In situ hybridisation was used to detect IL-2 mRNA expression in frozen sections of 
reproductive tract tissue and lymph nodes. The protocol was basically adopted from a 
booklet "Nonradioactive in Situ Hybridisation Application Manual" (Boehringer 
Mannheim) with some modifications. This protocol was carried out with care to avoid 
RN ase contamination until the hybridisation step. 
The tissue sections were prepared as in section 2.2.3.3. After air drying, the sections 
were dehydrated in 70%, 90% and 100% ethanol, 2 minutes each, in a staining container 
and allowed to air-dry. Pre-hybridisation was conducted on each section before 
hybridisation, 100 µl pre-hybridisation solution was applied to each section and the 
sections were kept in a humidity box at 42°C for 5 hours. After this, the anti-sense probe 
was diluted 1: 100 in pre-hybridisation solution and 100 µl was applied to each section. 
A sense probe was similarly diluted and applied to control sections. The sections were 
all covered with coverslips and incubated at 48°C overnight in a humidity box. After 
hybridisation, 5 washes at 42°C were applied and these consisted of 2 washes with 2x 
SSC, 1 wash with 0.2x SSC and 2 washes with 0.lx SSC. Each wash took 15 minutes. 
Pre-hybridisation solution: 
Stock solution 
Formamide 
20xSSC 
50xDenhardt's solution 
10 mg/ml tRNA 
10 mg/ml salmon sperm DNA 
1 u/µl RNAsin 
H20 
Total volume 
Required concentration 
50% 
5x 
5x 
250 µg/ml 
250 µg/ml 
2 u/ml 
Make up 1 ml 
500 µl 
250 µl 
100µ1 
25 µl 
25 µl 
2 µl 
98 µl 
1000 µl 
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The immunological detection of hybridisation basically followed the instructions of 
the manufacturer (Dig Kit, Boehringer Mannheim). Briefly, 100 µl Buffer 1 (section 
2.1.3.4) was applied to each section and the sections were kept at room temperature for 
2 minutes. Then the sections were blocked by applying 100 µl Buffer 2 (section 2.1.3 .4) 
to each section and incubating at 37°C for 30 minutes in a humidity box. The sections 
were then incubated with 100 µl antibody solution (1 :5000 dilution in Buffer 2) at 37°C 
for another 30 minutes in a humidity box. After two washes in Buffer 1, 100 µl Buffer 3 
(section 2.1.3.4) was added to each section and the sections were kept at room 
temperature for 5 minutes. The sections were then moved into 20 ml colour solution 
(section 2.5.4) for colour development in the dark. For the first 10 minutes the sections 
were kept in this solution without shaking; the sections were then checked under the 
microscope until the signal on the positive section (sections from lymph nodes) could be 
seen clearly (about 30-60 minutes). The colour reaction was stopped by putting the 
sections into TE buffer ( section 2.1.3) for 10 minutes. 
2. 7 Data analysis and statistics 
Antibody titers determined by ELISA were transformed into logarithms and 
expressed as Log10 titers in figures and tables. Student t-test (Microsoft, Excel) was 
used to test for differences between treated groups and untreated controls. A P<0.05 in a 
two tailed test was considered as significant. 
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CHAPTER 3: IMMUNE CELLS IN THE FEMALE 
RABBIT REPRODUCTIVE TRACT 
3.1 Introduction 
Most vaccine and immunological studies of the reproductive tract have been done 
using rodent models (Parr and Parr, 1997, 1998; Medaglini, et al. 1997; Wira and 
Sandoe, 1987; 1995, Xiang et al. 1999). These species have the advantage of having 
well-characterised and well-understood immune responses and agents for studying their 
immune responses are readily available. 
The rabbit is much less well understood and very few reagents are available for its 
immunological characterisation. If we are to examine fertility control by immunological 
means in the reproductive tract of the female rabbit, it will first be necessary to 
characterize those reagents that are available for studying immune responses in rabbits 
and to contrast the rabbit reproductive tract with that of other species. Furthermore, 
since the rabbit is an induced ovulator rather than going through a cyclical oestrus, it is 
necessary to induce ovulation in order to study possible variations in immunological 
response in different reproductive states. In this chapter, a panel of monoclonal and 
polyclonal antibodies was used to investigate the presence and localisation of immune 
cells such as T cells, MHC class II positive cells, and B cells in the oviduct, uterus, 
cervix and vagina of the rabbit both before and after ovulation. 
The identification and characterisation of rabbit immune cells is hampered by the 
fact that far fewer monoclonal antibodies to rabbit CD antigens are available than to 
those of mouse and human. A previous study on rabbits reported that a dominant 
50 
Chapter 3 
population of T cells, together with a few IgA plasma cells and macrophages, were 
present in the endometrium and that the T cell number increased following the induction 
of ovulation (Otsuki et al. 1990). Another study in rabbits showed that strong IgG 
staining was present in the lamina propria of the reproductive tract and IgG plasma cells 
were present in the vagina (Symons and Herbert, 1971). However, systematic and 
detailed information about immune cells such as T and B cells, as well as APC in the 
whole reproductive tract, is not available. This is important for understanding antigen 
presentation and immune response in the reproductive tract following immunisation and 
for developing strategies to stimulate an immune response in the reproductive tract. 
T cells are the dominant lymphocytes in the female reproductive tract of humans 
(Morris et al. 1985; Fernandez-Shaw et al. 1995; Givan et al. 1997; Johansson et al. 
1999), mice (Parr and Parr, 1991; Nandi and Allison, 1993), cows (Cobb and Watson, 
1995) and mares (Watson and Thomson, 1996). A large proportion of the T cells 
present in the reproductive tract of these species was located within the epithelium 
(intra-epithelial lymphocytes, IEL). Both CD4+ (T helper) and CD8+ (T cytotoxic 
/suppressor) T cells were reported in the endometrium with CD8+ being the dominant 
population in human (Pace et al. 1991) and mice (Croy et al. 1993). However, in the 
vagina, CD4+ cells were more common than CD8+ cells in rhesus macaques (Miller et 
al. 1992) and were the dominant sub-population in the mouse (Fidel et al. 1996). These 
data suggest that the distribution of T cells in the female reproductive tract varies from 
region to region and from species to species. In rabbits, little information is available 
about T cells or T cell subsets in the different compartments of the female reproductive 
tract. 
In contrast to T cells, only a few B cells are present in the female reproductive tract 
of most reported species (Parr and Parr, 1996). Nevertheless, IgG and IgA plasma cells 
were reported in the reproductive tract of female mice (Rachman et al. 1983; Parr and 
Parr, 1985) and IgA plasma cells together with a few IgG plasma cells were described in 
the human fallopian tube (Kutteh et al. 1990). Plasma cells are usually considered to 
contribute to local antibody production; they have not yet been studied in the 
reproductive tract of female rabbits. 
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Local APC in the reproductive tract probably play a crucial role in presenting 
antigenic peptides to T cells in the draining lymph nodes, thus initiating an immune 
response that allows effector cells to return to the reproductive tract (McGhee et al. 
1994). These APC are MHC class II positive. Therefore, detecting MHC class II 
expression in the reproductive tract could provide information about the presence and 
localisation of APC. However, it must be borne in mind that other cells, including B 
cells, also express MH C class II and it has been suggested that rabbit T cells and 
neutrophils may also express MHC class II (Mage, 1998). In studies of rat (Kaushic et 
al. 1998) and human (Morris et al. 1985; Ljunggren and Anderson 1998; Johansson et 
al. 1999), MHC class II positive cells were reported in the female reproductive tract. In 
rabbits, although macrophages were found in the endometrium (Otsuki et al. 1990) their 
distribution in the lower reproductive tract and that of other APC in the whole 
reproductive tract remains unknown. To determine whether APCs are present in 
mucosal compartments of the rabbit reproductive tract and whether their distribution is 
affected by ovulation, the distribution of MHC class II positive cells in the female rabbit 
reproductive tract was examined. 
Studies in rodents and humans indicated that the stage of the oestrous cycle and the 
level of ovarian hormones had a significant effect on the number, location, and function 
of immune cells in the female reproductive tract (mice, Parr and Parr, 1991, rats, Wira 
and Rossoll, 1995; Kaushic et al. 1998; humans, Given et al. 1997; White et al. 1997). 
However, the rabbit is an induced ovulator and so does not have an oestrous cycle. This 
means that oestrogen is the dominant ovarian hormone in the rabbit until mating occurs; 
mating triggers follicle maturation, ovulation and the formation of the corpora lutea 
after which progesterone predominates. Although Otsuki (1990) showed that T cell 
number increased in the rabbit uterus after induction of ovulation, the effect of ovulation 
on T cells in other regions of the reproductive tract and on the distribution of other 
immune cells such as APC in the reproductive tract is still to be investigated. 
There is considerable variation in the endocrine control of reproduction and in 
immune responses in the female reproductive tract. Furthermore, very little is known 
about either of these factors in the rabbit. Accordingly, this chapter describes an 
examination of potential immune response elements in the female rabbit reproductive 
tract, both before and after ovulation, to determine how these might differ, in both type 
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and location, from other species. This will provide us with the background necessary for 
later studies aimed at generating an immune response in the reproductive tract against a 
virally-delivered stimulator as a potential model of virally-vectored vaccination for 
fertility contro 1. 
3.2 Experimental design 
The immunological status of the reproductive tract was assessed in two groups of 
rabbits. Four female rabbits aged 10-12 months which had been kept apart from males 
('normal rabbits') formed the control group. To determine the effect of ovulation on 
immune cell distribution, four female rabbits of similar age ( ovulated group) were 
injected with hCG (Chapter 2 section 2.2.2.2). Tissue samples from the oviduct, uterus, 
cervix and vagina were collected from both groups for frozen and paraffin embedded 
sections (Location diagram below; Chapter 2 section 2.2.3 .2). In addition, tissue 
Oviduct 
Uterus 
Cervix 
Vagina 
Location diagram. 
Examination sites of the 
reproductive tract of 
female rabbits. Sites from 
which tissue samples were 
collected lie between the 
parallel lines on the 
diagram. 
samples of the small intestine and popliteal lymph nodes were collected from the 
normal rabbits for use as positive controls in immunohistochemistry. Monoclonal 
antibodies to rabbit CD45, CD43 , the T-cell antigen KENS, CD4, lg µ chain, MHC 
class II (Chapter 2 Table 2-1) and polyclonal antibodies to rabbit IgA and IgG (Chapter 
2, Table 2-2) were used to label leucocytes, T cells, B cells, APC, and plasma cells on 
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frozen sections of the reproductive tract using immunofluorescent methods (Chapter 2 
section 2.4). For monoclonal antibody labelling, normal mouse ascites fluid (MAF) was 
used as a negative control for each assay. For polyclonal antibody staining, normal goat 
serum (Nordic) was used as a negative control for each staining. The slides were viewed 
using confocal microscopy and digital images were collected (Chapter 2 section 2.4.4). 
Paraffin embedded sections of the reproductive tract were prepared and stained for 
histological examination (Chapter 2 section 2.2.3.4). These sections were viewed using 
light microscopy and photographed using standard techniques. 
3.3 Results 
3.3.1 The effect of ovulation on the mucosal structure of the 
reproductive tract 
Induction of ovulation with hCG treatment resulted in a substantial increase in the 
size of the uterus, cervix and vagina. The mucosa of the uterus and vagina expanded 2-5 
fold. 
The histological structure of the mucosa at the examined sites (location diagram) of 
the oviduct, uterus, cervix, and vagina from normal and ovulated rabbits are shown in 
Figures 3-1.1, 3-1.2, 3-2.1, and 3-2.2. The epithelial cells of the luminal epithelium at 
those sites in most cases formed a simple columnar epithelium, the thickness and height 
of which varied from region to region (Figure 3-1.2, 3-2.2). However, in the ovulated 
uterus and cervix, the epithelium became pseudo-stratified columnar (Figure 3- l .2d, 3-
2.2b ). In addition, after induction of ovulation, the lamina propria was expanded (Figure 
3-1.1, 3-2.1) and the epithelia became thicker in the uterus, cervix, and vagina, 
compared with those of normal rabbits (Figure 3-1.2, 3-2.2). In the cervix, the blood and 
lymphatic vessels in the lamina propria were enlarged and the epithelial cell layer was 
thickened compared with normal rabbits (Figure 3-2.2). In the oviduct, the cell density 
in the lamina propria increased after induction of ovulation (Figure 3-1.1 , 3 .1.2). These 
observations show that induction of ovulation has physically changed the structure of 
the mucosa in the reproductive tract. 
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Figure 3- 1. 1. The mucosa) structure of the oviduct and uterus from normal and ovulated rabbits. 
A is oviduct from a normal rabbit. B is· oviduct from an ovulated rabbit. C is uterus fro1n a norn1al rabbit 
and D is uterus from an ovulated rabbit. All are 1 00x 111agnification. 
The rabbit oviduct (A and B) consists of three layers, from the lumen (Lu): mucosa (M), muscular layer 
(Mu) and serosa (Se). The n1ucosa includes the luminal epithelium and lamina propria. The two 
histological layers closest to the lumen (Lu) of the uterus (C and D) are the endometrium (Ed, including 
epitheliun1 and stroma) and myometrium (My). 

Figure notes are on the other side 
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Figure 3-1. 2. The luminal epithelium of the oviduct and uterus from normal and ovulated rabbits. 
a is oviduct from a normal rabbit. b is oviduct from an ovulated rabbit. c is uterus from a normal rabbit 
and d is uten.1s from an ovulated rabbit. All are 400x n1agnification. 
The luminal epithelia of normal ( a) and ovulated (b) rabbit oviducts are typical simple colu1nnar ciliated 
epithelium. The luminal epitheliuin of the uterus from normal rabbits ( c) is also single columnar ciliated 
epithelium though the epithelial cells are thinner and shorter than those in the oviduct. Glands are also 
present in the normal uterine stroma ( c, G). Lp: lamina propria; Ep: lun1inal epithelium; St: stron1a. 

Figure notes are on the other side 
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Figure 3- 2. 1. The mucosa( structure of the cervix and vagina fro1n normal and ovulated rabbits. 
A is cervix fro1n a nonnal rabbit. B is cervix fron1 an ovulated rabbit. C is vagina fro1n a nonnal rabbit 
and D is vagina fron1 an ovulated rabbit. All are 1 00x magnification. 
The two histological layers closes{ to the lumen (Lu) of the cervix (A and B) are the endon1etriun1 (Ed) 
and n1yometr:iu1n (My). The two iimer histological layers for the vagina (C and D) are the mucosa (M, 
including the epitheliun1 and lan1ina propria) and muscularis (Mus). 

Figure notes are on the other side 
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Figure 3-2. 2. The Iuminal epithelium of the cervix and vagina from normal and ovulated rabbits. 
a is cervix fro1n a norn1al rabbit. b is cervix from an ovulated rabbit. c is vagina from a norn1al rabbit 
and d is vagina fro1n an ovulated rabbit. All are 400x 1nagnification. 
The lun1inal epithelia (Ep) of the cervix and vagina from norn1al ( a and c) and ovulated (b and d) 
rabbits are sin1ple columnar epithelium. However, the epitheliun1 of the cervix is ciliated whereas the 
vaginal epitheliun1 is not. Glands (G) can be seen in the stroma (St) of the cervix. LP: lan1ina propria. 
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3.3.2 CD45 positive leucocytes in the reproductive tract 
3.3.2.1 CD45 + cells in the normal reproductive tract 
CD45 is a pan leucocyte marker. Anti-rabbit CD45 monoclonal antibody (Chapter 2 
Table 2-1) binds to the leucocyte common antigen (LCA) and · was employed to label 
leucocytes on frozen sections of the four reproductive tract regions using indirect 
immunofluorescence (Chapter 2 section 2.4.1 ). Normal mouse ascites fluid (MAF) was 
used as a negative contro 1. 
In most regions, numerous CD45+ cells were found in the luminal epithelium and in 
the area immediately beneath it but there were far fewer cells deep in the stroma or in 
the muscle layer (Figure 3-3). No positive cells were seen in any sections treated with 
MAF instead of monoclonal antibody (Figure 3-3). In addition, as positive and negative 
controls, frozen sections of popliteal lymph nodes were treated with anti-CD45 antibody 
or mouse ascites fluid. Whereas almost all of the cells were positive on the antibody-
treated sections, no positive cells were seen on the sections treated with MAF (Figure 3-
4). These results demonstrate the specificity of the CD45 antibody and the lack of 
background staining that occurred with this procedure. 
The numbers of CD45+ cells in the mucosa of each region were counted using 
confocal microscopy (Chapter 2 section 2.4.4). Table 3-1 shows the mean of two or 
Table 3- 1. CD45 positive cell (leucocyte) numbers in the mucosa of the normal 
reproductive tract 
Rabbit No. Oviduct Uterus Cervix Vagina 
361 72 28 120 194 
437 90 17 128 130 
440 l"'"' _).) 19 115 156 
456 62 12 63 98 
Mean ± S.D 89 ± 31.4 19 ± 6.7 a< 107 ± 29.5 145 ± 40.6 
J The values are the cell number per mm- mucosa and represent the means of three counts m representative 
mucosal areas of each section. *: P<0.01 against other regions. 
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Figure 3-3. CD45 positive cells in the reproductive tract of normal female rabbits. 
The immunofluorescent images show CD45+ positive cells in the reproductive tract of 
normal female rabbits (four images on the left) and corresponding negative controls 
(four images on the right). A and B: oviduct; C and D: uterus; E and F: cervix, and G 
and H: vagina. Lu: lumen; Ep: luminal epithelium; St: stroma. All images are at the 
same magnification. 
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Figure 3-4. CD45 staining in rabbit popliteal lymph nodes. The immunofluorescent 
images show CD45 staining in popliteal lymph nodes as positive and negative controls 
for the staining. Positive control sections were treated with CD45 monoclonal 
antibody. Negative control sections were treated with MAF. 
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three counts in each of 2-3 representative mucosa} areas. Where positive cells were not 
evenly distributed, and particularly in some cervical or vaginal sections with 
lymphocyte clusters, three counts were conducted in areas of low, medium, and high 
cell density. Although no significant differences were found between vagina, cervix and 
oviduct, significantly fewer CD45+ cells (P<0.01) were present in the endometrium of 
the uterus than in the mucosa of other regions (Table 3-1 ). 
3.3.2.2 CD45 + cells in the ovulated reproductive tract 
There was little change in the pattern of distribution of CD45+ cells in the four 
reproductive tract regions from ovulated rabbits compared with normal rabbits (Figure 
3-5, Table 3-2). As in normal rabbits, significantly fewer positive cells were present in 
the uterus than in the other three regions (Table 3-2) and no differences in cell number 
were found between oviduct, cervix, and vagina. The cell number of each region in the 
hCG treated rabbits was not statistically different from that in normal rabbits (Table 3-1 
and 2). However, there was an increase in the number of CD45+ cells around the blood 
vessels in the vaginal muscularis mucosa in 3 of 4 hCG treated rabbits compared with 
normal ones (Figure 3-6). For both normal and hCG treated rabbits, in some cervical 
and vaginal sections a large number of CD45+ cells were present directly beneath the 
epithelium forming cell clusters (Figure 3-6). Because these cells were located so close 
to the mucosal surface they may play an important role in local immunity. 
Table 3- 2. CD45 positive cell (leucocyte) number in the mucosa of the ovulated 
reproductive tract 
Rabbit No. Oviduct Uterus Cervix Vagina 
398 71 51 139 149 
351 137 10 110 135 
453 0 a 41 206 133 
441 99 27 69 123 
Mean± S.D 102 ± 33 (n=3) 32 ± 17.8" 131±57.7 135 ± 10.7 
., The values are the cell number per mm- mucosa and represent the means of three counts m representative 
mucosa! areas of each section. *: P<0.01 against vagina and P<0.05 against oviduct and cervix. a: no 
positive cells were found on the section, a repeat stain gave a similar result. 
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Figure 3-5. CD45 positive cells in the reproductive tract of ovulated rabbits. 
Immunofluorescent images show CD45+ positive cells in the reproductive tract of 
ovulated rabbits (four images on the left) with corresponding negative controls treated 
with MAF (four images on the right). A and B: oviduct; C and D: uterus; E and F: 
cervix, and G and H: vagina. Lu: lumen; Ep: luminal epithelium; St: stroma. All 
images are at the same magnification. 
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Figure 3-6. Sub-epithelial CD45+ cells in the cervix and CD45+ cells in the mucosa 
muscularis of the vagina after ovulation. Immunofluorescent images of CD45+ cells 
in the cervix of A) normal and B) ovulated rabbits highlight intra-epithelial CD45+ 
cells (narrow arrows) and sub-epithelial CD45+ cells (wide arrows). Some CD45+ 
cells form clusters (shaded arrow). C: Stromal tissue of ovulated rabbit vagina showing 
CD45+ cells around blood vessel (arrow). D: Stromal tissue of normal rabbit vagina 
showing scant CD45+ staining (arrow indicates blood vessel). Ep: luminal epithelium 
St: stroma. 
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3.3.3 CD43 positive cells in the reproductive tract 
To classify T cells in the female rabbit reproductive tract, anti-rabbit CD43 
monoclonal antibody Ll 1/135 (Chapter 2, Table 2-1) was employed to stain T cells in 
frozen sections of the four reproductive tract regions. This monoclonal antibody was 
first described by Jackson et al. (1983) who reported that it specifically bound to rabbit 
T cells. A later study showed that Ll 1/135 bound to the rabbit equivalent of human 
leukosialin/CD43, a molecule expressed on a wide variety of cells in the peripheral 
blood. However, in rabbits Ll 1/135 binding was restricted to thymocytes and T cells 
with only a weak reaction to monocytes and macrophages (Wilkinson et al. 1992). 
3.3.3.1 CD4 3 + cells in normal reproductive tract 
Large numbers of CD43+ cells were present predominantly in the mucosa! area of 
oviduct, cervix and vagina of the normal reproductive tract, with no significant 
differences in cell numbers between these regions (Figure 3-7, Table 3.3). The uterus 
had significantly fewer CD43+ cells (P<0.01). Few positive cells were present in the 
deep stroma or in the muscular layers of these regions. No positive cells were seen in 
any sections treated with MAF (not shown). 
Table 3- 3. CD43+ T cell numbers in the mucosa of the normal reproductive tract 
Rabbit No. Oviduct Uterus Cervix Vagina 
361 41 21 104 146 
437 41 17 113 96 
440 47 6 83 123 
456 oa 2 35 76 
Mean± S.D 43 ± 3.5 (n=3) 12 ± 7.8 • 84 ± 34.8 110 ± 30.6 
2 The values are the cell number per mm mucosa and represent the means of three counts in 
representative mucosal areas of each section. *: P<0.01 against other regions. a: no positive cells 
were found on this section, the staining was repeated and a similar result was obtained. 
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Figure 3-7. Immunofluorescent images of CD43+ cells in the reproductive tract of 
normal and ovulated female rabbits. The four images on the left are from normal 
rabbits and the four on the right are from ovulated rabbits. A, B: oviduct; C, D: uterus; 
E, F: cervix, and G, H: vagina. CD43+ cells were mainly located in the luminal 
epithelium (long arrows) and sub-epithelium (short arrows). All images are at the same 
magnification. 
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3.3.3.2 CD43 + cells in the ovulated reproductive tract 
Induction of ovulation did not change the location or number of CD43+ cells in the 
four reproductive tract regions (Figure 3-7, Table 3-4). Like normal rabbits, CD43+ 
cells were mainly seen in the mucosal area of each region of the ovulated reproductive 
tract (Figure 3-7) and the cell number in each region was not statistically different from 
that in comparable regions from non-treated rabbits (Table 3-3 and 3-4). However, after 
ovulation the variability in cell number between individuals increased in most regions 
compared with normal rabbits (Table 3-4) and, as a consequence, the only significant 
difference in cell number in the different compartments was between the vagina and the 
uterus (P<0.01, Table 3-4). 
Table 3- 4. CD43+ T cells in the ovulated reproductive tract 
Rabbit No. Oviduct Uterus Cervix Vagina 
398 8 32 102 80 
351 77 2 40 77 
453 22 25 127 110 
441 72 9 29 101 
Mean±S.D 45 ± 34.9 17±13.9. 75±47.5 92±16.1 
The values are the cell number per mm2 mucosa and represent the means of three counts in 
representative mucosa! areas of each section. *: P<0.0 1 against vagina. 
As shown in Figure 3-7, the majority of CD43+ cells in the mucosa of the 
reproductive tract were located within the epithelium, or immediately beneath it, in both 
normal and ovulated rabbits. Because Ll 1/135 mainly labels T cells in rabbits, those 
CD43+ cells located within the epithelium are presumably intra-epithelial lymphocytes 
(IEL, Figure 3-7 arrows). IEL have been suggested to play an important role in other 
species, in providing local immunity in the reproductive tract and/or in providing a 
suitable environment for implantation (Pace et al. 1991 ; Lohman et al. 1995). 
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3.3.3.3 The proportion of CD43+ cells to CD45+ cells 
In humans, CD3+ cells (all T cells) form 30-60% of CD45+ leucocytes in the female 
reproductive tract (Givan et al. 1997). A similar trend was seen in rabbits. More CD45+ 
leucocytes than CD43+ cells were found in the female reproductive tract (Table 3-1, 2 
and 3-3, 4; Figure 3-8) with CD43+ cells constituting 30-77% of CD45+ leucocytes 
(Table 3-5). For a direct visual comparison of CD43 and CD45 staining, adjacent 
sections of the four reproductive tract regions from a normal rabbit were labelled with 
CD43 and CD45; fewer CD43+ than CD45+ cells were seen in the comparable mucosal 
areas (Figure 3-8). After hCG treatment, the ratio of CD43+ cells to CD45+ cells 
' 
decreased slightly but not significantly (Table 3-5). 
Table 3- 5. The percentage of CD45+ cells that were also CD43+ in normal and 
ovulated reproductive tracts 
Groups Oviduct Uterus Cervix Vagina 
Normal 46 + 11 56 + 38 76+ 15 77 + 2 
Ovulated 30 + 23 44 + 21 53 + 17 69 + 16 
Notes: the values are mean+ S.D for four animals. 
3.3.4 KEN-5 positive cells in the reproductive tract 
Since monoclonal antibody Ll 1/135 may also bind weakly to macrophages and 
monocytes in rabbits (Wilkinson et al. 1992), another monoclonal antibody, KEN-5 , 
which was reported to bind to rabbit CDS (Chapter 2 Table 2-1) was used to further 
classify T cells in the female rabbit reproductive tract. There were two monoclonal 
antibodies established against rabbit CDS. Clone R-CD5 was reported to mainly 
recognise rabbit B cells (Raman, 1992) whereas KEN-5 was reported to specifically 
recognise T cells without detection of any B cells in rabbits (Kotani et al. 1993). It is 
now considered that KEN-5 does not recognise CDS but an unidentified T cell marker 
(Mage, 1998). Therefore the cells identified by KEN-5 are referred to as KEN-5 
positive cells in the following text. 
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Figure 3-8. Comparison of CD45+ and CD43+ cells in the reproductive tract of 
normal rabbits. Immunofluorescent images show CD45+ (left panel) and CD43+ 
(right panel) cells in adjacent sections of oviduct (A, B), uterus (C, D), cervix (E, F), 
and vagina (G, H) from a normal rabbit. Lu: lumen; Ep: luminal epithelium. All images 
are at the same magnification. 
69 
Chapter 3 
3.3.4.1 KEN-5+ cells in normal reproductive tract 
As was found for CD45+ and CD43+ cells, most KEN-5+ cells were located in the 
mucosa! areas of each region and more positive cells were seen in the vagina and cervix 
than in the oviduct and uterus (Figure 3-9). However, compared with CD45+ or CD43+ 
cells, somewhat fewer KEN-5+ cells were present throughout the reproductive tract 
(Figure 3-9 cf Figure 3-8). In the oviduct and uterus, fewer than 20 KEN-5+ cells/mm2 
were present in the epithelium or sub-epithelium. No cells were stained in the negative 
controls treated with normal MAF (not shown). Because of the difficulty of separating 
individual KEN-5+ cells in the epithelium of some cervical and vaginal sections no 
accurate count of positive cells in the mucosa} area of these tissues could be conducted. 
However, it was estimated that more positive cells (,--20-50 cells/mni2) were seen in the 
epithelium and sub-epithelium of the cervix. Even more positive cells ( ,_,50-100 
cells/mm2) were found in the epithelium and sub-epithelium of the vagina. 
3.3.4.2 KEN-5 + cells in the ovulated reproductive tract 
After induction of ovulation, an increase in the number of KEN-5+ cells in the 
endometrium was seen in 3 of the 4 ovulated rabbits compared to normal rabbits 
(Figures 3-9 and 3-10). In tissues from ovulated animals, some positive cells formed 
clusters in the endometrium close to the epithelium (Figure 3-10), making identification 
of individual cells, and hence, counting of positive cells, impossible. Few changes in 
cell staining were seen in cervix or vagina after induction of ovulation (Figure 3-9) and 
no cells were stained in the negative controls treated with MAF. 
3.3.5 Unsuccessful CD4 staining in the reproductive tract 
A monoclonal antibody to rabbit CD4 (Chapter 2 Table 2-1) was also employed in 
an attempt to label CD4+ T cell (T helper cells). However, this antibody did not bind to 
any cells in the four reproductive tract regions and these data are therefore not shown. 
Other researchers attempting to stain tissue sections with this monoclonal antibody have 
experienced similar problems (P. J. Kerr, personal communication). 
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Figure 3-9. Immunofluorescent images of KEN-5+ cells in the female rabbit 
reproductive tract. The four images on the left are from normal rabbits and the four 
on the right are from ovulated rabbits. A, B: oviduct. C, D: uterus. E, F: cervix. G, H: 
vagina. Lu: lumen; Ep: luminal epithelium. All images are at the same magnification. 
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Figure 3-10. Immunofluorescent images of KEN-5+ cells in the endometrium of 
normal and ovulated rabbits. A: normal rabbit# 440. B: normal rabbit# 437 (normal 
rabbit #456 is shown in Figure 3-9c). C: ovulated rabbit # 453. D: ovulated rabbit # 
441, ( ovulated rabbit #351 is shown in Figure 3-9d). Lu: lumen; Ep: luminal 
epithelium. All images are at the same magnification. 
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3.3.6 MHC class II positive cells in the reproductive tract 
MHC class II molecules (MHC II) expressed on APC play a crucial role in antigen 
presentation to CD4+ T cells by presenting processed peptides to the T-cell receptor 
(Chapter 1 section 1.5). In the reproductive tract of the female rat, MHC II expression 
was also shown to be important for antigen presentation in the tract (Wira and Rosso 11, 
1995b ). Furthermore, in the female reproductive tract of rats (Wira and Rosso 11, 1995; 
Wira et al. 2000) and humans (Fahey et al. 1999), both epithelial and stromal cells were 
shown to have the capabilities to present antigen. Rat uterine and vaginal epithelial or 
stromal cells were also MHC II positive (Kaushic et al. 1998). However, no such 
information is available for rabbits. To investigate this, a monoclonal antibody clone 
2C4 (Chapter 2 Table 2-1) was employed to detect MHC II expression in frozen 
sections of the reproductive tract using immunofluorescence. The clone 2C4 was 
previously shown to recognise rabbit MHC Class II expressed on B cells and 
macrophages in lymphoid tissues (Lobel and Knight, 1984). In the reproductive tract, it 
may also recognise other MHC II positive cells such as Langerhans' cells or dendritic 
cells. 
3.3.6.1 MHC II+ cells in normal reproductive tract 
It is abundantly clear that MHC II+ cells are present in all mucosa! compartments of 
the normal female rabbit reproductive tract (Fig 3-11 ). MHC II+ cells were 
predominantly present in the mucosal area of each region of the tract and fewer positive 
cells were present in the uterus than in the cervix, oviduct, and vagina (Figure 3-11 ). 
However, unlike leucocytes or CD43+ and KEN-5+ cells, the shape of MHC II+ cells 
varied from region to region. For instance, in the oviduct and uterus, most positive cells 
were still basically round-shaped (Figure 3-11) but in the cervix and vagina, most 
positive cells, especially those within the epithelium, were amorphous. The staining 
signals of positive cells within the epithelium were weak and the boundary of individual 
cells was difficult to identify (Figure 3-11) which made cell counting impossible. 
In addition to the changes in cell shape, there were variations in the location of 
positive cells between regions. In the oviduct, positive cells were mainly located in the 
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Figure 3-11. Immunofluorescent images of MHC-11+ cells in the female rabbit 
reproductive tract. The four images on the left are from normal rabbits; those on right 
are from ovulated rabbits. A, B: oviduct; C, D: uterus; E, F: cervix; G, H: vagina. Lu: 
lumen; Ep: luminal epithelium. All images are at the same magnification. 
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lamina propria and very few positive cells were seen in the epithelium (Figure 3-1 lA). 
However, in the cervix, positive cells were mainly located in, or immediately beneath 
the epithelium, with only a few positive cells in the lamina propria. In the vagina, 
though positive cells were present in the epithelium and immediately beneath it, they 
were also frequently seen in the lamina propria (Figure 3-11 ). When MAF was applied 
instead of the antibody no positive cells were seen in any sections (not shown). 
3.3.6.2 MHC II+ cells in the ovulated reproductive tract 
After induction of ovulation, there was an increase in the number of MHC II+ cells 
in the endometrium of 3/4 hCG injected rabbits compared with normal rabbits (Figure 
3-11, 12) but there were no changes in the other three regions (Figure 3-11 ). In the 
uterus, after ovulation, some positive cells gathered closely together forming patches in 
the endometrium close to the luminal epithelium (Figure 3-12). Similar to CD43+ cells 
(Table 3-4), the extent of the variation in numbers of cells between animals increased 
after ovulation, especially in oviduct and cervix, suggesting that individual animals may 
have different responses to hCG treatment. No positive staining was seen in the 
negative controls treated with MAF (data not shown). 
3.3.6.3 Double labelling with MHC class II and KEN-5 monoclonal antibodies 
Double labelling with MHC class II and KEN-5 monoclonal antibodies results in the 
staining of three classes of cells. These are double-stained cells MHCII+/KEN5+ and 
two classes of single-stained cells, MHCil+/KEN5- and MHCII-/KEN5+. It appears 
that MHCII+/KEN5+ cells are T cells expressing MHC II. MHCII+/KEN5+ cells were 
found in all the regions of the reproductive tract but the cell number was not great 
(Figure 3-13). MHCII+/KEN5- cells were the dominant population in the cervix and 
vagina ,vhereas MHCII-/KEN5+ cells were the majority in the oviduct (Figure 3-13). 
Far fewer positive cells were present in the uterus and these were mostly double 
positive cells. 
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Figure 3-12. Comparison of MHC-11 + cells in the endometrium of normal and 
ovulated rabbits. Immunofluorescent images of MHC-II+ cells in the uterus before 
and after ovulation. A, Bare from two normal rabbits, different from the one in Figure 
3-1 l(C). C, Dare from two ovulated rabbits different from the one in Figure 3-1 l(D). 
In some cases, positive cells formed clusters (C, D, arrows) Lu: lumen; Ep: luminal 
epithelium. All images are at the same magnification. 
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Figure 3-13. MHC II and KEN-5 double positive cells in the reproductive tract of 
normal female rabbit. Immunofluorescent images show double labelling with KEN-5 
and MHC II monoclonal antibodies on frozen sections of oviduct (A), uterus (B), 
cervix (C, D) and vagina (E, F) of normal rabbits. Each image contains two parts; the 
left part shows KEN-5 staining and the right part shows MHC II staining on the same 
section. In the oviduct (A) more KEN-5+ than MHC II+ cells were present and KEN-5 
staining was stronger than MHC II staining. In the uterus (B), most KEN-5+ cells were 
also MHC II positive (arrows). In the cervix and vagina, more MHC II+ cells than 
KEN-5+ cells are present in epithelium (C and E) or sub-epithelium (D and F) although 
there are some double positive cells (D and E, arrow). Ep: luminal epithelium. All 
images are at the same magnification. 
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3.3.7 lmmunoglobulin µ-chain positive B cells in the reproductive tract 
Antibody in the reproductive tract has two possible sources, transudation from 
serum or secretion by local plasma cells. The presence of localised, uncommitted B 
cells was examined by staining for Jg µ-chain to determine whether B cells were present 
in aggregates that could indicate a potential for local antigen presentation or the 
involvement of antibody responses. Normal MAF was used as a negative control. 
3. 3. 7.1. Jg µ-chain positive cells in normal reproductive tract 
lg µ-chain positive B cells were sparse in the oviduct, cervix, and vagina and were 
rarely found in the uterus of the normal reproductive tract (Figure 3-14). The few 
positive cells were mainly in the lamina propria of the oviduct and vagina, or in the sub-
epithelium and stroma of the cervix. No positive cells were seen in the negative control 
sections treated with MAF. As a positive contro~ frozen sections of popliteal lymph 
nodes were stained for lg µ chain positive cells. These cells were comtnon in the cortex 
of lymph nodes (Figure 3-15). In addition, when similar staining was applied to frozen 
sections of the vagina from a birth-experienced rabbit, positive cells were easily found 
in the mucosa! area (Figure 3-15). These positive controls demonstrate that the 
monoclonal antibody is able to recognise positive cells in frozen sections and confirm 
the sparsity oflg µ-chain positive cells in the normal reproductive tract. 
3. 3. 7. 2. Jg µ-chain positive cells in the ovulated reproductive tract 
Induction of ovulation had no effect on B cell number or location within the 
reproductive tract. As with normal rabbits, no positive cells were found in the uterus 
and very few positive cells were present in the oviduct, cervix, or vagina (Figure 3-14). 
No positive cells were seen in the control sections treated with MAF. 
3.3.8. IgA containing cells in the reproductive tract 
lg µ-chain bearing B cells were not commonly present in the female rabbit 
reproductive tract. However, the presence oflgA plasma cells may be more important 
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Figure 3-14. Immunoglobulin µ-chain positive cells in the female rabbit 
reproductive tract. Immunofluorescent images show rabbit lg µ chain positive cells in 
the oviduct (A, B), uterus (C, D), cervix (E, F), and vagina (G, H) of the female rabbit. 
The four images on the left are from normal rabbits and the images on the right are 
from ovulated rabbits. Arrows indicate positive cells. Lu: lumen; Ep: luminal 
epithelium. All images are at the same magnification. 
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Figure 3-15. lg µ chain positive cells in the popliteal lymph nodes and vagina. 
Immunofluorescent images of lg µ chain staining of frozen sections of popliteal lymph 
nodes. A: cortex of the lymph nodes. B: vagina from a birth-experienced rabbit (arrows 
indicate positive cells). Lu: lumen; Ep: luminal epithelium. 
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for local mucosal immunity (Chapter 1 section 1.4.2). A previous study showed that a 
few IgA plasma cells were present in the endometrium of rabbits (Otsuki et al. 1990), 
but no information was available on IgA plasma cells in any other regions of the tract. 
To detect IgA producing cells, goat anti-rabbit IgA antibody (Chapter 2 Table 2-2) was 
employed to label IgA containing cells in frozen sections of the reproductive tract using 
indirect immunofluorescence (Chapter 2 section 2.4.1 ). Normal goat serum (Nordic) 
was used as negative controls. 
3.3.8.1. IgA containing cells in normal reproductive tract 
IgA positive cells were not commonly seen in any regions of the reproductive tract 
including the cervix and vagina and the IgA staining on the positive cells was usually 
weak (Figure 3-16). These weakly positive cells were mainly located in the lamina 
propria of the oviduct, the sub-epithelium or around the glands of the uterus, the sub-
epithelium or deep stroma of the cervix, and sub-epithelium or lamina propria of the 
vagina. Apart from these positive cells, strong IgA staining was consistently seen along 
the apical area (Figure 3- l 6c ), or sometimes both apical and basal areas of the luminal 
epithelium of the uterus. IgA staining was also seen in the basal areas of cervical 
epithelial cells or sometimes in a small part of the vaginal epithelium. In addition, in the 
uterus and vagina, IgA staining was seen on the internal epithelial surface of some 
glands (Figure 3-16). In contrast, no positive cells and no other staining were found in 
the negative controls treated with normal goat serum (Figure 3-16). 
IgA staining was also examined in the small intestine as a positive control. Far more 
IgA positive (plasma) cells were seen in the lamina propria and sub-epithelium of the 
intestine (Figure 3-17), demonstrating that this antibody can specifically bind to IgA 
containing cells in frozen sections. 
3.3.8.2.IgA containing cells in the ovulated reproductive tract 
After induction of ovulation, no change in the number or location of IgA positive 
cells in the reproductive tract was seen and IgA staining along the surfaces of luminal 
and glandular epithelia of the uterus was still observed (Figure 3-18). Furthermore, IgA 
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Figure 3-16. lgA staining in the reproductive tract of normal female rabbits. The 
four immunofluorescent images on the left show IgA staining in the normal rabbit 
reproductive tract and the four images on the right are the negative controls treated 
with normal goat serum. A and B: oviduct; C and D : uterus; E and F : cervix, and G 
and H : vagina. Note: strong IgA staining along the apical edge of the luminal 
epithelium of the uterus and on the epithelial surface of glands in the uterus and vagina 
(C and G, arrows). In the negative controls there was a little non-specific background 
in cervix (F) and vagina (H). Lu: lumen; Ep: epithelium. All images are at the same 
magnification. 
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Figure 3-17. Positive control, lgA staining in small intestine. Immunofluorescent 
images show IgA in small intestine as a positive control for IgA staining. A and B are 
from individual rabbits. Note: many IgA plasma cells in the mucosal area of the small 
intestine (arrows) in association with glands (A, arrow) or glandular epithelial cells (B, 
arrow). Lu: lumen; Ep: luminal epithelium; Gl: gland. All images are at the same 
magnification. 
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Figure 3-18. lgA staining in the reproductive tract of ovulated rabbits. The four 
immunofluorescent images on the left show IgA staining in the ovulated reproductive 
tract and the four images on the right are the MAP-treated negative controls. A and B: 
oviduct; C and D: uterus; E and F: cervix, and G and H: vagina. Note: IgA staining 
along the apical edge of the luminal epithelium in the uterus (C), on the epithelial 
surface of glands (arrows) and along the basal membrane region of the luminal 
epithelium of the cervix (E). There is a small amount of non-specific background 
staining in the negative control for the uterus (D). Lu: lumen; Ep: epithelium. All 
images are at the same magnification. 
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staining was seen along the basal membrane of the epithelial cells in the cervix (Figure 
3-18). The negative controls stained with normal goat serum showed no positive cells or 
staining on the uterine and cervical epithelia (Figure 3-18). 
After induction of ovulation, there was an increase of IgA staining in the deep 
muscular layer of the oviduct and in the mucosa muscularis of the vagina, compared 
with that of normal rabbits (Figure 3-19). Because IgA plasma cells did not increase, . 
this observation suggests that lgA transport from circulation into the reproductive tract 
tissues may increase after induction of ovulation. 
3.3.9. IgG containing cells in the reproductive tract 
Unlike other mucosa! sites where IgA predominates, lgG was the dominant antibody 
class in the female reproductive tract of rodents (Parr and Parr, 1996). Both serum and 
local IgG plasma cells in the reproductive tract could contribute to the IgG antibody 
present in the luminal fluids of the tract (Chapter 1 section 1.4.1 ). To examine the 
presence of IgG containing cells and IgG distribution in the reproductive tract, goat anti-
rabbit IgG antibody (Chapter 2 Table 2-2) and indirect immunofluorescence (Chapter 
section 2.4.1) were employed. Normal goat serum (Nordic) was used in negative 
controls. 
3. 3. 9.1.IgG containing cells in normal reproductive tract 
Compared with IgA (section 3.3.8), IgG staining was stronger in all regions of the 
reproductive tract (Figure 3-20). In addition, IgG positive (plasma) cells were more 
easily found in most regions of the reproductive tract than IgA positive cells (Figure 3-
20 and 16). However, IgG staining in each region of the tract was slightly different. 
In the oviduct, strong IgG staining was seen in the lamina propria and sometimes 
also in the muscular layer but the luminal epithelium was basically IgG negative (Figure 
3-20). Because of the strong, widespread IgG staining, the identification of individual 
IgG positive cells was impossible in this region (Figure 3-20). In the uterus, strong IgG 
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Figure 3-19. IgA staining in the deep muscular layer of the oviduct and in the 
mucosa muscularis of the vagina after induction of ovulation. Immunofluorescent 
images show the increase of IgA staining in the deep muscular layer of the oviduct (A) 
and in the mucosa muscularis of the vagina (C) after induction of ovulation compared 
with before ovulation (B and D) Se: serosa. All images are at the same magnification. 
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Figure 3-20. IgG staining in the female reproductive tract of normal and ovulated 
rabbits. The four immunofluorescent images on the left (A, C, E, G) are from normal 
rabbits and the four on the right (B, D, F, H) are from ovulated rabbits. A and B are 
oviduct; C and Dare uterus; E and Fare cervix, and G and Hare vagina. Lu: lumen; 
Ep: luminal epithelium; L.P: lamina propria; arrows: IgG positive cells. All images are 
at the same magnification. 
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staining was seen along the surface of the luminal epithelium, but IgG positive cells 
were not commonly seen in this region. In the cervix and vagina, IgG staining and 
individual IgG positive (plasma) cells were clearly restricted to the sub-epithelium or 
stroma rather than the epithelium (Figure 3-20). More IgG positive cells were present in 
the vagina than the cervix (Figure 3-20) and the epithelia of some glands in the cervix 
were also IgG positive. When normal goat serum was applied as a negative control, no 
positive cells or staining were observed and the stained sections were similar in 
appearance to those shown in Figure 3-16. 
3. 3. 9. 2.lgG containing cells in the ovulated reproductive tract 
The intensity of IgG staining in all regions of the reproductive tract decreased 
following induction of ovulation (Figure 3-20). In the oviduct, it was clear that although 
IgG staining in the lamina propria was much reduced, weak IgG positive cells were 
frequently present. In the uterus, IgG staining along the surface of the luminal 
epithelium was still observed though it was weaker than in normal rabbits. In the cervix 
and vagina, the staining ofigG in the sub-epithelium was reduced compared with that of 
normal rabbits. However, more IgG positive (plasma) cells were seen in the cervix of 
ovulated animals compared to non-ovulated animals. This was probably due to the 
decrease of IgG background staining that made the identification of IgG positive cells 
easier. But in the vagina, the reduction of IgG staining was also accompanied by a 
reduction in the number of IgG positive cells (Figure 3-20). When normal goat serum 
was applied to the sections as a negative contro~ no staining was observed and the 
sections appeared similar to those shown in Figure 3-18. 
3.3.10. IL-2 mRNA expression in the uterus 
IL-2 is an important Thl cytokine involved in T-cell activation (Roitt, 1997). To 
examine IL-2 production in the uterus, the level of IL-2 mRNA expression was assessed 
in frozen sections of the uterus from normal and ovulated rabbits using in situ 
hybridisation with sense and anti-sense IL-2 RNA probes (Chapter 2 section 2.13). As 
positive controls, frozen sections from popliteal lymph nodes were used. Strong IL-2 
mRNA expression was found on sections of popliteal lymph nodes hybridised with the 
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anti-sense RNA probe; only a few very weak positive signals were seen on comparable 
sections hybridised with sense RNA probe (Figure 3-21). This demonstrated the 
specificity of the in situ hybridisation method. 
On the uterine sections of normal rabbits ( 4 rabbits) IL-2 rnRNA was not strongly 
expressed (Figure 3-21) and there was no signal on sections hybridised with sense 
RNA. IL-2 rnRNA expression was substantially increased after induction of ovulation 
in all 3 rabbits tested. As in normal rabbits, there was no signal on the sections 
hybridised with the sense probe. The increased IL-2 rnRNA expression was mainly 
concentrated in the deep stroma of one of the three rabbits while in another rabbit IL-2 
mRNA was mainly distributed in the areas immediately beneath the epithelium (Figure 
3-21 ). In the third rabbit, IL-2 mRNA expression was found in both deep stroma and 
sub-epithelium. 
3.3.11. A summary of results: 
Histological examination has shown that induction of ovulation has physically 
expanded the mucosa (lamina propria and epithelium) in most regions of the female 
rabbit reproductive tract. Immunofluorescent results show the presence of large 
numbers of CD45+ and CD43+ cells in the mucosal areas of the oviduct, cervix, and 
vagina but significantly fewer cells in the uterus. Induction of ovulation did not affect 
the cell density in the mucosal area of each region. CD45+ and CD43+ cells were 
commonly present in the epithelium: even greater numbers of these cells were present 
immediately beneath the epithelium of the lower reproductive tract and formed cell 
clusters. KEN-5+ T cells and MHC-II+ cells were frequently present in the mucosal 
areas of the reproductive tract but far fewer cells were present in the uterus in normal 
rabbits. After induction of ovulation the cell numbers of both cell types increased in the 
uterus. 
lg µ-chain and IgA positive B cells were not commonly seen in the reproductive 
tract and ovulation did not affect this. However, compared with Ig µ-chain and IgA 
positive B cells, more IgG positive cells were present in the reproductive tract and the 
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Figure 3- 21. IL-2 mRNA expression in popliteal lymph nodes and the uterus of normal and ovulated 
rabbits. A represents the lyn1ph node section hybridized with IL-2 anti-sense probe. B represents the ly111ph 
node section hybridized with IL-2 sense probe. C represents the nonnal uterus hybridised with IL-2 anti-sense 
probe. D represents the ovulated uterus hybridised with IL-2 anti-sense probe. All are 1 00x magnification. 
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Chapter 3 
vagina contained more cells than other regions. Induction of ovulation decreased IgG 
staining in the lamina propria of most regions of the tract and IgG positive cell numbers 
in the vagina but increased IgA staining in the muscular layer of the oviduct and the 
mucosa muscularis of the vagina. Low level IL-2 mRN A expression was seen in the 
normal uterus but this dramatically increased after ovulation. 
Comparing between the regions, the vagina and cervix contain the greatest number of 
immune cells, the uterus contains the lowest number of immune cells under oestrogen 
dominated conditions and the oviduct is intermediate. However, the uterus shows the 
most sensitive reactions to ovulation with the numbers of KEN-5+ T cells and MHC II+ 
cells being increased in the endometrium after induction of ovulation and IL-2 
expression being strongly up-regulated. 
3.4. Discussion 
3.4.1. Leukocytes and T cells in the reproductive tract 
Understanding the immunology of the female reproductive tract is a first step in 
rational design of immunocontraceptive vaccines. To achieve fertility control using 
immunological means in the reproductive tract of the female rabbit, it is necessary that 
we understand the local immune response in the tract. However, there has, until now, 
been relatively little interest in rabbit reproductive immunology and, in contrast to the 
situation in rodents and humans, information on the immunology and immune responses 
of the female rabbit reproductive tract is very limited. In addition, since the rabbit is an 
induced ovulator and does not exhibit a regular oestrous cycle like rodents and humans, 
immune responses in the rabbit reproductive tract could be very different from these 
species. In this chapter, the basic immune cells in the rabbit reproductive tract have been 
examined and the available reagents were characterised under the normal condition of 
oestrogen dominance and after induction of ovulation by hCG injection. Because this 
study was directed at examining the immunology of the reproductive tract with a view 
to developing an anti-fertility response, immune cells in the reproductive tract of 
pregnant rabbits were not examined. 
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Numerous CD45+ cells were present in the mucosal areas of the vagina, cervix, and 
oviduct, both before and after ovulation. CD45 is expressed on all leucocytes and is also 
referred to as the common leucocyte antigen. However, compared with other regions of 
the reproductive tract, the rabbit uterus contains significantly fewer leukocytes. This 
contrasts to the finding in human where CD45+ cells were more abundant in the 
endometrium and fallopian mucosa than in the cervix or vagina (Givan et al. 1997) and 
reflects the variation between species on the distribution of CD45+ cells within the 
tract. Leucocytes are also abundant in the vagina and cervix of mice (Parr and Parr, 
1991) and in the uterus and vagina of rats (Kaushic et al. 1998). 
CD45 is expressed on B and T lymphocytes, monocytes, granulocytes and 
thymocytes. To specify more precisely the types of leucocyte present, sections of the 
reproductive tract were stained with the Mab Ll 1/135 which recognises the CD43 
antigen. This antigen is predominantly expressed on T cells in rabbits although Mab 
Ll 1/135 can also bind weakly to macrophages and monocytes (Wilkinson et al. 1992). 
The staining result showed that CD43+ cells constituted 30-77% of the total CD45+ 
1 leucocyte population in rabbits. Because most CD43+ positive cells labelled with 
Ll 1/135 showed strong fluorescence and were mostly round in shape (Figure 3-7), the 
majority of the positive cells are probably T cells. 
In humans, CD3 (T cell specific marker) positive T cells were shown to be the 
dominant population (30-60%) of CD45+ leucocytes in the reproductive tract (Givan et 
al. 1997). In addition, T cells are also the predominant lymphocytes in the female 
reproductive tract of mice (Parr and Parr, 1991; Nandi and Allison, 1993), cows (Cobb 
and Watson, 1995), and mares (Watson and Thomson, 1996). Thus, it is a common 
feature for many species, including the rabbit, that T cells are the predominant 
lymphocytes in the female reproductive tract. 
T cell functions such as lysing target cells for CD8+ T cells or producing cytokines 
for both CD4+ and CD8+ T cells can be associated with their locations in the 
reproductive tract. In rhesus macaques, T cells isolated from vaginal epithelium (IEL), 
but not sub-mucosa, could lyse antigen-specific cells (Lohman et al. 1995). As these 
cells were responding to simian immunodeficiency virus antigen, it is possible that IEL 
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are key effectors for cell and viral immunity. In humans, IEL in proliferative 
endometrium (before ovulation with oestradiol dominance) consist mainly of T cells, 
predominantly of the CD8+ subset. It has been suggested that these cells regulate the 
immune response to implantation (Pace et al. 1991 ). In rabbits, many CD43+ T cells 
were also located within the epithelium (Figure 3-7) but the functionality of these cells 
has not been examined. 
As well as IEL, in rabbits the leucocytes and CD43+ cells immediately beneath the 
epithelium ( sub-epithelial T cells) of the vagina or cervix could also be important in the 
immunity of the reproductive tract. There are more of these sub-epithelial T cells than 
IEL and they are located close to the epithelium (Figure 3-6). In humans, T 
lymphocytes were found to cluster in a distinct band beneath the epithelium of both 
cervix and vagina and it was suggested that these cells were not randomly scattered in 
the tissue but were organised in a distinct pattern (Johansson et al. 1999). However, 
their functional role in local immunity is still not clear. It is possible that these cells 
have a dynamic relationship with IEL in both rabbits and other species but further 
studies will be needed to examine this possibility. 
Classifying T cell subsets is important for understanding their functions. For 
example, CD4+ and CD8+ T cells are two major functional T cell sub-populations. 
CD4+ cells are T helper cells which recognise peptides presented by lvfHC II on 
professional APC and provide signals to activate T and B cells. CD8+ cells recognise 
antigens in association with MHC I molecules and can directly kill these cells, once 
activated. Both of these broad populations can be further sub-divided into sub-
populations including Thl/Th2 and suppressor cells/memory cells. The differences in 
their distribution in each region of the reproductive tract may reflect differences in local 
immunity in each region. In B cell deficient mice, CD4+ T cells could still maintain 
immunity to Chlamydia trachomatis infection in the genital tract (Johansson and Lycke, 
2001) which suggests that CD4+ cells play a major immune effector role in local 
immunity in the tract. In the current study, anti-rabbit CD4 monoclonal antibody 
(Chapter 2, Table 2-2) was employed to label CD4+ T cells in the reproductive tract. 
However, although this Mab binds strongly to the rabbit T cell line RL-5 , it did not bind 
to any cells in frozen sections. Similar negative results have been obtained with primary 
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rabbit lymphocytes in culture (P. Kerr, unpublished data). These data suggest that a new 
Mab to rabbit CD4 may be needed to work on frozen sections. 
3.4.2. The effect of ovulation on leucocyte and T cell distribution and 
activation 
In many species including rodents and humans the stage of oestrus has a profound 
effect upon the distribution and function of lymphocytes in the reproductive tract (Parr 
and Parr, 1991; Kaushic et al. 1998; Givan et al. 1997; White et al. 1997). For example, 
in mice, significantly (P<0.05) more Thy-1+ (T cells and some NK cells) lymphocytes 
were present in the vagina at dioestrus than during other stages of oestrus (Parr and Parr, 
1991 ). In humans, T cell numbers in the endometrium were significantly lower in the 
secretory stage (post-ovulation with high level of progesterone) than in the proliferative 
stage (Givan et al. 1997). In rabbits, the induction of ovulation has physically expanded 
the lamina propria and epithelia of the reproductive tract (Figures 3-1.1 , 3-2.1). However, 
there were no changes in CD45+ and CD43+ cell density. Therefore, since the tissues 
have expanded, ovulation must be associated with a substantial increase in the overall 
numbers of CD45+ and CD43+ cells in these tissues. Interestingly, in the vagina more 
CD45+ cells were found around the blood vessels in the mucosa muscularis of the 
ovulated rabbits than in non-ovulated rabbits, indicating that CD45+ cells were probably 
moving from blood into the vaginal tissues after hCG treatment. Whether this increase in 
CD45+ cell number was associated with the elevated progesterone level or blood vessel 
expansion is not clear because no such increase was observed in other regions. In addition 
to the general increase in T cell numbers, induction of ovulation also increased the 
numbers of KEN-5+ cells in the rabbit uterine endometrium. It was concluded that this 
was most likely due to up-regulation of KEN-5 on resident CD43+ T cells or to 
immigration of activated T cells since some immigration would be necessary to maintain 
T cell density in the expanded tissues. Otsuki et al ( 1990) previously showed that T cell 
numbers increased in the rabbit endometrium by 11 hours after hCG treatment (Otsuki et 
al. 1990). This is consistent with the current findings regarding KEN-5+ cells. However, 
the increase of T cell numbers in rabbit uterus differs from the findings in humans where 
the T cell number decreased when the progesterone level increased (Givan et al. 1997). 
These differences between rabbits and rodent or human again reflect a variation between 
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species in T cell response to the increasing level of progesterone during the oestrous cycle 
(rodents and humans) or after induction of ovulation (rabbits). 
As well as there being an increase in T cells expressing KEN-5, rabbit IL-2 mRNA 
expression in the uterus increased at the time of ovulation. IL-2 is an early product of 
activated T cells and a proinflammatory cytokine (Roitt, 1997). Given the increase in 
KEN-5+ cell number and the increased IL-2 mRNA expression, it is possible that KEN-
S+ expression is indicative of T cell activation. These increases could be important for a 
successful implantation because the normal ( oestrogen dominated) uterus contains only 
a very small number of immune cells including T cells. After ovulation, T cells, 
probably including immunosuppressive or regulatory T cells increased in number and 
became activated; this may be important in creating an environment for a successful 
implantation (Robertson, 2000). 
3.4.3. MHC class II expression in the reproductive tract 
The ability of cells in the reproductive tract to take up, process and present antigens 
is essential for induction of a local immune response in the tract (McGhee et al. 1994). 
MHC class II molecules on APC present processed antigen peptides in a MHC-peptide 
complex to CD4+ T cells followed by T cell receptor recognition and activation of 
antigen-specific T cells (Chapter 1 section 1.5). On the other hand, antigen presentation 
in the absence of correct signalling (eg CD40-CD40L interaction) may lead to T cell 
anergy. Therefore, detection of MHC class II expression in the reproductive tract 
provides a starting point for determining the numbers of potential APC in the 
reproductive tract. In rabbits, MHC II+ cells were frequently seen in the mucosa of 
oviduct, cervix, and vagina under both oestrogen dominated and ovulated conditions but 
were seen frequently in the uterus only after ovulation (Figure 3-11 ). MHC II+ cells 
could include activated T cells, B cells, and APC (Mage, 1998). It was shown in the 
current study that KEN-5+ cells could be MHC II+ in the normal reproductive tract 
(Figure 3-13). However, the majority of MHC II+ cells in the vagina and cervix were 
KEN-5 negative (Figure 3-13). 
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Uncommitted B cells were rare in the female rabbit reproductive tract based on lg µ-
chain staining and IgA plasma cells were also uncommon (Figures 3-14, 3-16). 
Although IgG positive cells were frequently seen in the normal vagina they were 
distinguished by being round-shaped and not located in the luminal epithelium (Figure 
3-20g). Since most MHC II+ cells in the vagina or cervix were KEN-5- and given the 
rarity and location of B cells, most MHC II+ cells in these regions, especially those in 
or very close to the luminal epithelium, are potential APC. From their irregular cell 
shape (Figures 3-11 e, f, g, h), they are potentially tissue macrophages or professional 
APCs such as dendritic or Langerhans' cells. In humans, MHC II+ cells were shown to 
be abundant in the lamina propria of both the cervical and vaginal mucosa. In the 
epithelium of these tissues, positive cells were found at a mean frequency of 94 cells per 
mm
2 (Johansson et al. 1999). Similarly in rat, numerous MHC II+ cells were present in 
vaginal sub-epithelial layers and the number was greater than that in the uterus (Kaushic 
et al. 1998). MHC II+ cells were also reported in the epithelia and stroma of the mouse 
vagina (Parr and Parr, 1991 ). These data collectively suggest that most species, 
including rabbits, have an abundant MHC II+ cell presence in vagina or cervix. 
In the rat, Wira et al (2000) showed that vaginal macrophages and dendritic cells 
have the ability to present antigens ( ovalbumin) to T cells in vitro (Wira et al. 2000). 
Similarly, epithelial or stromal cells in the vagina expressed MHC II and were capable 
of presenting antigens in the female human reproductive tract (Fahey et al. 1999). By 
extension to the rabbit, APC in vagina and cervix could present antigens introduced into 
the vagina to T cells in the draining lymph nodes and initiate an immune response 
(Mc Ghee et al. 1994 ). It remains to be determined whether the effector cells can then 
migrate back to the vagina and cervix. 
3.4.4. The effect of ovulation on MHC II expression 
In rabbits induction of ovulation increased the number of cells in the uterine 
' 
endometrium which expressed MHC class II (Figures 3-11, 12). It is possible that these 
positive cells were derived from blood such as migrating macrophages or were activated 
T lymphocytes expressing MHC-II. But it is also possible that these positive cells 
resulted from up-regulation of MHC II on local epithelial cells. In the rat, uterine 
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epithelial and stroma cells could present antigen ( ovalbumin) to ovalbumin-specific T 
cells and stimulate T cell proliferation; this ability was MHC II dependent and could be 
blocked by MHC II antibody (Wira and Rossoll, 1995b ). It is therefore assumed that 
these cells express MHC II. In humans, freshly isolated uterine epithelial cells were 
MHC II positive (Wallace et al. 2001). In rabbits, it is possible that the increase ofMHC 
II expression in the uterus reflects an increase of MHC II expression on local epithelial 
cells. This was supported by the observation that most MHC II+ cells in the uterus were 
associated with luminal and glandular epithelium (Figures 3-12 c, d). If this is correct, 
the antigen presentation ability of rabbit uterine epithelial cells could be determined as 
in the rat study (Wira and Rosso 11, 1995b ). But there is a potential difference between 
rabbits and rats. In the rat, the antigen presenting ability of uterine epithelial cells was 
high at late dioestrus when oestradiol levels are increasing (Wira and Rosson, 1995b ). 
However, in rabbits, MHC II expression increased in the uterus after ovulation when the 
progesterone level increases, and so antigen presenting ability is most likely high after 
ovulation. Whether this indicates that MHC-II expression and antigen presentation on 
rabbit uterine epithelial cells could be involved in T cell activation, or potentially T cell 
anergy due to lack of co-stimulation molecules, has not been investigated. 
In either situation, the increased MHC II expression on rabbit uterine cells suggests 
that the uterus is more immunologically active after ovulation and this agrees with the 
up-regulation of KEN-5+ T cells and increased IL-2 mRNA expression in the uterus 
after ovulation. All these up-regulations in the uterus driven by the increasing level of 
progesterone may be an essential step for building up an immune balance between 
tolerance (to the foetus) and immunity against infection and may be a necessary 
inflammatory response in preparing for implantation. 
Apart from the uterus, no increase of MHC II expression was seen 1n other 
reproductive tract regions of rabbits. However, in other species, the ovarian hormone 
progesterone has been reported to affect MHC II+ expression in the vagina. For 
instance, in the mouse, more MHC-II+ and F4/80+ (macrophage specific marker) 
dendritic cells were present in both cervix and vagina at dioestrus than at prooestrus or 
oestrus (Parr and Parr, 1991). In the rat, MHC II+ cell numbers in vagina were greater at 
dioestrus than at oestrus (Kaushic et al. 1998). This indicates a clear species difference 
that may be associated with differing immune capacities at different stages of the 
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oestrous cycle. It is probable that APC and immune responses would be more important 
after mating when large amounts of foreign material are deposited in the vagina and 
there may also be a greater likelihood of trauma and infection. Why these cells are not 
up-regulated in the rabbit is not at all clear. 
3.4.5. IgA and IgG positive cell distribution in the reproductive tract 
In the rabbit, uncommitted B cells were uncommon in the normal female 
reproductive tract as judged by lgµ chain expression. lgA-expressing plasma cells were 
also uncommon (Figure 3-16) although lgG plasma cells were present in vagina and 
cervix (Figure 3-20). B cells expressing the lg µ chain have been described in rabbit 
uterus ( Otsuki et al. 1990) and lgG plasma cells have been described in the vagina 
(Symons and Herbert, 1971). This is consistent with the current result. These findings 
suggest that local production of lgA is not significant in the rabbit reproductive tract but 
that local expression of lgG is potentially important in the cervix and vagina. 
In contrast, there was a strong staining for both lgA and lgG at both basal and 
luminal surfaces of the uterine epithelium, indicating that mucosal barriers of lgA and 
lgG may well be important in the uterus and possibly also in more distal regions of the 
tract if the antibodies are carried along in reproductive tract secretions. The low 
numbers of plasma cells, especially in the uterus, indicate that these antibodies are 1nost 
likely derived from the serum and pass through the epithelial cells by the well-
characterised passive transfer or poly-lg transporter mechanisms (Chapter 1 section 
1.4). 
There are considerable species differences in the· distribution of plasma cells in the 
reproductive tract. In mice, lgA plasma cells predominated in the uterus at pro-oestrus 
and oestrous (Rachman et al. 1983) or at all stages of the oestrus cycle (Parr and Parr, 
1985). The uterus and oviduct also contained more IgG and IgA plasma cells than did 
the cervix and vagina (Parr and Parr, 1985). In humans, IgA plasma cells predominated 
in the fallopian tube (Kutteh et al. 1990). Compared with these species, the rabbit differs 
in both the numbers and location in the distribution of lgG and IgA positive cells in 
uterus and oviduct. The plasma cells in the upper reproductive tract of these species can 
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contribute to local lg production but this is not the case for rabbits because of the lack of 
IgG+ plasma cells. But IgG plasma cells found in normal rabbit vagina may contribute 
to local IgG production in this region. In the rat, lgA plasma cells were absent from the 
whole female reproductive tract. It was suggested that the IgA present in the tract was 
mainly derived from serum (Parr and Parr, 1989). Like the rat, the rabbit has few if any 
IgA positive cells in the reproductive tract. Therefore the IgA in rabbit reproductive 
tract is more likely to be derived mainly from serum. This would explain why the 
epithelial surfaces of the rabbit uterus were covered with IgA under normal oestrogen 
dominated conditions, despite the lack of local IgA plasma cells. In addition, compared 
with the vagina, far fewer IgG positive cells were present in the upper reproductive tract 
of the rabbit, but strong IgG staining was present along the surface of the uterine 
epithelium (Figure 3-20c ). This IgG is also probably largely derived from serum, with 
perhaps some contribution from local plasma cells. 
3.4.6. The effect of ovulation on lgA and IgG presence in the -
reproductive tract 
In rabbits, induction of ovulation decreased IgG positive cell numbers in the vagina 
but did not influence the number of IgA and IgG positive cells in other reproductive 
tract regions. However, there were very few IgA and IgG positive cells in either uterus 
or oviduct at any stage. In rodents, oestrous cycles have significant effects on IgG and 
IgA plasma cell distribution in the uterus. For example, in mice, numerous IgA plasma 
cells were found in the uterus at pro-oestrus and oestrus but much fewer at other stages 
of oestrus (Rachman et aL 1983). IgA and IgG plasma cells were also reported to 
increase markedly in mouse uterus between day 1 and days 4-5 of pregnancy (Parr and 
Parr, 1985). In the rat, oestradiol treatment of the ovariectomised rat increased the 
infiltration of IgA and IgA plasma cells into the uterus (Wira and Sulliva~ 1981 ), 
though the uterus is lacking IgA plasma cells during the normal oestrous cycle (Parr and 
Parr, 1989). This indicates that the rabbit is quite distinct from the common rodent 
models of reproductive tract immunity, both in terms of total leucocytes and in terms of 
plasma cells. 
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An increase of IgA staining in the deep muscular layers of the oviduct and mucosa 
muscularis of the vagina was observed after induction of ovulation in the rabbit (Figure 
3-19). This staining was not associated with a specific cell type, suggesting that IgA 
transudation from serum to tissue was enhanced by hCG treatment. In contrast to IgA, 
IgG staining weakened in the lamina propria or stroma of oviduct, cervix and vagina 
after induction of ovulation (Figure 3-20). However, no such changes were observed in 
the uterus. In rats, in contrast, IgG and IgA levels in uterine tissues were high at pro-
oestrus, IgA remained high but IgG dropped at oestrus, and both IgA and IgG were low 
at dioestrus (Wira and Sandoe, 1980). Similar results were reported in the mouse 
(Rachman et al. 1983). These comparisons suggest that the reaction of the rabbit uterus 
to ovulation is different from rodents, which may once more reflect a variation between 
species or the difference in endocrine status between cyclic oestrus (rodents) and 
induced ovulators (rabbits). 
3.4. 7. Epithelial surface lgA and IgG and the specificity of the staining 
An interesting observation in the current study is the presence of both IgA and IgG 
along the epithelial luminal surfaces of the uterus (Figures 3-16c, 3-18c, 3-20c ). The 
staining was mainly located in the apical area of the epithelial cells but sometimes also 
in basal areas. It is unlikely that this staining was non-specific. Firstly, there was little or 
no background staining on the negative controls (Figure 3-16), suggesting that the 
antibody binding is specific. Secondly, on the antibody treated sections, the staining was 
seen only on the cells or on specific parts of the tissue but not all over the section, 
suggesting again the specific binding of the antibody. In addition, on sections of the 
small intestine the antibody reaction was mainly on the plasma cells in lamina propria 
or around the glands but not on the epithelial luminal surface (Figure 3-17). These data 
confirm that this antibody specifically reacts with IgA in frozen sections. 
It is also highly unlikely that this staining is an edge effect of the antibody conjugate 
because no such staining was found on the edges of sections from other reproductive 
tract regions in the same assay, eg. the oviduct and vagina (Figures 3-l 6a, g and Figures 
3-20a, g). In the cervLx (Figure 3-18e) in w-hich the epithelial cells are similar to those 
in the uterus, the staining was clearly seen in the basal area of the epithelial cells 
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following ovulation but not at the luminal surface. Similarly, IgG staining in the vagina 
was restricted to the sub-epithelium with no staining in the epithelium or at the luminal 
epithelial surface (Figure 3-20g). These data collectively confirm the staining is specific 
and not an edge effect. 
The surface IgA and IgG are either within the epithelial cells or very tightly attached 
to the cell surface because these molecules were not removed by fixation and repeated 
washing during section preparation and immunofluorescent staining (Chapter 2, section 
2.2.3.3 and 2.4.1). Such staining has not been documented in other species and it 
appears that this is a special characteristic of rabbits. In mice, during oestrus, the lumen 
of reproductive tract was full of fluid (Parr and Parr, 1998) but this was not observed in 
rabbits either before or after ovulation. This suggests the secretion mechanism of the 
uterine epithelial cells of rabbits is different from mice. More investigation is needed to 
address these issues. 
3.4.8. Conclusion 
It is clear in rabbits that each region of the female reproductive tract has its unique 
pattern of immune cell distribution, a pattern that may well be linked to its immune 
function. In the female reproductive system, the vagina and cervix are anatomically at a 
position frequently exposed to a variety of antigens (including bacteria and viruses) 
either from faecal or environmental contamination or at mating where sperm are also 
antigenically foreign. In the rabbit, the vagina and cervix contain more leukocytes, T 
cells, potential APC and plasma cells than other regions of the reproductive tract and are 
more likely to have the capacity to mount an immune response against infection. Rats 
have a similar immune cell distribution to rabbits (Kaushic et al. 1998) and in humans, 
T cells and APC are also abundant in the vagina (Givan et al. 1997). The presence of 
these cells in the lower reproductive tract of several species is probably an important 
feature of the defence against external infection. 
The uterus is where implantation and fetal development occur. Protecting the "half-
self' fetus from immunological rejection by immune suppression and regulation 
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(Robertson, 2000) and the prevention of infection by active immune responses are both 
important. Before ovulation when oestrogen is dominant, the rabbit uterus contains 
small numbers of immune cells so it may be not be immunologically active. However, 
the uterus is the only region in which immunological changes occur following 
ovulation. Following hCG treatment, there was an increase of KEN-5+ and MHC II+ 
cells and IL-2 mRNA expression in the uterus. This could be important for setting up 
defensive immunity and also contribute to immune regulation for implantation. 
However, in humans and rodents, other regions as well as the uterus were also sensitive 
to ovulation (Parr and Parr, 1991; Kaushic et al.1998; Givan et al. 1997). 
The oviduct is the site where fertilisation occurs and the embryos undergo early 
development. In rabbits, it contains medium levels of immune cells, higher than the 
uterus but lower than the vagina or cervix. The oviduct is dominated by T cells with less 
frequent MHC II positive cells and plasma cells. These T cells may be more involved in 
immuno-suppression or some immune regulatory function that is involved in protecting 
the conceptus rather than in mounting an immune response against potential infections. 
In contrast, in humans, the oviduct contains more CD45+ cells (Givan et al. 1997) and 
IgA plasma cells (Kutteh et al. 1990) than the vagina; these are more likely to be 
involved in local immune responses. 
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CHAPTER 4: IMMUNE RESPONSE IN THE FEMALE 
RABBIT REPRODUCTIVE TRACT TO A MODEL 
ANTIGEN INFLUENZA HA DELIVERED BY A 
RECOMBINANT MYXOMA VIRUS 
4.1 Introduction 
Myxoma virus has been chosen as a potential vector to deliver immunocontraceptive 
vaccines for rabbit population control (Tyndale-Biscoe, 1994; Holland and Jackson, 
1994 ). It has previously been shown in rabbits that both IgG and IgA antibody in the 
reproductive tract fluids are contributors to blocking fertilisation (Menge and 
Lieberman, 1974). Therefore, induction of a satisfactory antibody response including 
both IgG and IgA antibody classes in the reproductive tract fluid by the recombinant 
myxoma vrrus may well be crucial for the success of viral-vectored 
immunocontraception acting in the reproductive tract. 
However, it has not proved easy to induce a satisfactory antibody response in the 
female reproductive tract with conventional immunisation regimes (Menge et al. 1993; 
Gallichan and Rosenthal, 1995; Russell and Mestecky, 2002). Many researchers are 
exploring new ways to enhance the mucosal immune response in the female 
reproductive tract such as using viral-like particles or synthetic oligodeoxynucleotides 
containing immunostimulatory CpG motifs (Gallichan et al. 2001; Li, et al. 2001; 
Dumais et al. 2002; Russell and Mestecky, 2002). Using a viral vector to deliver the 
antigen is one of such methods (Michalek et al. 1994; Gallichan and Rosenthal, 1995; 
Rosenthal et al. 1996; Morrow et al. 1996). It is believed that the replication of the 
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recombinant virus and its ability to penetrate through the mucosa! surfaces are essential 
for stimulating a good mucosa! antibody response (Rosenthal et al. 1996; Parr and Parr, 
1994). 
Like many other poxviruses, myxoma virus has been investigated as an antigen 
delivery vector for vaccines acting through a systemic immune response (Kerr and 
Jackson, 1995; Bertagnoli et al. 1996). Female rabbits infected intradermally with a 
recombinant myxoma virus expressing influenza haemagglutinin (MV -HA) had a high 
and sustained IgG response to HA in blood plasma and a detectable level of IgG 
antibody in vaginal washings (Kerr and Jackson, 1995). However, whether the 
recombinant myxoma virus could induce an effective immune response with high levels 
of antibody in the female rabbit reproductive tract has not been determined. This is 
important in determining whether a strategy for immunocontraception that envisages 
high levels of antibody in the reproductive tract is practical. In the mouse, recombinant 
adenovirus is able to induce an effective mucosal immune response in the female 
reproductive tract (Gallichan et al. 1993; Gallichan and Rosenthal, 1995; Xiang and 
Ertl, 1999). It is necessary to investigate whether a recombinant myxoma virus could 
similarly deliver an antigen and induce a mucosal immune response in the female rabbit 
reproductive tract. 
IgG antibody in serum can passively transfer into the reproductive tract (Chapter 1 
section 1.4.1 ). Polymeric IgA and IgM produced locally by plasma cells in the lamina 
propria can be transferred across the epithelium into the reproductive tract lumen 
through pigR on epithelial cells (Chapter 1 section 1.4.2). Therefore, how best to 
present antigen and achieve a maximal IgG antibody transfer into the reproductive tract 
lumen and have plasma cells homing back to the reproductive tract are major objectives 
for inducing an effective antibody response in the tract. 
The female reproductive tract is considered to be a part of the common mucosal 
immune system. Studies in both human and mouse have demonstrated that 
immunisation at distal mucosal surfaces such as the nasal mucosa can be effective in 
inducing mucosal immune responses in the female reproductive tract (Ogra and Ogra, 
1973; Gallichan and Rosenthal, 1995; De Haan et al. 1995; Johansson et al. 1998; 
Xiang and Ertl, 1999; Gallichan et al. 2001; Russell, 2002). In mice, for example, 
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intranasal immunisation with recombinant adenovirus expressing HSV-1 glycoprotein B 
induced specific and protective IgA and IgG responses in serum and vaginal secretions 
(Gallichan et al. 1993; Gallichan and Rosenthal, 1995). Antigen specific antibody-
secreting cells were also found to home back to the reproductive tract after intra-nasal 
immunization (Gallichan and Rosenthal, 1998). Similar results were obtained in mice 
with a recombinant adenovirus expressing rabies virus glycoprotein (Xiang et al. 1999). 
In the rabbit, intranasal immunisation with HN-1 C4N3 peptide and a subsequent 
intranasal booster showed better antibody responses in vaginal secretions than intra-
vaginal administration and boosting (Zinckgraf et al. 1999). 
Intra-vaginal immunisation is an effective way of inducing local mucosa! immune 
responses in the female genital tract of mice (Johansson et al. 1998, Kato et al. 2000), 
rats (Menge et al. 1993), macaques (Lehner et al. 1992) and humans (Kozlowski et al. 
1999; Johansson et al. 2001 ). In addition, neutralising IgA and IgG antibody responses 
to HIV-1 envelope protein was elicited in mouse vaginal secretions after intra-vaginal 
immunization with a DNA vaccine (Wang et al. 1997). In rabbits, a detectable specific 
IgA response was induced to horseradish peroxidase in the reproductive tract secretions 
following intra-vaginal immunization and boosting (McAnulty and Morton, 1978). 
Results from Chapter 3 (sections 3.3.6 and 3.4) showed that many potential APC (MHC 
class II positive cells) were present in the lower reproductive tract of female rabbits, 
suggesting that this part of the tract may have the ability to present antigens to the T 
cells in local draining lymph nodes and then stimulate a local immune response 
(McGhee et al. 1994). 
In rats and rmce, IgA antibody titers in reproductive tract secretions were 
significantly elevated in ovariectomised animals treated with oestradiol (Wira and 
Sandone, 1987; Wang et al. 1996). IgA antibody titers in murine vaginal washings were 
also significantly higher during oestrus than dioestrus or proestrus but IgG antibody was 
significantly higher in dioestrus than oestrus (Gallichan and Rosenthal, 1996). These 
results illustrate the close relationship between endocrine status and the immune 
response. Unlike these rodents, which exhibit regular oestrous cycles and ovulation, 
ovulation in rabbits is induced by mating, with oestrogen being the dominant ovarian 
hormone before mating (Hammond and Marshall, 1925). Although changes in immune 
cell (including IgG plasma cell) distribution and Ig presence in reproductive tract tissues 
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were observed after induction of ovulation (Chapter 3 section 3.3.8 and 3.3.9) it was 
unclear how this would affect the immune response and antibody production in the 
reproductive tract. 
An alternative approach to achieve immunocontraception is to use ovarian antigens, 
which are accessible to systemic antibodies (Chapter 1 section 1.6.3). If an ovarian 
antigen were to be vectored by the recombinant myxoma virus for 
immunocontraception strong antibody responses in serum and ovarian follicular fluids 
would be essential (Chapter 1 section 1.6.3). 
To investigate these issues, a model antigen delivery system of recombinant myxoma 
virus expressing influenza virus HA was used to infect female rabbits by different 
routes. Immune responses to HA or myxoma virus were monitored in serum, 
reproductive tract fluids and ovarian follicular fluids. 
4.2 Experimental design 
Experiment 1: Eight female rabbits were intradermally inoculated with 106 pfu of 
MV-HA (Chapter 2 section 2.2.2.1) to determine whether a high-level antibody 
response could be induced in the female rabbit reproductive tract with a natural 
infection of MV-HA. Four rabbits were killed at 15 days and four at 30 days post-
infection, the peak period of specific antibody production (Kerr and Jackson, 1995). 
Another four female rabbits injected with PBS instead of the recombinant virus served 
as controls and were killed at 15 days. 
Ovulation and its associated hormonal changes influence antibody entry into the 
female reproductive tract (Chapter 1 section 1.5.3; Chapter 3 section 3.3.8.2, 3.3.9.2). 
To examine the effect of ovulation on antibody titers, another eight female rabbits were 
similarly infected with 106 pfu of MV-HA and ovulation was induced by intravenous 
administration of hCG (Chapter 2 section 2.2.2.2) 12 hours before they were killed 
either at day 15 or day 30 post infection. Another four non-infected rabbits treated with 
hCG were killed as controls. When the rabbits were killed blood samples were collected 
for preparation of serum. Luminal fluids were collected from oviduct, uterus and 
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vagina by both flushing ( 4 rabbits of each group) and capillary micro-puncture (two 
rabbits of each group, Chapter 2 section 2.2.3 .1 ). For collection of capillary micro-
puncture samples, rabbits were anaesthetised with pentobarbitone; after sampling, they 
were killed with an overdose of pentobarbitone. Micro-puncture samples were collected 
by Dr Russell Jones. Tissue samples from oviduct, uterus, cervix and vagina were 
collected for preparation of frozen and paraffin-embedded sections (Chapter 2 section 
2.2.3.2) to examine the cellular response and histological changes. 
Experiment 2: To test the ability of immunisation at distal and local mucosal sites to 
induce an effective mucosal immune response in the female reproductive tract, two 
groups of 8 female rabbits were used. One group was immunised intra-nasally and 
another intra-vaginally with 106 pfu of MV-HA (Chapter 2 section 2.2.2.1). Blood, 
nasal and vaginal washlngs were taken from each rabbit before immunisation. Four 
rabbits from each group were killed at days 15 and 30 post-infection and blood and 
reproductive tract flushing samples were co~ected as described above. In addition, nasal 
washings (Chapter 2 section 2.2.3.1) were collected for antibody measurement and 
tissues from each region of the reproductive tract were collected and prepared for frozen 
and paraffin-embedded sections. 
Experiment 3: In order to investigate IgA and IgG titers in reproductive tract fluids 
over a longer time frame after NIV-HA infection or after boosting with HA antigen, four 
rabbits were immunised with 106 pfu MV-HA, hvo intra-nasally and two intra-
vaginally. At day 70 post-infection, these animals were boosted intra-vaginally with 
influenza virus (Chapter 2 section 2.2.2.1 ). Blood, nasal and vaginal washlngs (Chapter 
2 section 2.2.3.1) were taken at days 3, 15, 30, 45, 70 after immunization and at days 3, 
6, 10 after boosting. These animals were killed on day 15 post-boost and blood samples 
and reproductive tract flushings were collected. 
Experiment 4: Four female rabbits 'vvere intradermally immunized with 106 pfu MV-
HA to compare antibody levels in serum and ovarian follicular fluids. Blood samples 
were collected before immunization for preparing pre-immune serum and at 15 days 
after immunisation for antibody assay. For collecting ovarian follicular fluids the 
animals were injected with PMSG (72 hours before sampling) and hCG ( 12 hours 
before sampling) to induce super-ovulation (Chapter 2 section 2.2.2.2). Blood samples 
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and ovarian follicular fluids were collected for antibody measurement (Chapter 2 
section 2.2.3 .1 ). 
4.3 Results 
4.3.1 Antibody response to HA following intradermal immunisation 
withMV-HA 
HA specific antibody titers of IgG, IgA, and IgM classes in reproductive tract fluids 
(including flushing and micropuncture samples) and serum were measured using 
ELISA (Chapter 2 section 2.3.1). High titers of HA specific IgG were detected in serum 
at both 15 and 30 days post-infection (Figure 4-1 ). HA specific IgG was also detectable 
in reproductive tract fluids but the titers were 100-1000 fold lower than those in serum 
(Figure 4-1 ). No significant change of IgG antibody titers was detected between day 15 
and day 30 in either serum or reproductive tract samples. The titers in samples obtained 
from different regions of the tract were comparable. No HA specific IgG was detected 
in serum and reproductive tract fluids from uninfected controls. 
HA IgG titers in the micropuncture samples were not different from those in flushing 
samples in any region (Figure 4-1 ). The micropuncture samples were collected from 
free-flowing fluids in the lumen of the reproductive tract (volume of 100-150µ1) 
whereas flushing samples were collected by flushing the lumen with 1ml PBS. 
Therefore, compared with micropuncture samples the flushing samples were diluted 
about ten times. However, similar HA IgG titers were obtained in the samples collected 
by the two different methods, suggesting that flushing samples might contain mucus 
flushed from the mucosal layer and which contained higher levels of specific IgG than 
the free fluids (micropuncture samples). This result also suggests that specific IgG titers 
in flushing samples can be used to represent antibody titers in the reproductive tract free 
flow fluids. 
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Figure 4- 1. HA specific IgG titers in serum and reproductive tract fluids after 
intradermal infection with MV-HA 
Rabbits were immunised with 106 pfu MV-HA. Specific IgG titer to HA was determined by ELISA in 
serum and reproductive tract fluids collected from oviduct, uterus and vagina by both flushing and micro-
puncture at either 15 or 30 days post-infection. The titers were transformed into logarithms and expressed 
as mean Log 10 titers for four (flushing samples) or two (micropuncture samples) rabbits. F: flushin g 
samples. M: micropuncture samples. The error bars represent standard deviation. 
HA specific IgM was always above 1: 100 in serum but was only detected in one 
oviduct flushing sample at a titer of 1 :5. HA IgM was also detected in two 
micropuncture samples, an oviduct sample from one rabbit and a vaginal sample from a 
second at the same titer of 1 :5. There was no significant difference between the average 
titer of HA IgM in serum at day 15 (iv'Iean ± S.D, 2.7 ± 0.4) and day 30 (Mean+ S.D~ 
2.2 ± 0.3) post-infection (P=0.11 ). HA specific IgM was not detected in serum or 
reproductive tract fluids from uninfected controls. 
HA specific IgA was not detectable in serum or reproductive tract fluids from either 
infected or control rabbits. 
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4.3.2 The effect of ovulation on HA antibody titers 
HA antibody titers were also measured in serum and reproductive tract fluids in 
rabbits infected with MV-HA and treated with hCG 12 hours before sampling. HA 
specific IgG titers in reproductive tract fluids were still much lower than those in serum 
and were not different from un-ovulated animals at either time point (Figure 4-2). There 
were no significant differences in HA specific IgG titers between samples collected 
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Figure 4- 2. HA specific IgG in serum and reproductive tract fluids of rabbits 
infected with MV-HA and treated with hCG 
Rabbits were intradermally immunised with 106 pfu MV-HA. Ovulation was induced by hCG injection 12 
hours prior to sampling. Specific IgG titer to HA was determined by ELISA in serum and reproductive 
tract fluids collected from oviduct, uterus and vagina by both flushing (mean of four rabbits) and micro-
puncture (mean of two rabbits) at 15 and 30 days post-infection. The antibody titers were transformed 
into logarithms and expressed as mean Log 10 titers for four (flushing samples) or two (micropuncture 
samples) rabbits. F: flushing samples. M: micropuncture samples. 
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from different regions of the reproductive tract. However, HA specific IgG titers in 
serum and oviductal flushings were higher at 30 days than at 15 days (P<0.05 for both 
samples). Similar HA specific IgG titers were obtained in micropuncture samples and in 
flushing samples (Figure 4-2). No HA IgG was detected in serum or reproductive tract 
fluids from uninfected animals after induction of ovulation. 
HA IgM titers in serum ranged from 1: 100 to 1: 1600 (Mean± S.D, 2. 7 ± 0.5 and 2.2 
± 0.2 for day 15 and 30 post-infection) whereas HA IgM was only detected in 
oviductal, uterine and vaginal flushings from a single rabbit at titers of 1: 10, 1: 10, and 
1 :40 respectively. These values are similar to those obtained prior to ovulation. No HA 
IgM was detected in micropuncture samples or serum or reproductive tract flushings 
from uninfected controls after induction of ovulation. 
HA specific IgA was not detectable in serum or reproductive tract samples ( flushing 
or micropuncture) from infected or uninfected rabbits after induction of ovulation. 
4.3.3 Antibody response to HA following intranasal infection with 
MV-HA 
Intradermal immunisation did not induce a high level of HA specific IgG in 
reproductive tract fluids. It produced a poor IgM response and completely failed to 
stimulate an IgA response in either serum or reproductive tract fluids. In an attempt to 
provoke an IgA response in the reproductive tract, the rabbits were infected through the 
intranasal route, an effective inductive site of the common mucosal immune system. As 
ovulation had not influenced antibody titers in the previous experiment, hCG treatment 
was not used in these trials. 
Between 10-20 days after intranasal inoculation, serous ocular discharges and red 
conjunctivae were observed in 7 /8 of the infected rabbits. This was probably due to 
local virus replication. 
Similarly to intradermal immunisation, intranasal immunisation induced high titers 
of HA specific IgG in serum and much lower titers in reproductive tract flushings at 
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both 15 and 30 days post infection (Figure 4-3). No differences were found between 
samples collected from different regions of the reproductive tract. Compared with intra-
dermal immunisation (Figure 4-1 ), the intra-nasal route elicited higher serum IgG titers 
at both 15 days (P<0.01) and 30 days (P<0.01) post-infection. The titers obtained in 
reproductive tract flushings were comparable to those generated by intra-dermal 
inoculation, except for titers in oviductal flushings which were higher than in the intra-
dermal group at 30 days post-infection (P<0.05). HA specific IgG was detectable in 
nasal washings at similar titers to those detected in reproductive tract flushings (Figure 
4-3). No HA specific IgG was detected in serum, nasal and vaginal washings collected 
before immunisation. 
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Figure 4- 3. HA specific IgG titers in serum, reproductive tract flushings and nasal 
washings after intranasal infection with MV-HA 
Rabbits were intra-nasally immunised with 106 pfu MY-HA. IgG titers to HA were measured by ELISA 
in serum, reproductive tract flushings (from oviduct, uterus and vagina) and nasal washings at 15 and 30 
days post-infection. The antibody titers were transformed into logarithms and expressed as mean Log 10 
titers; n = four rabbits. 
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The HA specific IgM titer was always above I :50 in serum (Mean ± S.D, 3.1 + 0.2 
for day 15 group; 1. 9 ± 0.2 for day 30 group) but was detected in only one uterine 
flushing and one nasal washing at a titer of 1 :5. The mean titer in serum of rabbits at 30 
days post-infection was lower (P=0.001) than that at 15 days post-infection. No specific 
IgM was detectable in pre-immune serum, nasal washings or vaginal washings. 
HA specific IgA was detected in oviductal samples from 4 rabbits and one uterine 
sample at a titer of I :3. One nasal washing also showed a HA specific IgA titer of 1 :6. 
No HA specific IgA was detected in any other samples either before or after infection. 
4.3.4 Antibody response to HA following intra-vaginal infection with 
MV-HA 
Local immunisation in the female reproductive tract is thought to be capable of 
inducing antigen presentation in the draining lymph nodes of the reproductive tract 
(McGhee et al. 1994) resulting in B cell homing and local IgA antibody production 
(McGhee et al. 1999, Chapter I section 1.5.2). The results from Chapter 3 (section 
3.3.5) showed that many MHC II+ cells that are potential antigen-presenting cells were 
present in the vagina. To examine antigen presentation and local antibody response in 
the rabbit reproductive tract, a group of rabbits was immunised intra-vaginally with 
MV-HA. 
4.3.4.1 Replication of recombinant virus in the reproductive tract 
For intra-vaginal immunisation to be effective, the virus must replicate and produce 
HA or be transported to and replicate within the cells of the draining lymph node. After 
immunisation, red and swollen vaginas were observed in 6/8 infected rabbits between 
10 and 15 days post-infection. This indicated that the virus might be replicating locally. 
To confirm this, frozen sections of the reproductive tract tissues were collected at day 
15 and day 30 and examined by immunofluorescence (Chapter 2 section 2.4.1) for 
myxoma virus antigen. Viral positive cells were found in the epithelium and sub-
epithelium of the vagina and cervL'( (Figure 4-4) from rabbits at both infection time 
points. However, viral positive cells were not found in the oviduct although a few 
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Figure 4- 4. MV positive cells in the reproductive tract of rabbits intra-vaginally 
immunised with MV-HA. The irnmunofluorescent images show the presence of MV 
positive cells in the reproductive tract. A represents the vagina from rabbits 15 days 
after intra-vaginal immunisation with MV-HA. B represents the cervix from the same 
group. MV positive cells were also found in the glandular epithelium in the stroma of 
the cervix (B, arrow). C and D represent the uterus and oviduct from the same infected 
group. E represents the vagina from intra-nasally immunised rabbits at the same 
infection time point and shows no MV positive cells were present. F is vagina from an 
intra-vaginally infected rabbit treated with MAP. Lu: lumen; Ep: luminal epithelium. 
All images are at same magnification. 
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positive cells were seen in the uterus of the same infected rabbits (Figure 4-4). As 
negative controls, frozen sections of reproductive tract tissues from the intranasal and 
uninfected groups were also examined for the viral antigen. No MV positive cells were 
found in those sections (Figure 4-4) or in sections treated with MAF, the negative 
control for the staining, although there is some weak background staining (Figure 4-4). 
In addition to MV antigen, HA antigen was also detected in the vagina from the 
intra-vaginally immunised rabbits using rat anti-HA antibody (Chapter 2 Table 2-2). As 
predicted, HA positive cells were found in the luminal epithelium of the vagina from 
these rabbits (Figure 4-5), suggesting that HA was expressed within the virally infected 
cells. No examination of the draining lymph node was made. 
To further identify the viral positive cells, frozen sections of the vagina and cervix 
from the intra-vaginally immunised group were double labelled with anti-MV and anti-
MHC class II monoclonal antibodies using double immunofluorescence (Chapter 2 
section 2.4.3). Almost all MV positive cells in these two regions were also MHC class 
II positive (Figure 4-6) suggesting that recombinant MV has infected MHC class II 
positive cells in the vagina and cervix and that these cells might then present viral 
antigens to T cells in the draining lymph nodes of the reproductive tract and initiate the 
immune response (Mc Ghee et al. 1994 ). 
4.3.4.2 HA antibodies in serum and reproductive tract flushings 
Similarly to intradermal and intra-nasal immunization, intra-vaginal immunization 
also induced a high titer of HA specific IgG in serum and much lower titers of IgG in 
most flushing samples from all regions of the reproductive tract at both time points 
(Figure 4-7). In some of the flushing samples, especially some vaginal flushings, HA 
IgG was undetectable (Figure 4-7). As a consequence, the mean HA specific IgG titer in 
vaginal flushing was significantly lower (P<0.05) than that in oviductal flushing at 30 
days post-infection. 
Compared to the intra-nasal immunisation group (Figure 4-3), intra-vaginal infection 
induced a lower HA specific IgG response in serum at either 15 days (P<0.05) or 30 
days (P<0.05) post-infection and a lower HA specific IgG response in oviductal 
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Figure 4- 5. The location of HA positive cells in the vagina of intra-vaginally 
immunised rabbits. Image A shows the location of HA positive cells in the vagina. 
Image B is a higher magnification of A. Positive cells are mainly present in the 
epithelium or the sub-epithelium immediate beneath the epithelium. This location was 
similar to that of MV positive cells shown in Figure 4-4A. Image C is vagina from same 
infected rabbit treated with normal rat serum. Lu: lumen; Ep: luminal epithelium. 
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Figure 4- 6. Myxoma virus and MHC class II double staining in the lower 
reproductive tract of intra-vaginally immunised rabbits. The immunofluorescent 
images show double staining of MV and MHC II positive cells on the same sections. A 
is the vagina and Bis the cervix. Each image contains two parts: the left part shows MV 
staining and the right part shows MHC II staining. Positive cells were located mainly in 
the epithelium. In both regions, most MV positive cells were also MHC class II positive 
(A and B, arrows). Lu: luminal epithelium; Ep: epithelium. Both images are at same 
magnification. 
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Figure 4- 7. HA specific lgG titers in serum, reproductive tract flushings and nasal 
washings after intra-vaginal immunisation 
Rabbits were intra-vaginally immllllised \\'ith 106 pfu MV-HA. IgG titers to HA were measured by 
ELISA in serum and flushings from oviduct, uterus and vagina at 15 and 30 days post-infection. The 
antibody titers were transformed into logarithms and expressed as mean Log10 titers. n = four rabbits. 
(P<0.05) and vaginal (P<0.05) flushings at 30 days post-infection. However, the HA 
antibody titers in the serum or reproductive tract flushings obtained after intra-vaginal 
immunisation were not significantly different from those following intradermal 
immunisation, except that the HA IgG titre in vaginal flushings was lower (P<0.05) at 
the 30 day time point. HA IgG was detected in only one nasal washing sample at a titer 
of 1 :50, reflecting a poor IgG response in the nasal passage following intra-vaginal 
immunisation compared with intranasal immunisation. No HA specific IgG was 
detectable in serum, nasal washings or vaginal washings collected before infection 
except for one serum sample that showed some background reactivity. However, this 
was 60-fold lower than the titer after infection. MV antibody was not detectable in pre-
immune serum of this rabbit but was present after infection. 
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HA IgM ranged from 1:25 to 1:1600 in serum and was higher (P<0.05) at 15 days 
(mean + S.D, 2.6 + 0.5) than 30 days (mean+ S.D, 1.8 + 0.3) post-infection. However, 
HA IgM was detected only in oviductal flushings from 2 rabbits at a titer of 1: 5 but was 
not detectable in other flushing samples, pre-immune serum or nasal and vaginal 
washings. 
HA IgA was detected in one oviductal and one uterine flushing sample from 
different rabbits at a titer of 1 :3 but was not detectable in serum or other flushing 
samples. 
4.3.5 Antibody response to the vector, myxoma virus 
Because HA was delivered by recombinant myxoma virus an antibody response was 
mounted not only to HA but also to myxoma virus itself. IgG and IgA to myxoma virus 
were measured in serum, reproductive tract flushings, and nasal washings from intra-
nasally and intra-vaginally immunised rabbits using ELISA (Chapter 2 section 2.3 .1 ). 
A strong specific IgG response to myxoma virus was detected in serum (Table 4-1 ). 
MV specific IgG was also detectable in most reproductive tract flushings from the intra-
nasal group and some flushings from the intra-vaginal group but the titers were much 
lower than those in serum (Table 4-1 ). Intra-nasal infection i!]-duced a higher MV 
specific IgG response in both serum and reproductive tract fluids compared to the intra-
vaginal infection, which was similar to the IgG response to HA. MV IgA was not 
detectable in any of these samples by ELISA. 
Table 4-1. Individual MV IgG titers in serum, reproductive tract flushings, and 
nasal washings after mucosal immunisations with MV-HA 
Group Time point Serum Oviduct Uterus Vagina Nasal 
Intra- Day 15 4.1, 4.1 1.3, 1.6 1.6, 1.3 1.0, 0 1.0, 1.0 
nasal Day30 4.7, 4.7 2.9, 2.9 2.0, 2.0 2.0, 1.3 1.6, 1.3 
Intra- Day 15 3.2, 2.6 1.6, 0 1.0,0 0,0 0,0 
vaginal Day 30 3.5, 4.1 1.6, 1.3 1.3, 0 0,0 1.0, 0 
The values are Log10 titers. 
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4.3.6 Time course of antibody response after mucosal infection with 
MV-HA and intra-vaginal boost with HA 
To extend the time-course of the study, two rabbits were intra-nasally and two intra-
vaginally immunised with MV-HA. IgG and IgA to HA and MV in serum and vaginal 
washings were measured at 3, 15, 30, 45, and 70 days post-infection to determine 
whether there was a delayed antibody response. To investigate whether subsequent 
boosting would elevate IgA antibody production, the infected rabbits were then intra-
vaginally boosted with influenza virus (HA) at 70 days post-infection. Specific IgG and 
IgA to HA were measured in serum and vaginal washings at day 3, 6, and IO after 
boosting. 
4.3.6.1 HA IgG and IgA response in serum and vaginal washings 
High and lasting specific IgG responses to HA were induced in serum following 
immunisation via both routes (Figure 4-8). The titers of HA specific IgG in vaginal 
washings basically paralleled those in serum but at titres about 100-fold lower (Figure 
4-8). Compared with the intra-vaginal route, intra-nasal immunisation stimulated a 
higher HA specific IgG response in both serum and vaginal washings. No anamnestic 
response was seen following boosting at day 70. Although antibody levels were 
elevated slightly 3-6 days after boosting, this was not a typical secondary antibody 
response. 
HA IgA was not detectable in any serum or vaginal washing samples after 
immunisation by either intra-vaginal or intra-nasal routes followed by intra-vaginal 
boosting. 
4.3.6.2 HA IgG and JgA in re~roductive tract flushings after boost 
The boosted rabbits were killed 15 days after the boost and blood and reproductive 
tract flushings from each region were collected for antibody measurement. Compared 
with serum,"'much lower HA specific IgG was detected in reproductive tract flushings 
(Table 4-2). HA specific IgA was not detectable in any of these samples. : 
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Figure 4- 8. HA specific lgG titers in serum and vaginal washings after mucosal 
infection with MV-HA and intra-vaginal boost with HA 
Rabbits were intra-nasally (I.n) or intra-vaginally (I.va) infected with 106 pfu MY-HA followed by an 
intra-vaginal boost (arrow) with influenza virus (HA) at 70 days post- infection. HA IgG titers were 
determined by ELISA in serum and vaginal washings collected at day 3, 15, 30, 45, 70 post-infection and 
3, 6, 10 post-boosting. The antibody titers were transformed into logarithms and expressed as Log 10 titers 
(mean of two rabbits). 
Table 4- 2. HA specific IgG titers in serum and reproductive tract flashings after 
infection with MV-HA and 15 days after boosting with HA 
Routes Serum Oviduct Uterus Vagina 
Intra-nasal 5.3 , 5.0 2.6, 2.3 2.6, 2.3 2.3 , 2.3 
Intra-vaginal 4.7, 4.4 2.0, 1.7 1.7, 1.4 2.3 , 2.0 
The values are Log 10 titers. 
4.3.6.3 MV specific IgG and IgA in vaginal washings 
IgG and IgA specific to the vector, myxoma virus, were also measured in serum and 
vaginal washings over the time course experiment. MV IgG titers were high in serum 
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and much lower in vaginal washings (Table 4-3). No MV IgG was detectable in serum 
collected before immunisation. IgA to MV was undetectable in either serum or the tract 
fluids before or after immunisation. 
Table 4- 3. MV IgG titers in serum and vaginal washings in a time course after 
infection with MV-HA 
Groups 15 days PI 30 days PI 45 days PI 
Serum Vagina Serum Vagina Serum Vagina 
Intra-nasal 4.1,3.8 2.0, 1.6 4.7, 4.7 2.3, 1.0 4.7, 4.4 2.0, 1.0 
Intra-vaginal 3.5, 3.5 1.6, 1.3 4.1,3.8 1.6, 1.3 3.8, 3.5 2.0, 1.0 
The values are Log 10 titers. PI: post-infection with MV-HA. 
4.3.7 Antibody production in the reproductive tract 
4.3.7.1 Total IgA titers in serum and reproductive tract fluids 
If IgA plasma cells specific for HA homed back to the reproductive tract after · 
mucosal immunisation and contributed to local IgA production, an elevated total IgA 
level might be expected in the luminal fluids. To test this, total IgA titers were measured 
by immunodiffusion as an alternative to ELISA (Chapter 2 section 2.3 .2.2). 
In intradermally infected or uninfected control groups, total IgA titers in serum were 
about 100 fold higher than that in reproductive tract fluids and IgA was undetectable in 
about half the fluid samples (Table 4-4). Compared with normal rabbits, induction of 
ovulation (hCG treatment) and route of infection did not significantly change the total 
IgA titers in either serum or reproductive tract fluids. No differences in total IgA titer 
could be seen between the samples from different regions of the reproductive tract or 
between the samples collected by flushing or micropuncture (Table 4-4). After mucosa! 
immunisation, the total IgA titers in reproductive tract flushings were not significantly 
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Table 4- 4. Total IgA titers in serum and reproductive tract fluids of control and 
intradermally immunised rabbits 
Groups Serum Flushings Micro punctures 
Oviduct Uterus Vagina Oviduct Uterus Vagina. 
Controls 256, 128 l, 0, 0, 0 2, l, 1, 0 1, 0, 0, 0 nd nd nd 
HCG 258, 128 4, 2, 0, 0 1, l, 0, 0 8, 0, 0, 0 1, 0 2, 0 2, 1 
Day 15 128, 64 2, 1, 0, 0 2, 1, 1, 0 1, 0, 0, 0 1, 0 1, 1 2,0 
Day 15 256,256 1, 0, 0, 0 l, 0, 0, 0 2, 1, 0, 0 1 a 2 a 4, 0 
+hCG 
Day 30 256,256 8, l, 1, 0 4, l, l, 0 1, 1, 0, 0 0, 0 2, 0 2, 1 
Day 30 256,128 4, 1, 0, 0 2, 1, 0, 0 0, 0, 0, 0 1, 0 1, 0 8, 1 
+hCG 
The values are reciprocal titers of the last dilution in a two-f o Id serial dilutio~ giving a positive 
result. 1: means without dilution of the sample; 0: means no precipitate band. HCG: hCG treated 
controls; Day 15, Day 30: 15 or 30 days post-infection with MV-HA; + hCG: infection with 
induction of ovulation. nd: not measured; a: the sample is not available because the rabbit died 
before sampling. 
elevated at either 15 or 30 days compared to controls and the intra-dermal group (Table-
4-5). Total IgA titers in nasal washings from both mucosal immunisation groups were 
also measured and were not different from reproductive tract flushings (Table 4-5). 
4.3. 7.2 HA specific antibody producing cells in reproductive tract tissues 
To further examine whether plasma cells in the reproductive tract were HA antibody-
specific cells, influenza virus was used to bind to HA antibody in these cells. Virus 
binding was detected by rat anti-HA followed by anti-rat FITC on frozen sections from 
various regions of the reproductive tract (Chapter 2 section 2.4.2). Popliteal lymph 
nodes draining the inoculation site of intradermally infected rabbits or from uninfected 
rabbits were also labelled as positive or negative controls. This assay had a considerable 
background which shows as punctate staining in Figure 4-9. This background might be 
due to influenza virus binding to sialic acid residues on the cell surface; sialic acid is 
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Table 4- 5. Total IgA titers in serum and reproductive fluid samples after mucosal 
immunisations with MV-HA 
Groups Day 0 Day 15/30 Oviduct Uterus Vagina Nasal 
serum Serum 
Intra- Day 128, 64, 128, 64, 64, 1, 0, 1, 0 1, 0, 1, 0 1, 0, 0, 1 0, 0, 1, 1 
nasal 15 64,64 128 
Day 256, 256, 256, 512, 4, 2, l, l 0, 0, 0, 0 0, 0, 0, 0 l, 2, 0, 0 
30 128, 128 128, 128 
Intra- Day 128, 64, 128, 64, 64, 1, 1, 1, 4 0, 0, 0, 1 0, 0, 0,0 0, 0, 1, 0 
vaginal 15 128, 512 256 
Day 256, 64, 64, 128, 1, 4, 1, 1 1, 0, 0, 0 0, 0, 0, 0 0, 0, 0, 0 
30 256, 128 256,256 
The values are reciprocal titers of the last dilution in a two-fold serial dilution giving a positive 
result. l: means no dilution of the sample; 0: means no precipitate band. 
the normal receptor for influenza virus. Nevertheless, the strong signal of the antibody 
producing cells can be easily identified in Figure 4-9. This assay also included anti-sera 
controls (normal rat serum instead of rat anti-HA serum) and antigen controls ( omit 
influenza virus antigen). This second control is extremely important because anti-HA 
serum can also detect virus-infected cells that are producing HA protein. 
Whereas positive cells were frequently seen in the sections of popliteal lymph nodes 
from the intradermally infected rabbits, positive cells were rarely found in the sections 
of reproductive tract tissues from the same infected rabbits at 30 days post-infection 
(Figure 4-9). Even in serial sections of the uterus from several intra-dermally 
immunised rabbits only a few positive cells were found ( data not shown). Some vaginal 
and cervical sections contained a few more positive cells than uterine sections. No 
positive cells were found in reproductive tract sections from uninfected controls or from 
the negative controls. Induction of ovulation by HCG treatment did not affect the 
number of HA antibody-producing cells. 
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Figure 4-9. HA specific antibody secreting cells in popliteal lymph nodes and the 
uterus of MV-HA infected rabbits. The immunofluorescent images show that rnany 
HA specific antibody producing cells were present in the lymph node (A, arrow) 
draining the inoculation site whereas only one was found in whole uterine section (B, 
arrow) from the same rabbit. Image C shows no positive cells were seen in the negative 
control with normal rat serum replacing rat anti-HA serum on an uterine section from an 
infected rabbit. Image D shows an uterine section from an uninfected rabbit stained for 
HA antibody producing cells. E and F show the controls omitting influenza virus in the 
uterus and cervix, respectively. Lu: lumen; Ep: luminal epithelium. The scale bars 
represent 25 micro-meters. 
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Following intra-nasal immunisation, positive B cells were occasionally seen in the sub-
epithelium of the oviduct and uterus and a few positive cells were observed in the 
epithelium of the cervix from some rabbits. This was similar to figure 4-9b ( data not 
shown). In the intra-vaginal group, the virus replicated in vagina and cervix and HA was 
expressed in these tissues ( section 4.3 .4.1 ). This interfered with the staining of HA 
specific antibody producing cells in the vagina and the cervix. Nevertheless, positive 
cells were occasionally found in the oviduct and uterus of some rabbits in this group 
( data not shown). These results suggest that the local production of HA specific 
antibody is of limited importance. 
4.3.7.3 Source of IgG in reproductive tract fluids 
Low titers of HA specific IgG were present in the reproductive tract fluids after 
either intradermal or mucosa! immunisation with MV-HA. However, as shown above, 
very few HA antibody-secreting cells were present in the reproductive tract which 
suggests that HA antibody in the reproductive tract must be derived predominantly from 
serum. To test this further and to examine the effect of ovulation on IgG titer in 
reproductive tract fluids, the total IgG titers in serum and reproductive tract fluids were 
measured using ELISA (Chapter 2 section 2.3 .2.1) and the ratio of total IgG and HA 
specific IgG was calculated. While the total IgG and the HA IgG ELISA titers are not 
necessarily comparable, this does allow a comparison to be made between 
compartments and treatments within the experiment. 
In all control and intradermal immunised groups, the total IgG titers in serum were 
more than 100 fold higher than those in reproductive tract fluids (Table 4-6 and 4-7). 
Induction of ovulation did not significantly change total IgG titers in either serum or 
reproductive tract flushings. No significant differences were found between samples 
collected from different regions for either immunised or unimmunised groups (Table 4-
6). The total IgG titers obtained in flushing samples were not significantly different 
from those obtained in micro-puncture samples though they were generally slightly 
lower (Table 4-7). 
After mucosal immunisation, the total IgG titers in serum were more than 100 fold 
higher than those in reproductive tract flushings at either day 15 or day 30 (Table 4-8). 
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Table 4- 6. Total lgG titers in serum and reproductive tract flushings in 
intradermal infected and uninfected control rabbits 
Groups Serum Oviduct Uterus Vagina 
Controls 4.9 + 0.2 2.5 + 0.3 2.7 + 0.3 2.1 + 0.3 
hCG 4.8 + 0.2 2.7 + 0.3 2.5 + 0.4 2.4 + 0.7 
MV-HA Day 15 4.8 + 0.3 2.5 + 0.4 2.3 + 0.7 2.3 + 0.5 
Day 30 4.8 + 0.2 2.5 + 0.6 2.6 + 0.4 2.2 + 0.5 
MV-HA+ Day 15 5.0 + 0.3a 2.4 + 0.3 2.5 + 0.3 2.4 + 0.6 
hCG Day30 4.9 + 0.3 2.8 + 0.4 2.3 + 0.4 2.2 + 0.4 
The values represent mean Log10 titers + S.D for four rabbits. hCG: hCG treated controls; 
+hCG: infection with induced ovulation. a: One rabbit dies so only three samples were 
available. 
Table 4- 7. Total IgG titers in micropuncture sami;les of reproductive tract from 
intradermal infected and uninfected control rabbits 
Groups Oviduct Uterus Vagina 
HCG 2.9, 2.6 2.9, 2.6 3.2, 2.9 
MV-HA Day 15 2.9, 1.7 2.3, 2.3 2.3, 2.0 
Day 30 2.6, 2.3 2.9, 2.6 2.9, 2.9 
MV-HA+ Day 15 3.2a 2.9a 2.9, 2.6 
HCG Day 30 2.3, 2.0 2.9, 2.6 2.9, 2.6 
The values are Log 10 titers. a: One rabbit was dead before sampling. 
In the intra-nasal immunised group, the mean IgG titers in oviduct were higher than 
those in uterine (P<0.01) or vaginal (P<0.001) flushings at 30 days post-infection 
(Table 4-8). In the intra-vaginal immunised group, total IgG titers in the oviduct were 
higher than those in uterine (P<0.01) or vaginal (P<0.05) flushings at 15 days post-
infection and higher than those in vaginal flushings (P<0.05) at 30 days post-infection 
(Table 4-8). However, no differences of total lg titers were found between the intranasal 
and intra-vaginal groups except that the total IgG titer in vaginal flushings of the intra-
vaginal group was lower (P<0.05) than that of intra-nasal group. In addition, total IgG 
titers in uterine flushings of the intranasal group at 30 days post-infection and total IgG 
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Table 4- 8. Total IgG titer in serum and reproductive tract flushings after mucosal 
immunisations 
Groups Day0 Day 15/30 Oviduct Uterus Vagina 
serum serum 
Intra- Day 15 4.9 ± 0.2 5.2 ± 0.3 2.8 ± 0.4 2.6± 0.4 2.4± 0.4 
nasal Day 30 4.7± 0 5.2 ± 0.2 2.8 ± 0.2 1.7 ± 0.5 1.9 ± 0.2 
Intra- Day 15 4.9±0.3 4.9± 0.2 3.1 ±0.3 2.1 ± 0.4 2.0 ± 0.7 
vaginal Day 30 4.7± 0 5.0 ± 0.2 2.2 ± 0.5 1. 1 ± 1.3 0.8 ± 0.9 
The values are mean Log10 titers + S.D for four rabbits. 
titers in vaginal flushings of the intra-vaginal at 30 days post-infection were lower 
(P<0.05 for both) than those in the uninfected control group. 
For most MV-HA infected groups, the ratio of total IgG in serum to that in the 
reproductive tract fluids was similar to the that of HA IgG in these compartments (Table 
4-9). The similarity in these ratios suggested that the HA specific IgG in the 
reproductive tract fluids was mainly derived from serum and that local antibody 
production did not contribute significantly. However, in the intra-vaginal group, the 
ratio of specific IgG was higher than that for total IgG at both 15 and 30 days post-
infection. In addition, the ratios of specific IgG were generally a little higher at 15 days 
than at 30 days, suggesting that, if there were a small amount of local IgG production, it 
might occur at around 15 days post-infection. 
4.3.8 Antibodies to HA in serum and ovarian follicular fluids 
following MV-HA infection 
Ovarian fluid is derived from serum and might therefore be expected to have similar 
antibody titers to serum. To verify if serum antibodies do indeed freely transfer into 
ovarian follicles, rabbits were intradermally infected with MV-HA and HA specific 
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Table 4- 9. The ratios of total IgG and HA-IgG in serum and reproductive tract 
flashings from rabbits immunised with MV-HA through different routes. 
Immunisation routes Oviduct Oviduct Uterus Uterus Vagina Vagina 
and days of sampling total HA-IgG total HA-IgG total HA-IgG 
IgG IgG IgG 
Intra- Day 15 1.9 2.3 2.1 2.6 2.1 2.3 
dermal Day 30 1.9 2.0 1.8 1.8 2.2 2.2 
Intra-dermal Day 15 2.1 2.3 2.0 2.4 2.1 2.5 
+hCG Day 30 1.8 1.8 2.1 2.1 2.2 2.2 
Intra- Day 15 1.9 2.1 2.0 2.4 2.2 2.6 
nasal Day 30 1.9 1.7 3.1 2.0 2.7 2.3 
Intra- Day 15 1.6 1.9 2.3 2.3 2.5 3.1 
vaginal Day30 2.3 2.0 4.5 4.1 6.3 7.5 
The values are ratios of mean IgG titers for four rabbits. 
antibody levels in serum and ovarian follicular fluids were measured at 15 days post-
infection. 
After super-ovulation, three of the 4 infected rabbits developed very good pre-
ovulatory follicles. Follicular fluids from all four rabbits were collected as described in 
Chapter 2 (section 2.2.3.1) and pooled for each rabbit. Generally, 20-50 µI was 
collected from each ovary. HA specific IgG, IgM and IgA in serum and ovarian 
follicular fluids were measured using ELISA (Chapter 2 section 2.3.1 ). 
There were no differences in the titers of HA IgG or IgM in ovarian follicular fluids 
and serum of the four immunised rabbits (Figure 4-10). Specific IgA to HA was not 
detectable in either serum or ovarian follicular fluids. This result suggests that the anti-
HA immunoglobulins in serum induced by recombinant myxoma virus can freely 
transfer into ovarian follicle fluids. This implies that if high antibody titers are required 
for immunocontraception, then the ovarian follicle may be a more appropriate target 
than the mucosa! compartments of the reproductive tract. 
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Figure 4- 10. HA IgG and IgM titer in serum and ovarian follicular fluids. 
Rabbits were infected with MV-HA by the intradermal route. HA titers ofigG and IgM were measured in 
serum and ovarian follicle fluids (ovary-fl) at 15 days post-infection using ELISA. Antibody titers were 
transformed into logarithms and expressed as Log10 titer. The bars represent means of four rabbits and 
error bars are S.D. 
4.4 Discussion 
4.4.1 Is myxoma virus an efficient vector for inducing a mucosal 
antibody response in the female reproductive tract? 
4.4.1.1 Immunisation through intradermal inoculation 
The ability of antigens to induce a strong, specific antibody response within the 
female reproductive tract is crucial to the success of immunocontraceptive vaccines 
which seek to act through prevention of fertilisation (Chapter 1 section 1.2.2). In this 
chapter, the antibody response in serum and within the different regions of the female 
rabbit reproductive tract to the influenza HA delivered by a recombinant myxoma virus 
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was investigated as a model for a virus delivering a reproductive antigen. Several 
different routes of administration were compared for their capacity to induce a sustained 
antibody response within the tract. Measures were made in both sexually quiescent 
animals and in animals within 12 hours of ovulation. 
Kerr and Jackson ( 1995) first constructed and described the recombinant virus used 
in this study. They showed that as little as 5 pfu was sufficient to infect the animals and 
induce an immune response to the HA antigen, despite the fact that insertion of the HA 
gene resulted in attenuation of the virus compared to the parental strain. The 
recombinant virus did not cause significant clinical disease in domestic rabbits making 
it an ideal model to study the properties required of an immunocontraceptive vector. In 
addition, HA is a well-characterised, highly immunogenic protein which is not present 
in the female reproductive tract hence making the antibody response easy to measure. 
Indeed in Kerr and Jackson's original study, HA specific antibody was present in 
vaginal fluids as well as plasma. In our initial experiment we sought to confirm and 
extend these results to the oviduct, uterus and cervix. 
Following intradermal immunisation with MV-HA, HA antibody titers were induced 
in serum by day 15 post-infection and they remained elevated at 30 days post-infection. 
However, IgG antibody titers in the fluids of the oviduct, uterus and vagina were only 
0.1-1 % of those detected in serum. Moreover, IgA to HA was not detectable in either 
serum or reproductive tract fluids after the infection. Titers of IgG and IgA to HA in 
reproductive tract fluids were not · significantly influenced by ovulation. These results 
are in sharp contrast to a number of studies in rodents (Wira and Sandone, 1987; 
Gallichan and Rosenthal, 1995; 1996; Johansson et al. 1998). In these studies, specific 
IgG antibody levels in reproductive tract fluids were about 10% of the serum level in 
mice (Gallichan and Rosenthal, 1995; Johansson et al. 1998). IgA antibody levels 
increased in female genital secretions after oestradiol treatment in mice (Wang et al. 
1996) and rats (Wira and Sandone, 1987), whereas IgG antibody titers in vaginal 
washes were significantly higher at the dioestrus stage or after progesterone 
administration (Gallichan and Rosenthal, 1996). These findings indicate that, in rodents 
at least, IgG and IgA vary cyclically through the oestrous cycle with IgA being high 
when oestrogen levels are high and IgG being elevated when progesterone dominates. 
These cyclical changes in immunoglobulin concentration are probably associated with 
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the protection of the reproductive tract from external infections and with facilitating the 
implantation of the conceptus. However, unlike rodents, the rabbit does not have an 
oestrous cycle being held in prooestrus under the control of oestrogen until ovulation is 
stimulated by mating and it is probably not surprising that there are differences in the 
immune response between rodents and rabbits. 
These results suggest that, by the natural infection route, the recombinant virus is 
unable to induce a high-level antibody response in the reproductive tract fluids of 
female rabbits under either oestrogen domination or post ovulation. In particular, IgA to 
HA could not be induced. Data from a previous study in rabbits also demonstrated that 
systemic immunisation was not effective at inducing an IgA response in the female 
reproductive tract to a model antigen horse-radish peroxidase (HRP) compared with 
local immunisation routes though IgG antibody was induced in serum by both systemic 
and local immunisations (McAnulty and Morton, 1978). The reason for this may be 
because lg switching to IgA isotype occurs mainly in mucosa! tissues such as Peyer' s 
patches (Spieker-Polet et al. 1993) and not in other lymphoid organs. Obviously, if 
recombinant myxoma virus is to be used as an immunocontraceptive vaccine vector 
alternative ways of antigen presentation need to be considered if an antibody response 
in the reproductive tract is necessary. 
4.4.1.2 Immunisation via mucosa/ routes 
Antigen presentation through common mucosa! inductive sites and local antigen 
presentation through the vaginal mucosa are considered to be effective ways to 
stimulate mucosa! antibody responses in the female reproductive tract (Chapter 1 
section 1.5.1 and 1.5.2). To be able to maximise the antibody response in the 
reproductive tract and induce an IgA response, administration of MV-HA through a 
distal mucosa! site, the nasal mucosa, and a local mucosa! site, the vaginal mucosa, was 
tested. Both the inflammatory response and direct staining indicated that the 
recombinant virus replicated locally following the infection. However, antibody titers to 
HA in the reproductive tract were essentially similar to those following intradermal 
immunisation. HA IgA was not detectable in serum and only present in trace amounts in 
a few cases in reproductive tract fluids. These findings differ from those obtained in 
murine studies following immunization with a recombinant adenovirus 
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(Gallichan et al. 1993; Gallichan and Rosenthal, 1995; Xiang and Ertl, 1999). In these 
studies, specific IgA and IgG were induced in both serum and vaginal secretions to 
either HSV-1 glycoprotein B (Gallichan et al. 1993; Gallichan and Rosenthal, 1995) or 
rabies virus glycoprotein (Xiang and Ertl, 1999) following intra-nasal immunisation. 
Therefore, compared with recombinant adenovirus in the mouse, recombinant myxoma 
virus is much less efficient at inducing an IgA antibody response in the rabbit. However, 
it is unclear whether rabbits would mount a good IgA response to an antigen presented 
by an adenovirus because the appropriate experiment has not been done. 
The antibody response to the vector, myxoma virus, was also assayed in serum and 
reproductive tract fluids following mucosa! immunisation with MV-HA. The antibody 
responses to MV were similar in timing and titer to those to HA and no IgA response to 
MV was detected. This result suggests that MV itself is not effective at stimulating an 
IgA response. The inability of the recombinant myxoma virus to provoke an IgA 
response systemically or locally to either the vectored antigen HA or to the virus itself 
makes it a poor delivery vehicle for induction of an effective IgA response within the 
reproductive tract. This inefficiency may relate to its immuno-suppressive effect. MV 
produces several homologues of Thl cytokine receptors (such as TNF-aR, INF-yR) that 
will interfere with cytokine networks (McFadden et al. 1995). MV infection also down 
regulates MHC-I molecules on the surfaces of infected cells (Nash et al. 1999; Guerin et 
al. 2002) which will inhibit antigen presentation to cytotoxic T-lymphocytes. Myxoma 
virus also specifically down-regulated the CD4 molecule on the surface of infected cells 
by degrading CD4 in lysosomal vesicles (Barry et al. 1995). This would result in the 
inhibition of recognition by these cells of peptides presented by MHC-II on APC or B 
cells thus affecting activation of T cells and potentially the generation of cellular and 
humoral immune responses. The IgA response has been reported to be highly dependent 
on CD4+ T helper (Th) cells and Th2 cytokines such as IL-4, 5, 6 and 10 are essential in 
IgA isotype-switching and IgA production (Husband et al. 1994). The viral infection of 
CD4+ cells and down-regulation of CD4 molecules on CD4+ T cells may thus disturb 
the production of these Th2 cytokines and hence IgA isotype-switching and production. 
A recent study showed that co-expression of IL-5 and 6 within a recombinant 
adenovirus could enhance the IgA response and IgA antibody production in the lung 
following intra-nasal infection (Braciak et al. 2000). This result supports the view that 
Th2 cytokines are important in IgA antibody response. This indicates a potential 
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strategy for enhancing the mucosa! response to myxoma virus but may not be relevant 
following intradermal inoculation because the virus is so attenuated that it is unlikely to 
spread to mucosa! sites. 
The data above collectively suggest that recombinant MV is not an effective vector 
for inducing a high-titer IgA or IgG antibody response in the female rabbit reproductive 
tract. If a reproductive antigen gene replaced the HA gene in the recombinant virus a 
lower antibody response in the reproductive tract would be anticipated because such 
antigens are usually less immunogenic than HA. This implies that without further 
modification of the recombinant myxoma virus it is not suitable to deliver reproductive 
antigens, such as sperm or oocyte antigens because it will not induce a high antibody 
titer within the reproductive tract that is capable of blocking fertilisation. 
In the current study, the intra-vaginal route was less efficient at inducing systemic 
and local antibody responses compared with intra-nasal immunization. This was 
indicated by lower levels of HA IgG in serum and fewer reproductive tract fluid 
samples being positive for HA IgA. This result is consistent with many studies in both 
mouse (Gallichan and Rosenthal, 1995; Wu et al. 2000; Russell, 2002) and human 
(Kozlowski et al. 2002). For example, in mice, intra-vaginal immunisation with 
adenovirus expressing HSV-1 glycoprotein B resulted in a lower serum IgG and vaginal 
IgA antibody response than that following intra-nasal immunisation (Gallichan and 
Rosenthal, 1995). In humans, intra-vaginal immunization with 1 mg recombinant CTB 
( cholera toxic sub-unit B) was necessary to induce an IgA antibody response 
comparable to that generated by intra-nasal immunization with only 0.1mg recombinant 
CTB (Kozlowski et al. 2002). These results suggest that the vaginal mucosa is less 
effective than the nasal mucosa at mounting an immune response. This inefficiency of 
the vaginal mucosa could be explained in many ways. One possibility is the fact that 
compared with nasal mucosa, the female reproductive tract (including that of rabbits) 
lacks mucosa! inductive site follicle-associated epithelium, M cells, and organized 
lymphoid tissues (McGhee et al. 1999). Direct antigen transport and antigen 
presentation, similar to that in the bronchus, could not occur in the vagina. The APC in 
the vagina must carry antigen (peptide) and migrate to local draining lymph nodes to 
initiate an immune response (McGhee et al. 1994). This suggests that relatively less 
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antigen presentation and a weaker immune response was mounted following intra-
vaginal immunisation, with fewer B cells homing back to the reproductive tract. 
Another possibility is the immunosuppressive effect of oestradiol on antigen 
presentation. Wira and Rossoll (1995a) showed that high levels of oestradiol 
administered to ovariectomised rats could inhibit the ability of vaginal APC to present 
antigen to T cells and that this inhibitory effect was reversed when progesterone was 
given along with oestradiol. The rabbit vagina is always under the control of oestradiol 
before mating, and so when MV-HA was administered locally into the vaginal mucosa, 
oestradio 1 might have inhibited antigen presentation by APC in the vagina and led to the 
lower antibody response. However, it remains to be determined if intra-vaginal 
administration of MV-HA after ovulation, a very artificial circumstance, could induce a 
stronger antibody response in rabbits. 
4.4.2 Antibody response and transfer in the reproductive tract of 
female rabbits 
4.4.2.1 lgA transfer in the reproductive tract 
Induction of ovulation might increase IgA transudation from serum into the tissues in 
the oviduct and vagina (Chapter 3, section 3 .3. 7.2). But this was not reflected by the 
changes of general IgA titers in the luminal fluids. One possible explanation for this is 
that IgA might adhere tightly to the surface of the luminal epithelium or might even be . 
within the epithelial cells, and not be efficiently transferred into the luminal fluids. This 
explanation is consistent with the observation of strong epithelial IgA staining along the 
luminal epithelial surface of the uterus and some cervices from both infected and 
uninfected rabbits. This phenomenon has not been reported in other species, so it is 
postulated that it could relate to the oestrogen domination in the reproductive tract of 
female rabbits. 
The rabbit has 13 IgA constant region heavy chain genes (Spieker-Polet et al. 1993) 
whereas mice and human have only one or two isotypes. Furthermore, in the rabbit, 
different tissues express different IgA isotypes. For example, Ca4 mRNA is only 
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expressed in lung and spleen whereas Cal, 6, 9, 10 and 12 are expressed in small 
intestine, mammary gland, salivary gland and appendix (Spieker-Polet et al. 1993). 
Among those isotypes, some are expressed at high levels, others at low levels (Spieker-
Polet et al. 2002). It is not known how many isotypes are expressed in the reproductive 
tract or whether the anti-IgA antibody used in the present study, which was raised 
against pooled serum IgA, could measure all isotypes. Although it would be interesting 
to study IgA heavy chain expression in different tissues, such studies were beyond the 
scope of this thesis. 
Previous studies showed that IgA in the epithelial cells or lamina propria could 
neutralise viruses and function locally (Kaetzel et al. 1991; Mazanec et al. 1992, 1993). 
In rabbits, the IgA on the epithelial surface or in the epithelial cells might act in the 
same way. 
4.4.2.2 IgG antibody transfer in the reproductive tract 
The IgG antibody present in female reproductive tract fluids is considered to derive 
mainly from serum (Parr and Parr, 1996). This is also true in rabbits in the current study 
as suggested by the observation that the ratios of specific and total IgGs in the 
reproductive tract fluids to those in serum were very similar. But local IgG production 
in the vagina may contribute a small amount following intra-vaginal immunisation. This 
is consistent with the result of the presence of IgG plasma cells in the vagina (Chapter 
3). However, the IgG antibody titers in serum were about two orders of magnitude 
higher than those in the reproductive tract fluids following any immunisation 
procedures. These findings are consistent with other studies in rabbits and contrast with 
findings in the mouse. For example, IgG antibody was either not detected at all in the 
female rabbit reproductive tract (Edwards, 1960; Shapiro, 1971) or was detected in 
oviductal fluids at only 4 % of the levels in serum (Oliphant et al. 1977). Similarly, in 
oviductal fluids of rabbits immunised with sperm protein LDH-4 specific antibody 
levels were only 3-4% of those in serum (Kille and Goldberg, 1979). In contrast, in the 
mouse, immunisation with recombinant adenovirus or cholera toxin resulted in IgG 
titres in reproductive tract fluids that were more than 10% of those in serum ( Gallichan 
and Rosenthal, 1995; Johansson et al. 1998). Taken together, these results suggest that 
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rabbits have a lower efficiency of IgG transfer from serum into the reproductive tract 
fluids than the mouse. 
In rabbits, IgG staining and the number of IgG positive cells in reproductive tract 
tissues decreased after induction of ovulation (Chapter 3, section 3.3.8.2). But this did 
not affect the total or HA specific IgG concentrations in the luminal fluids. This is 
dramatically different from rodents where significant variations of IgG antibody levels 
in tissue or in the luminal fluids were demonstrated during oestrous cycles (Chapter 1 
section 1.5.3). HA IgG antibody and total IgG titers were not significantly different 
between reproductive tract fluids obtained by flushing and micro-puncture. The flushing 
method resulted in antibody dilution with PBS whereas the micro-puncture method 
collected only the free fluid in the lumen. Since comparable antibody titers were 
obtained with these two methods, flushing samples must contain an IgG source that is 
not sampled by micropuncture. Epithelial mucus, which stains strongly for IgG (Chapter 
3 ), is most likely to be the source of the additional IgG present in flushing samples. This 
suggests that, as for IgA, IgG is more concentrated at epithelial surfaces in rabbits rather 
than diffused into the fluids. 
4.4.3 Myxoma virus is an effective vector for inducing a strong lgG 
response in serum and in the ovarian follicle 
Although, as discussed above, the recombinant myxoma virus was not effective at 
inducing a strong antibody response in the reproductive tract, a consistent high-level 
IgG antibody response to HA was always induced in serum following any immunisation 
procedures. Therefore, it is assumed that good B memory cell, and probably T memory 
cell, responses to HA were generated. These results suggest that recombinant myxoma 
virus can be used as an effective vaccine vector to deliver rabbit antigens for disease 
control. A previous study in rabbits supporting this conclusion showed that recombinant 
myxoma virus expressing the rabbit hemorrhagic disease virus capsid protein could 
induce a protective immune response to this disease (Bertagnoli et al. 1996). It thus 
appears feasible that the recombinant virus could be used to deliver 
immunocontraceptive vaccines, but, if high antibody titers were needed, then the target 
antigen would have to be accessible to serum antibody. 
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In rabbits, previous studies showed that the IgG concentration to sperm antigen 
LDH-C4 in serum was comparable to that in ovarian follicular fluids (Symons and 
Herbert, 1971; Kille and Goldberg 1979). These data suggest that ovarian follicle 
antigens would be more accessible to serum antibody. To confirm this and extend it to 
viral vectored antigens, HA antibodies in ovarian follicular fluids were measured after 
MV-HA infection. In contrast to the mucosa! compartments of the reproductive tract the 
antibody levels in ovarian follicular fluids were similar to those in serum, confirming 
that antibodies in serum freely transfer into the ovarian follicles. This result has 
important implications. It is hypothesized that antibodies to antigens in the zona 
pellucida (ZP), the layer covering the oocyte, play a major role in blocking fertilisation 
by coating the ZP of oocytes and preventing sperm attachment and penetration (Epifano 
and Dean, 1994; Aitken et al. 1996; Paterson et al. 2000). The free transfer of serum 
IgG antibody to the ovarian follicle implies that if a strong IgG antibody response to a 
ZP antigen was induced in serum the antibody would enter the follicle and bind to the 
ZP. This might either damage the oocyte clinically or prevent sperm binding to the 
ovulated oocytes. 
The recombinant myxoma virus has the ability to deliver an antigen and induce a 
strong and lasting antibody response in serum. Therefore, it could be used as a vector to 
deliver ZP antigen for immunocontraception. During the course of this study, antibody 
levels in serum of rabbits immunised with zona pellucida protein B (ZPB) correlated 
with the extent of the resultant infertility (Kerr, et al. 1999). Kerr et al (1999) also 
showed that immunisation of female rabbits with a recombinant myxoma virus 
expressing rabbit ZPB induced a low antibody response to ZPB with 25% infertility in 
infected rabbits. In addition, it was shown that female mice immunized with a 
recombinant ectromelia virus expressing mouse ZP3 became infertile and antibody to 
ZP3 played an important role in this (Jackson et al. 1998). These results demonstrate 
that ZP antigens can induce infertility in mice when delivered by a recombinant virus 
but that recombinant myxoma virus was not an effective system in rabbits compared 
with protein immunization. Other ovarian antigens such as membrane proteins from the 
granulosa or cumulus cells could also be considered for developing viral vectored 
immunocontraception. 
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4.4.4 A summary 
In summary, the study has shown that the recombinant myxoma virus is inefficient at 
inducing an antibody response in the female rabbit reproductive tract. The high-level 
IgG antibody in circulation did not transfer into the reproductive tract fluids at high 
titer. Therefore, this vector is not suitable for inducing an immune response in the 
mucosa! part of the reproductive tract. However, the recombinant virus always induces a 
strong systemic antibody response to the vectored antigen and this is readily transferred 
to the ovarian follicle. This provides an opportunity to use recombinant MV as a vector 
to deliver an immunocontraceptive vaccine targeted at the ovary. 
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CHAPTER 5: IMMUNOLOGICAL AND HISTOLOGICAL 
RESPONSES IN OVARY TO INFECTIONS OF A 
RECOMBINANT MYXOMA VIRUS EXPRESSING 
RABBIT ZONA PELLUCIDA ANTIGEN B (ZPB) 
5.1 Introduction 
In Chapter 4, it was shown that the recombinant myxoma virus could induce a strong 
serum antibody response to a vectored foreign antigen but only a weak antibody 
response in the reproductive tract. However, high levels of antibodies were achieved in 
the ovarian follicles suggesting that if recombinant myxoma virus is used to deliver an 
immunocontraceptive vaccine, the targeted antigen needs to be accessible to serum 
antibodies. Ovarian follicular antigens meet this need better than antigens that are only _ 
present in the lumen of the reproductive tract and therefore should also be considered as 
targets for immunocontraception. 
Many studies have already shown that infertility can be achieved by immunisation 
with zona pellucida (ZP) antigens (Chapter 1 section 1.6.1 ). However, very little is 
known about the immune response in the ovary and the immunological mechanism of 
the infertility induced by immunization with such antigens, particularly following their 
presentation by a recombinant virus. 
The zona pellucida (ZP) is an extracellular matrix surrounding the oocytes and plays 
a role in oocyte development and fertilisation where it provides a receptor for sperm 
binding (Epifano and Dean, 1994). Like most species, the rabbit ZP consists of three 
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major glycoproteins ZPA, ZPB, and ZPC with predicted molecular weights of 75 , 55 , 
and 45 Kd respectively (Dunbar et al. 1994). The rabbit ZPB was shown to be the 
homologue of porcine ZP3a that is considered to be the primary receptor for sperm 
binding in the pig (Dunbar et al. 1994). It therefore may have the potential to be an 
immunocontraceptive antigen for rabbits. Antibodies to this antigen could act by one of 
two mechanisms, by destruction of ovarian follicles or by blocking sperm binding to the 
oocyte and hence blocking fertilization. 
Immunisation with rabbit native ZP protein or recombinant ZPB expressed in E.coli 
did not induce either antibody to ZP or ZPB or infertility in rabbits (Chapter 1 section 
1.6.1 ). The immunogenicity of rabbit recombinant ZPB was enhanced by expression in 
eukaryotic cells (Prasad et al. 1995) and during this PhD course, Kerr et al. (1999) 
showed that immunisation of female rabbits with rabbit ZPB that had been expressed in 
a rabbit cell line resulted in 75% infertility. However, although rabbit ZPB delivered by 
a recombinant myxoma virus (MV-ZP_B) could induce an antibody response in female 
rabbits, the resulting infertility rate was only 25% and was not sustained (Kerr et al. 
1999). These data suggested that glycosylation of ZPB in eukaryotic cells was an 
important determinant affecting the immune response needed for imrnunocontraception 
and that using recombinant myxoma virus to deliver the self-antigen, recombinant 
rabbit ZPB, is a prospective method for achieving immunocontraception, if infertility 
rates could be increased. However, the immunological and histological responses in the 
ovary during the course of the MV-ZPB infection were not investigated by Kerr et al. 
( 1999). This is necessary for understanding the mechanism of infertility and to provide 
a basis for further development of an effective viral vectored imrnunocontraceptive 
. 
vaccme. 
Immunisation with ZP antigens often causes ovarian pathology, follicle disruption 
and ovarian dysfunction (Chapter 1 section 1.6.2.2) which, in rabbits and other species, 
were shown to be closely linked to the infertility rate (rabbits: Wood et al. 1981 ; 
Skinner et al. 1984; Jones et al. 1992; Kerr et al. 1999; mice: Jackson et al. 1998; 
marmoset monkey: Aitken et al. 1996; bonnet monkeys: Bamezai et al. 1986, and 
hamster: Hasegawa et al. 1992). In the rabbit, ZP antibody binding to oocytes was 
suggested to play a major role in follicle disruption and ovarian dysfunction (Skinner et 
al. 1984), although the pathological mechanism of these effects remains unclear. In 
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addition to the potential effects of antibody, ZP specific cytotoxic or regulatory T cells 
can play a role in ovarian pathogenesis in mice (Tung and Teuscher, 1995; Garza, Lou, 
and Tung, 1998; Tung et al. 2001 ). It is unknown in rabbits whether a T cell response 
contributes to the ovarian pathology following ZP immunisation. 
In this chapter, a recombinant myxoma virus expressing rabbit ZPB (MV-ZPB, 
Chapter 2 section 2.1.1.1) was employed to investigate the immunological and 
pathological responses in the ovary following infection of rabbits with the virus. 
5.2 Experimental design 
Experiment 1. Time course studies of AfV-ZP B infection. Twelve female rabbits were 
intra-dermally immunised with 1 x 103 pfu of MV-ZPB (Chapter 2 section 2.2.2.1 ). 
Four rabbits were killed at day 5, four at day 15 and four at day 30 post-infection 
(termed as MV-ZPB D5, D15 and D30 groups in following text). Blood was collected 
for preparing serum for antibody measurement and ovaries were collected for 
preparation of frozen and paraffin embedded sections (Chapter 2 section 2.2.3.3, 
2.2.3.4). As an infected control, another 8 female rabbits infected with 1 x 106 pfu MV-
HA (Chapter 2 section 2.2.2.1) were killed at day 15 and day 30 post-infection ( 4 
rabbits at each time point, termed as MV-HA D15 and D30 groups) and blood and 
ovaries were collected as above. Another group of four normal female rabbits was killed 
as an uninfected control group. Blood and ovaries were collected for the same analyses. 
Experiment 2. The relationship between follicle reduction and infertility. To compare 
the immunological and histological changes in ovaries from rabbits infected with MV-
ZPB alone with rabbits infected with MV-ZPB and further boosted with recombinant 
ZPB protein (Kerr et al. 1999), four normal female rabbits were intradermally infected 
with 1 x 103 MV-ZPB and boosted twice with puri£ed recombinant ZPB protein 
(Chapter 2 section 2.2.2.1 ) at day 30 and day 44 post-infection. Blood and ovaries were 
collected for analysis when the animals were killed at 58 days post-infection. 
Experiment 3. Comparison of expanded interstitial cells and granulosa lutein cells in 
the ovary. After MV-ZPB infection, numerous large pale-staining cells appeared in the 
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ovary which resembled expanded interstitial or granulosa lutein cells. To compare these 
cells with granulosa lutein cells in the ovulated ovary, two female rabbits were injected 
with hCG to induce ovulation (Chapter 2 section 2.2.2.2) and another two were mated 
to induce ovulation. The four rabbits were killed 5 days later and ovaries were collected 
for histological analysis. 
5.3 Results 
5.3.1 Serum antibody response to ZPB following infection with MV-
ZPB 
Six days after inoculation with MV-ZPB, the skin at the inoculation site developed a 
typical primary lesion. Around 15 days, all rabbits developed myxomatous lesions on 
their ears, eyelids or noses. The rabbits started to recover about day 20 and by day 30 
post-infection the rabbits had recovered from myxomatosis and scars had replaced the 
lesions. 
IgG antibody titers to rabbit ZPB in serum were measured using ELISA (Chapter 2 
section 2.3 .1 ). ZPB IgG antibody was first detected in two of the four rabbits at 5 days 
post-infection, peaked at day 15 and had dropped at 30 days post-infection (Table 5-1 ). 
No IgG antibody to ZPB was detected in pre-immune serum of those rabbits or in serum 
from uninfected or MV-HA infected rabbits. 
Table 5- 1. IgG antibody to rabbit ZPB in serum of rabbits infected with MV-ZPB 
Day 5 Day 15 Day 30 
Rabbit No. Titer (Log10) Rabbit No. Titer (Log10) Rabbit No. Titer (Log10) 
515 1.7 511 2.9 505 2.0 
520 1.4 517 3.8 461 2.0 
522 0 488 3.5 521 2.6 
479 0 509 2.6 503 2.6 
Mean± S.D 0.78 ± 0.9 3.2 ± 0.5 2.3 ± 0.3 
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5.3.2 Antibody localisation in the ovary following MV-ZPB infection 
To determine whether the serum ZPB antibodies were also bound to oocytes, frozen 
sections of ovaries from all groups were stained for rabbit IgG, IgM and IgA with goat 
anti-rabbit lgG and lgA sera and anti-rabbit lg µ-chain monoclonal antibody (Chapter 2 
Table 2-1 and 2). Normal goat serum or MAF were used as negative controls for the 
appropriate sections. 
5.3.2.1 lgG staining in the ovary 
At day 5 post-infection (MV-ZPB D5 group) no IgG staining was found on the ZP in 
follicles at any developmental stage (Figure 5-1 ). Similarly, lgG was not detected on the 
ZP or on any cells in the negative controls treated with normal goat serum instead of the 
primary antibody (Figure 5-1). However, at day 15 post-infection (MV-ZPB D15 
group) strong IgG staining was seen on the ZP of oocytes in most secondary and tertiary 
follicles (Figure 5-2); this staining had increased at 30 days (Figure 5-3). Phase contrast 
images confirmed that the whole ZP and only the ZP of the oocytes stained strongly for 
IgG (Figure 5-2, 5-3). IgG staining was not usually found on the ZP in primary or 
primordial follicles in these groups. Very weak IgG staining was occasionally seen on 
the ZP in ovaries from MV-HA infected rabbits and uninfected controls, suggesting that 
a small amount of IgG binds non-specifically to the ZP (Figure 5-4). These results 
suggested that the IgG bound to ZP in the ovaries was specific IgG antibody to ZPB 
produced by immunisation with MV-ZPB. 
5.3.2.2 lgM staining in the ovary 
IgM bound weakly to the ZP in only a few ovarian follicles from any of the infected 
groups (Figure 5-5) though it has been shown to enter ovarian follicular fluids freely 
(Chapter 4 section 4.3.9). This lack of binding may reflect a low level of IgM antibody 
in serum although this was not measured in these experiments. 
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Figure 5- 1. lgG staining in ovaries of rabbits at day 5 post-infection with MV-ZPB 
and negative controls. Images A and B are from two rabbits in the MV-ZPB D5 group 
and show no IgG staining on the ZP of the oocytes (A, arrow) or in the follicles (B, Fo) 
though weak background staining could be seen on some granulosa or cumulus cells in 
one follicle (B, arrow). Images C and D show the negative controls treated with normal 
goat serum instead of the primary antibody. No IgG staining could be seen on the ZP of 
oocytes (C, arrows) or in the follicles (D). Fo: follicles. Co: cortex. All images are at the 
same magnification. 
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Figure 5- 2. IgG localisation in ovaries of rabbits at 15 days post-infection with 
MV-ZPB. The images A, B, C and D (from 3 different infected rabbits) show that 
strong IgG staining is localised on the ZP of oocytes in secondary (A and B) and tertiary 
(C and D) follicles. E and F show phase contrast images of the follicle structure and ZP 
location (left panel of E and F, arrows) and corresponding IgG fluorescent images (right 
panel, arrows), confirming strong IgG staining localised on ZP. All images are at the 
same magnification. 
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Figure 5- 3. IgG localisation in ovaries of rabbits at 30 days post-infection with 
MV-ZPB. A, B, C, and D are from 3 different rabbits at 30 days post-infection and 
show strong IgG staining on the ZP of oocytes in secondary follicles of different sizes 
(A, B, and C) and tertiary follicles (D). E and F are phase contrast images showing the 
morphology of the follicles (left side, ZP is labelled with arrow) and corresponding 
fluorescent images (right side, arrow). All images are at the same magnification. 
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Figure 5- 4. lgG staining in ovaries of rabbits infected with MV-HA or from 
uninfected controls. Images A and B are ovarian sections from rabbits infected with 
MV -HA at 15 and 3 0 days after infection. Image C is an ovary from an uninfected 
control. Weak IgG staining was seen in some follicles ( arrow A & C) but not in most. 
Image D is also from an uninfected control and consists of two parts: the left part is a 
phase contrast image showing the structure of the ZP ( arrow), the right part is the 
corresponding fluorescent image which shows very weak IgG staining on the ZP in a 
tertiary follicle (arrow). Fo: follicle. All images are at the same magnification. 
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Figure 5- 5. IgM staining in the ovary of rabbits infected with MV-ZPB. IgM 
staining in ovaries from rabbits at day 15 (A) and 30 (B) post-infection with MV-ZPB. 
No IgM staining was found on ZP of oocytes (A, B arrow) lg µ-chain positive cells 
were found around the follicles especially in A (A and B, Fo ), and granulosa or cumulus 
cells were also weakly positive (A). Image C shows a negative control of ovary from a 
MV-ZPB infected rabbit treated with MAF. Fo: follicle. All images are at the same 
magnification. 
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The presence and location of B cells in the ovaries was also examined after staining 
with anti-rabbit lg µ-chain monoclonal antibody. Whereas B cells were rarely seen in 
ovaries from uninfected controls, B cells were found surrounding some primary and 
secondary follicles in 3 of the 4 rabbits in the MV-ZPB D5 group (Figure 5-6). In the 
MV-ZPB D 15 group, follicles of all stages were positive for B cells (Figure 5-6) but far 
fewer B cells were present around the follicles in the MV-ZPB D30 group. In MV-HA 
infected rabbits, only a few B cells were present in the cortex or medulla or sometimes 
around the follicles of any ovaries at day 15 and day 30. This distribution was very 
similar to the MV-ZPB D30 group. No positive cells were seen on the sections treated 
with MAF instead of the antibody. The peak in B cell numbers at day 15 suggests that 
an inflammatory reaction may have occurred in the ovaries of MV-ZPB infected rabbits 
between 5 and 15 days post-infection. 
5.3.2.3 IgA staining in the ovary 
No IgA binding was observed in any ovarian sections. 
5.3.3 Specificity of serum IgG antibody 
5.3.3.1 Serum antibody binding to the zona pellucida in ovarian sections 
To confirm the specificity of serum ZP-IgG antibody, frozen sections of ovaries 
from the MV-ZPB D5 group, which have previously been shown not to have antibody 
binding to the oocytes (Section 5 .3 .2.1 ), were incubated with 1: 100 diluted positive sera 
(equal volumes of sera pooled from two rabbits from the MV-ZPB D15 and D30 
groups). Binding of IgG was assessed by incubation with anti-rabbit IgG conjugated 
with FITC (Chapter 2 Table 2-3). Most zona pellucida of oocytes in secondary and 
tertiary follicles were strongly positive (Figure 5-7), which confirmed that the IgG 
antibody in the serum could specifically bind to the ZP in vitro. Pooled sera from MY-
HA infected rabbits were used as controls~ no IgG staining was found on any ZP m 
sections treated with this serum. 
150 
Figure 5- 6. lg µ-chain positive B cells in ovaries of rabbits infected with MV-ZPB. 
Very few lg µ-chain positive cells were present in ovaries from uninfected (A) or MV-
HA infected (B) controls. More positive cells were found in the MV-ZPB infected 
rabbits at day 5 (C and D) and day 15 (E and F). Most of these cells were associated 
with follicles. At day 30 an occasional ZP was weakly positive for IgM (G) but few B 
cells were present in the ovary (H). All images are at the same magnification. 
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Figure 5- 7. Specificity of serum IgG antibody from rabbits infected with MV-
ZPB. The zona pellucida in secondary (A and B) and tertiary (C) follicles of rabbits at 5 
days post-infection, which were negative for IgG (Figure 5-3), were stained using 
positive serum from rabbits at 15 or 30 days post-infection as primary antibody and 
detected by FITC antibody conjugate. All images are at the same magnification. 
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5.3.4 T cell response in the ovary after MV-ZPB infection 
To examine the cell-mediated immune response in the ovary after MV-ZPB 
infection, the presence of rabbit T cells was assessed in frozen sections of the ovary by 
imrnunofluorescence (Chapter 2 section 2.4.1) using monoclonal antibodies to rabbit 
KEN-5 and CD43 (Chapter 2 Table 2-1 ). Since there were differences in the staining 
patterns of these two monoclonal antibodies (Chapter 3 section 3.4.1) both were used. 
MAF was used as the negative control. 
5.3.4.1 KEN-5 positive cells in the ovary 
KEN-5+ cell infiltrations were found in only one of four rabbits in the MV-ZPB D5 
group and one of four in the MV-ZPB D 15 group. The KEN-5+ cells were present in 
the cortex of the ovary, mostly located closely around secondary or tertiary follicles 
(Figure 5-8). Very few KEN-5+ cells were found in the ovaries of the other three rabbits 
in these two groups. In the MV-ZPB D30 group and the MV-HA group, only a few 
positive cells were present. These ovaries stained similarly to those of the negative 
rabbits in the day 15 group. Ovaries from the uninfected controls had some KEN-5+ 
cells but far fewer than in the positive rabbits from the MV-ZPB day 5 and day 15 
groups; the positive cells were not located round the follicles. No positive cells were 
seen in the negative control stained with MAF. 
5.3.4.2 CD43 positive cells in the ovary 
More CD43 positive cells than KEN-5+ cells were present in ovaries from all 
infected and uninfected groups. Large increases in CD43+ cell numbers were observed 
in the two rabbits from the MV-ZPB D5 and D15 groups that had also shown a 
substantial increase in KEN-5+ cell number; most CD43+ cells were located closely 
around secondary and tertiary follicles (Figure 5-9). In two adjacent ovarian sections 
from these rabbits labeled with CD43 and KEN-5, most CD43+ cells were also KEN-5+ 
cells though CD43 staining was stronger than KEN-5 (Figure 5-9). The numbers and 
distribution of CD43+ cells in the other 3 rabbits in the MV-ZPB day 5 and day 15 
groups, and in all rabbits in the MV-ZPB day 30 group, were similar to the uninfected 
controls. CD43+ cell numbers and locations in MV-HA infected rabbits did not appear 
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Figure 5- 8. KEN-5+ T cell response in ovaries of some MV-ZPB infected rabbits. 
Many KEN-5+ T cells were present around the follicles (Fo) in one of 4 MV-ZPB 
infected rabbits at 5 days post-infection (A, B) and one of 4 rabbits at 15 days post-
infection (C). In contrast, no (D) or very few (E) positive cells were present in ovaries 
from other infected rabbits including the day 30 group (D) and uninfected controls (E). 
F is ovary from a MV-ZPB infected rabbit at 5 days post-infection treated with MAF. 
All images are at the same magnification. 
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Figure 5- 9. Comparison of CD43+ and KEN-5+ T cells in ovaries from MV-ZPB 
infected rabbits. The images show CD43+ (A and C) and KEN-5+ (B and D) T cell 
labelling in two serial ovarian sections (A and B are from the positive rabbit in the day 5 
group and C and ·D are from the positive rabbit in the day 15 group of MV-ZPB 
infection). Most of the CD43+ and KEN-5+ cells were present round the follicles (Po). 
The scale bars represent 50 micro-meters. 
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different to those from uninfected control rabbits. However, in 2 of 4 day 15 rabbits, 
estimated numbers of CD43+ staining cells were intermediate between those in 
uninfected control sections and in the ZPB sections that were positive for T cell 
staining. Overall, it is difficult to draw firm conclusions about the role of T cells in 
ovarian pathology following immunization with MV-ZPB. 
5.3.5 Morphological and histological changes in the ovary after MV-
ZPB infection 
5.3.5.1 Ovarian weight and pro-ovulatory follicle losses 
Obvious changes in ovarian appearance were noticed at the time that the ovaries 
were collected for analysis. Ovaries from infected rabbits (both MV-ZPB and MV-HA) 
were flattened and smaller than those from uninfected controls (Table 5-2). Most 
ovaries in the MV-ZPB D15 and D30 groups had fewer pre-ovulatory follicles 
protruding at surfaces than uninfected controls. There were no differences in ovarian 
weight between MV-ZPB and MV-HA infected rabbits at either day 15 or day 30. 
Although the mean weight of the left ovaries in the MV-ZPB D5 group was lower 
(P<0.05) than that of uninfected controls the same was not true for the right ovary 
(P=0.067). Rabbits were randomly selected by animal house staff and there was no 
correlation between body weight and ovarian weight in any group. 
Table 5- 2. Fresh ovarian weight of rabbits infected with MV-ZPB or MV-HA 
Groups Left ovary (gram) Right ovary (gram) 
Controls 0.32 ± 0.04 0.33 ± 0.04 
MV-ZPB D5 0.22 ± 0.05* 0.25 ± 0.06 
MV-ZPB Dl5 0.15 ± 0.05** 0.13 ± 0.06** 
MV-HAD15 0.16 ± 0.07** 0.16 ± 0.06** 
MV-ZPB D30 0.19 ± 0.05** 0.19 ± 0.07* 
MV-HAD30 0. 13 ± 0.03** 0.14 ± 0.02** 
. . Notes: the values are mean weight ±S.D of 4 rabbits m each group. Statistical analysis: *: P<0.05 agamst 
controls; **: P<O.O l against controls. 
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The right ovaries from each rabbit were collected for histological examination 
(Chapter 2 section 2.2.3.4). Four to six longitudinal sections at 6-8 micrometer 
thickness were cut from each ovary. Fewer pre-ovulatory follicles were seen in sections 
from MV-ZPB infected ovaries than those of uninfected and MV-HA infected controls 
(Figure 5-10). To quantify this, the pre-ovulatory follicles (>0.5mm in diameter) in a 
section from each rabbit were counted and the average follicle number of each group is 
shown in Table 5-3. Compared with the uninfected controls and MV-HA D30 groups, 
MV-ZPB D30 group had significantly fewer follicles (P<0.05 for both, Table 5-3). 
Table 5- 3. The number of pre-ovulatory follicles (>0.5 mm in diameter) in ovarian 
sections 
Groups Number of pre-ovulatory follicles (>0.5 mm in 
diameter) per section 
Control 6.5 ± 1.7 
MV-ZPB D5 5.0 ± 2.2 
MV-ZPB D15 4.3 ± 1.9 
MV-HAD15 4.3 ± 1.3 
MV-ZPB D30 2.3 ± 1.5* 
MV-HAD30 5.8 ± 1.3 
Notes: the values are mean ±S.D of 4 rabbits for each group. *: P<0.05 with uninfected and MY-HA 
infected control groups. 
5.3.5.2 Follicle loss and degeneration 
A decrease in follicle numbers was observed in ovaries from most MV-ZPB infected 
rabbits compared with controls. To quantify this, the numbers of primary, secondary 
and tertiary follicles in these sections were counted. Compared with uninfected controls, 
MV-ZPB infected rabbits suffered a significant (P<0.05) loss of both secondary and 
tertiary follicles at 30 days post-infection but not at 15 and 5 days post-infection (Table 
5-4, Figure 5-11 ). The number of tertiary, but not secondary follicles was also 
significantly lower than that in the corresponding MV-HA infected group (P<0.05, 
Table 5-4). The number of primary follicles was not significantly affected in any ~fV-
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F i g u r e  5 - 1 0 .  T h e  l o s s  o f  p r e - o v u l a t o r y  f o l l i c l e s  i n  M V - Z P B  i n f e c t e d  o v a r i e s .  C o m p a r e d  w i t h  t h e  o v a r i a n  s e c t i o n s  
f r o m  u n i n f e c t e d  ( C o n t r o l )  a n d  M V - H A  i n f e c t e d  ( M V - H A )  c o n t r o l s ,  t h e  n u m b e r s  o f  p r e - o v u l a t o r y  f o l l i c l e s  i n  t h e  4  
o v a r i a n  s e c t i o n s  o f M V - Z P B  i n f e c t e d  r a b b i t s  ( M V - Z P B ,  a t  3 0  d a y s  p o s t - i n f e c t i o n )  w e r e  m a r k e d l y  r e d u c e d .  E a c h  o f  t h o s e  
s e c t i o n s  i s  r e p r e s e n t a t i v e  o f  4 - 6  o v a r i a n  s e c t i o n s  o b t a i n e d  f r o m  o n e  r a b b i t .  A l l  i m a g e s  a r e  2 x  m a g n i f i c a t i o n .  
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Figure 5- 11. Reduction in follicle numbers in ovaries from MV-ZPB infected rabbits (l00x). 
A is from an uninfected control rabbit; B is from a rabbit at day 5 post-infection with MV-ZPB; C is 
from a rabbit at day 30 post-infection with MV-ZPB; Dis from a rabbit at 30 days post infection with 
MV-HA. 
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ZPB infected group compared to the uninfected and MV-HA infected controls (Table 5-
4). The numbers of tertiary, secondary and primary follicles in MV-HA infected rabbits 
were not significantly different from uninfected controls. 
Table 5- 4. The numbers of follicles at different stages of development 
Groups Primary follicles Secondary follicles Tertiary follicles 
Controls 32.5 ± 5.8 28.8 ± 6.4 14.8 ± 1.7 
MV-ZPB D5 33.8 ± 7.3 25.8 ± 3.3 15.3 ± 3.3 
MV-ZPB D15 39.5 ± 20. 7 23.8 ± 15.1 14.5 ± 2.4 
MV-HAD15 32.3 ± 18.4 25.8 ± 11.3 12.0 ± 3.6 
MV-ZPB D30 29.5 ± 9.6 14.5 ± 4.9* 8.5 ± 4.1 * 
MV-HAD30 29.8 ± 13.9 20.8 ± 4.6 16.3 ± 3.9 
Notes: the values are mean ± S.D of 4 rabbits for each group. *: P<0.05 against uninfected 
controls for secondary follicles and against uninfected and MV-HA infected controls for tertiary 
follicles. The primary follicles were classified as follicles with one-layer of granulosa cells. 
Secondary follicles were classified as follicles with two or more layers of granulosa cells but 
without an antrum. Tertiary follicles were defined as follicles with multiple layers of granulosa 
cells and an antrum. One section from the same ovarian location for each rabbit was counted. 
Although the number of secondary follicles in the MV-ZPB D30 group was not 
statistically different from the MV-HA D30 group, there was an obvious difference in 
fo Ilic le distribution between these two groups. No secondary follicles were seen in large 
areas of the cortex in ovaries from the MV-ZPB D30 group ( 4 of 4 rabbits) and these 
areas were infiltrated with many large pale-staining cells (Figure 5-11 ). These cells 
resembled the expanded interstitial cells described by Hammond and Marshall ( 1925) 
and also resembled the granulosa lutein cells described by Leeson and Leeson, (1970). 
They were termed LPC (large pale-staining cells, see following section 5.1.1.2). 
However, in 2 of 4 rabbits, a few small areas in the cortex of the ovaries had normal 
morphology and normal numbers of secondary and primary follicles. 
Degenerate follicles were often seen in both the MV-ZPB and MV-HA infected 
groups. These were characterised by shrinkage and the presence of degenerate 
granulosa cells ( clusters of cells with dark-stained nuclei) in the follicles (Figure 5-12). 
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More degenerate follicles were seen in the day 15 groups than the day 30 groups. 
Although there were no obvious differences between the MV-ZPB and MV-HA 
infected rabbits at day 15 (Figure 5-12) there were more degenerated follicles in the 
MV-ZPB infected rabbits at day 30. These results suggest that infection of the rabbits 
with recombinant myxoma virus caused secondary and tertiary follicle disruption, 
which peaked between day 5 and 15 post-infection. This was also the peak period of the 
IgG antibody response. The findings also suggest that the initial follicle loss is 
maintained for longer in the presence of antibodies to ZPB. 
5.3.5.3 LPC accumulation in the infected ovaries 
As mentioned above, an obvious change in MV-ZPB infected ovaries was the 
accumulation of LPC, notably in 3 of the 4 rabbits in the MV-ZPB D30 group. Most 
areas of the ovarian cortex and medulla were infiltrated with LPC (Figure 5-13). 
Vacuoles were present in_ the cytoplasm of most LPC (Figure 5-13) though in some 
areas these cells were more pink-stained and the vacuoles were hard to see. 
Accumulation ofLPC appeared to be associated with follicle degeneration and loss with 
no follicles being found in the areas infiltrated with LPC (Figure 5-13). 
LPC were not found in ovarian sections from uninfected controls. They were first 
seen in the medullas of2 ovaries from the MV-ZPB D5 group and were found in greater 
numbers and more rabbits of the MV-ZPB D 15 group. In the day 15 group, LPC were 
not only found in the medulla but were also seen in the cortex in some rabbits. Massive 
accumulation of LPC in both medulla and cortex were observed in most ovaries from 
rabbits in the MV-ZPB D30 group (Table 5-5). This suggests that accumulation of LPC 
may start at about 5 days post-infection and progressively increase until at least 30 days 
post-infection. Accumulation of LPC was also observed in the MV-HA infected rabbits 
at both time points but at a lesser intensity than in the corresponding MV-ZPB infected 
groups (Figure 5-11, Table 5-5). Since follicle loss also occurred in the MV-HA 
infected rabbits, this accumulation of LPC may be an expression of ovarian pathology 
following any major physiological insult which subsequently leads to follicle 
degeneration. 
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Figure 5- 12. Follicle degeneration in ovaries from rabbits infected with recombinant MV (l00x). 
Degenerate follicles (arrows) are present in ovaries from MV-ZPB infected rabbits at both 15 days (A) 
and 30 days (B) post-infection. Degenerate follicles are also present in ovaries of rabbits infected with 
MV-HA at both time points (15 day, C and 30 day, D). 
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Figure 5-13. The pattern of LPC accumulation in ovaries from rabbits infected with MV-ZPB. 
LPC first appeared as small cells close to degenerate follicles (A, arrow, 1 00x). LPC then increased in 
size and progressively occupied more areas in the cortex (B, C, Le, 1 00x). As the area occupied by LPC 
expanded, the follicles degenerated at the edge (B, long arrow and C). Image D is a higher 
magnification ( 400x) of C showing the morphology of LPC which are large, pale-stained cells with 
vacuoles in the cytoplasm. 
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Table 5- 5. The rate and intensity of LPC accumulation in the ovary 
Groups 
- + ++ +++ I I I I 
Control 4/4 0 0 0 0 
MV-ZPB D5 2/4 2/4 0 
MV-ZPB D15 0 3/4 1/4 0 
MV-ZPB D30 0 0 0 1/4 3/4 
MV-HAD15 0 2/4 0 1/4 1/4 
MV-HAD30 0 2/4 1/4 1/4 0 
Notes: The values are rabbit number. The accumulation of LPC was ranged as: -, no LPC in 
whole section. +: LPC were present in some area of the medulla. ++, LPC were present in most 
areas of the medulla but not in the cortex.+++, LPC were seen in most areas of the medulla and 
some areas of the cortex. I I I I : LPC were present in the whole medulla and most areas of the 
cortex. 
LPC could originate from two locations. Firstly, LPC could originate in the medulla, 
accumulate there and spread to the cortex because in the day 5 group, LPC were only 
seen in the medulla, whereas in the day 15 and 30 groups these cells were also present 
in the cortex. Secondly, LPC might form from degenerating follicles, because some 
isolated LPC-like cells were seen in degenerate follicles from both the day 15 and day 
30 groups infected with either MV-ZPB or MV-HA (Figure 5-13). 
5.3.5.4 Infiltration of lymphoid cells in the tertiary follicles 
Leucocyte infiltration was examined earlier in the chapter by staining for B and T 
cells infiltrating into the ovary. To further examine this in H & E stained sections, the 
number of tertiary follicles that had lymphoid cells surrounding the oocyte was counted 
in one section from each rabbit (Table 5-6). No significant differences were found 
between MV-ZPB infected groups and their controls except MV-ZPB D15 against MV-
HA D 15 (Table 5-6). In the H & E stained sections, lymphocytes were identified by 
their morphology - dark stained nuclei, little cytoplasm and small, round, size and 
shape. While in some sections there was clearly a lymphocyte infiltration around some 
follicles overall there was no difference between infected and control rabbits. 
' 
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Table 5- 6. The number and ratio of tertiary follicles infiltrated with lymphoid 
cells in the ovarian sections 
Groups Infiltrated follicles Infiltrated follicles/ 
Total follicles 
Controls 1.3±0.9 0.09±0.06 
MV-ZPB D5 1.8±2.4 0.12±0.15 
MV-ZPB DIS 2.8±1.3* 0.19±0.08* 
MV-ZPB D30 1.3±1.5 0.09±0.11 
MV-HAD15 0.8±0.9 0.05±0.06 
MV-HAD30 2.3±0.9 0.13±0.04 
Notes: the values are mean± S.D for four animals. *: P<0.05 against MV-HA D15 group. 
5.3.6 The relationship between follicle number and infertility rate 
A significant reduction in follicle numbers at pre-ovulatory or tertiary stages was 
observed in the rabbits immunised with MV-ZPB (section 5.3.5.2). However, a previous 
study showed that only 25% females were infertile after immunisation with the same 
recombinant MV-ZPB (Kerr et al. 1999). This suggests that the reduction in pre-
ovulatory or tertiary follicle numbers obtained may not be sufficient to cause infertility 
in most rabbits. In the same study, it was shown that the infertility rate increased to 80% 
after the MV-ZPB infected females were boosted twice with recombinant ZPB protein 
(Kerr et al. 1999). To explore a possible relationship between follicle loss and infertility 
rate, four female rabbits were infected with MV-ZPB and boosted twice with 
recombinant rabbit ZPB protein in Freund's incomplete adjuvant (Chapter 2, section 
2.2.2.1) at 30 and 44 days post-infection. Blood and ovaries were collected at 58 days 
post-infection. ZPB-IgG titers were measured in serum and the immunological and 
histological changes in the ovaries were examined. 
5.3.6.1 JgG antibody in serum and in the ovary of boosted rabbits 
The mean serum IgG antibody titer at 58 days in the boosted rabbits was 2. 7 ± 0.51 
(mean± S.D), which was not different from that of the MV-ZPB D30 group and was 
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much lower than the antibody titer in the study of Kerr et al, (1999). A possible 
explanation for this is that the batch of recombinant rabbit ZPB used in the current 
study contained a lower ZPB protein concentration than was indicated. When the same 
protein solution was used for ELISA only a very low level of antibody binding was 
obtained and a similar result was obtained with immuno-blotting (data not shown). 
Taken together, these results suggest that this protein solution contained a lower ZPB 
protein concentration than the supplier indicated. This boost experiment could not be 
repeated because of time limitations. 
The location of IgG antibody in the ovaries was examined in frozen sections using 
immunofluorescence as described above (section 5.3.2). Stronger IgG staining than that 
of the MV-ZPB D30 group (Figure 5-3) was seen on the ZP of oocytes in most 
secondary or tertiary follicles of the four rabbits (Figure 5-14). The ZP of oocytes in 
primary follicles were not IgG positive. As in rabbits infected with MV-ZPB alone 
(section 5.3.2.2 and 5.3.2.3), only weak binding of IgM or IgA to the ZP was seen in a 
few follicles. This was probably non-specific. 
5.3.6.2 CD43 and KEN-5 + cells in the ovary of boosted rabbits 
Ovarian sections from the boosted rabbits were stained for both CD43+ and KEN-5+ 
as described in section 5.3.4. There were increases in both CD43+ and KEN-5+ cell 
numbers in two of the four boosted rabbits compared to the uninfected controls. These 
cells were located closely around the follicles (Figure 5-15). The other two boosted 
rabbits were not different from the uninfected controls described in section 5.3.4.2. 
5.3.6.3 Ovarian weight and pre-ovulatory follicles in boosted rabbits 
The mean ovarian weight of the boosted group was 0.14 ± 0.01 for right ovaries and 
0.14 ± 0.02 for left ovaries, significantly lower (P<0.01 ) than in uninfected controls 
(Table 5-2) but not different from the MV-ZPB D30 group or other infected groups. 
The mean pre-ovulatory follicle number in these ovaries was 2.3 ± 1.5, significantly 
lower (P<0.01) than that of the uninfected controls (6.5 ± 1.7) but not different from the 
MV-ZPB D30 group (2.3 ± 1.5, Table 5-3). 
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Figure 5- 14. IgG localisation in ovaries of rabbits infected with MV-ZPB and 
boosted with recombinant ZPB protein. Strong IgG staining was localised on ZP of 
oocytes in secondary (A and B) and tertiary (C) follicles from rabbits infected with MV-
ZPB and boosted with recombinant ZPB protein. All images are at the same 
magnification. 
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Figure 5- 15. KEN-5+ and CD43+ T cells in ovaries of rabbits infected with MV-
ZPB and boosted with recombinant ZPB protein. The images A and B show that 
KEN-5+ cells are present in the areas close to ovarian follicles (Fo) in boosted rabbits. 
C and D show that CD43+ T cells are also present around the follicles (Fo ). All images 
are at the same magnification. 
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5.3.6.4 Follicle loss and LPC accumulation in the ovary of boosted rabbits 
The number of tertiary follicles for the individual boosted rabbits was 6, 4, 10 and 
27. The mean± S.D was 12 ± 10.5. This number was not statistically different from the 
uninfected controls and the MV-HA D30 group. However, the reduction in follicle 
number in three of the four boosted rabbits is worth noting. The mean numbers of 
primary and secondary follicles in the four rabbits were 15.75 ± 11.1 and 16 ± 6.4, 
respectively, significantly lower (P<0.05 for both) than that of uninfected controls. 
Numbers of primordial follicles in the 3 rabbits with fewer tertiary follicles were also 
reduced compared with uninfected controls and severe LPC accumulation was also 
observed in these rabbits (Figure 5-16). However, less LPC accumulation was seen in 
the ovary with the high number of tertiary follicles. 
5.3. 7 Granulosa lutein cells 
As mentioned above, LPC had some resemblance to granulosa lutein cells which are 
described as large, pale-staining cells with large vesicular nuclei. They are derived from 
granulosa cells and are found in ovulated follicles (Leeson and Leeson, 1970). Because 
ovulation in rabbits occurs only after mating, granulosa lutein cells are usually not 
observed in ovaries from unmated rabbits. To compare granulosa lutein cells in ruptured 
follicles with LPC found in ovaries from infected rabbits, ovulation was induced in two 
rabbits by hCG injection (Chapter 2 section 2.2.2.2) and another two rabbits were mated 
to induce ovulation. The ovaries were collected 5 days after ovulation for histological 
examination. Granulosa lutein cells at different developmental stages were observed in 
these ovarian sections (Figure 5-16). Although some granulosa lutein cells at later 
developmental stages looked similar to LPC, overall they were smaller in size and 
lacked lipid droplets in the cytoplasm (Figure 5-16). In addition, the granulosa lutein 
cells were restricted to the follicles and did not appear to be invading other tissues. 
Furthermore, LPC accumulation occurred in the absence of ovulation which is the 
normal trigger for their formation. 
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F i g u r e  5 - 1 6 .  C o m p a r i s o n  o f  g r a n u l o s a  l u t e i n  c e l l s  i n  o v u l a t e d  f o l l i c l e s  a n d  L P C  ( l 0 0 x ) .  A ,  B  a n d  C  
s h o w  g r a n u l o s a  l u t e i n  c e l l s  ( G L )  a t  d i f f e r e n t  s t a g e s  o f  f o l l i c l e  d e v e l o p m e n t .  I m a g e  A  s h o w s  a n  e a r l y  
d e v e l o p m e n t  s t a g e  o f  G L  w h e r e  l a r g e  a m o u n t s  o f  b l o o d  w e r e  s t i l l  p r e s e n t  i n  t h e  c e n t e r  o f  t h e  f o l l i c l e s .  
I m a g e  B  s h o w s  t h e  n e x t  · s t a g e  o f  G L  w h e r e  t h e  b l o o d  h a s  a l m o s t  d i s a p p e a r e d .  I m a g e  C  s h o w s  a  l a t e r  s t a g e  
o f  G L  w h e r e  n o  b l o o d  c a n  b e  s e e n  i n  t h e  f o l l i c l e .  I m a g e  D  s h o w s  L P C  ( D ,  L e )  i n  o v a r i e s  f r o m  t h e  b o o s t e d  
g r o u p .  
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5.4 Discussion 
5.4.1 Immune response to ZPB in the ovary and immune tolerance to 
ZPB 
It is normally difficult to induce an immune response to a self-antigen because of 
immune tolerance. The mechanism of controlling self-tolerance can be at a central level 
such as negative selection and clonal deletion of autoreactive T and B cells before or 
immediately after birth -or by peripheral suppression of autoreactive lymphocytes 
(Miller, 2001; Huang and MacPherson, 2001). 
ZPB is a self-antigen, which is not produced in rabbits until about a month after birth 
(Kim Baker, PhD thesis, ANU, 1996). The tolerance of female rabbits to ZPB can be 
observed by immunising female and male rabbits with ZPB protein in Freund's 
complete adjuvant. Male rabbits mount a strong antibody response to the first (primary) 
immunisation whereas female rabbits generally require several boosts to generate high 
antibody titers. High antibody titres are also associated with a strong delayed type 
hypersensitivity response (Kerr et al., 1999). Thus, tolerance can be overcome in female 
rabbits by repeated immunisation with ZPB protein indicating that autoreactive T and B 
cells are present but are presumably controlled at the peripheral level. 
In contrast, female and male rabbits immunised with recombinant myxoma virus 
expressing ZPB (MV-ZPB) have an essentially identical antibody response to ZPB 
indicating that delivery of the antigen encoded in the virus overcomes the initial 
tolerance reactions in female rabbits. However, in both genders, the ZPB antibody 
response was not sustained following MV-ZPB immunisation (Kerr et al. , 1999). 
In this chapter, antibody titers to ZPB peaked at 15 days in female rabbits immunised 
with MV-ZPB but then dropped away, a result essentially similar to that of Kerr et al. 
(1999). Kerr et al. (1999) found no pathological changes in the ovaries of rabbits 
immunised with MV-ZPB but these were only examined 90-100 days after 
immunisation. In the present study, ovaries were examined at 5, 15 and 30 days after 
immunisation with MV-ZPB and stained for antibody, B and T cell responses in order 
to understand the early effects of immunisation at the ovarian level. 
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In the current study, an IgG antibody response to ZPB was induced in serum of 
female rabbits infected with MV-ZPB at 15 and 30 days post-infection. This result 
confirms that an antibody response to the self-antigen ZPB can be elicited when ZPB is 
delivered by a recombinant virus (Kerr et al. 1999). Previous studies in rabbits 
immunised with either native rabbit ZP or E. coli-expressed ZPB were unable to 
demonstrate an antibody response to ZP proteins (Wood et al. 1981; Prasad et al. 1995). 
IgG antibody specifically bound to ZP of oocytes in ovaries both in vivo following 
immunisation with MV-ZPB (IgG localisation, Figure 5-2, 5-3) and in vitro (immuno-
fluorescence assay, Figure 5-7). These results suggest that specific IgG to ZPB was 
induced in serum and that serum IgG had entered the ovarian follicle where it bound to 
ZP. Although IgM antibody could also freely transfer into the ovary from serum 
(Chapter 4 section 4.3.9), very little lgM was detected bound to the ZP. This may have 
been due to a lower titer of ZPB-IgM compared to ZPB-IgG in serum or to lower 
antibody affinity for ZPB. However, IgM serum titers were not measured here. As 
expected from the lack of a serum IgA response to MV-HA infection, no . IgA binding to 
ZP of oocytes in the ovary was found. These results confirmed that IgG is the dominant 
antibody class in both the serum and the ovarian follicle following MV-ZPB infection. 
The binding of IgG to ZP, particularly to the ZP of oocytes in tertiary follicles, may 
prevent sperm from attaching to the oocytes and so block fertilisation after ovulation 
(Chapter 1 section 1.6.2.1 ). This ability of MV-ZPB to induce antibody that binds to 
ZPB indicates that MV-ZPB has the potential to be an immunocontraceptive vaccine. 
However, results published during the course of this study indicated that immunisation 
with MV-ZPB induced only transient infertility in 3 of 12 female rabbits. This contrasts 
with the effect of repeated immunisation with ZPB protein in adjuvant which induced 
higher antibody titers and long-term infertility in 75% of immunised rabbits (Kerr et al. , 
1999). In addition, compared with the serum antibody response to HA, a model strong 
antigen, delivered by the same recombinant virus (Chapter 4), the serum antibody 
response to ZPB was much lower and shorter-lived. 
The mechanism of overcoming immune tolerance to self-antigens delivered by a 
recombinant virus is not fully understood. One possible explanation for the overcoming 
of self-tolerance to ZPB in the female rabbit is that the tolerance is due to peripheral 
suppression of ZPB reactive T cells. However it is possible that the viral protein-ZPB 
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complex could bind to B cells through their surface lg specific for MV protein or ZPB 
or be taken up by APC. These cells could then present both ZPB and MV peptides on 
MHC-II molecules to T cells. MV specific T. cells could then activate those B cells 
exhibiting both ZPB and viral peptides (Jackson et al. 1998). Alternatively, peripheral 
tolerance to ZPB might have been induced and maintained by immature dendritic cells 
that lack MHC II molecules and co-stimulation factors (Jonuleit et al. 2001; Mahnke et 
al. 2002). When ZPB carried by the recombinant virus infects these cells (Best and 
Kerr, 2000), the viral antigenic peptides could help in their activation and maturation 
including the promotion of expression of MHC II and co-stimulation factors (Mahnke et 
al., 2002). These matured dendritic cells may then develop the capacity to present ZPB 
peptides to T or B cells and induce an immune response to ZPB. A more general 
explanation is that the viral infection created an inflammatory micro-environment 
( enriched with pro inflammatory molecules such as cytokines) which non-specifically 
increased immune responsiveness, antigen presentation by APC and the responsiveness 
of auto-reactive T and B cells to ZPB. 
A previous study showed that mouse ZPC delivered by a recombinant mouse 
poxvirus induced both an antibody response to ZPC and infertility in female mice 
(Jackson et al. 1998). Similar results were obtained with murine cytomegalovirus 
expressing mouse ZPC (Chambers et al., 1999). Recombinant vaccinia virus, which 
delivered a mouse tumour antigen, was also shown to be able to overcome self-
tolerance and induce an autoimmune response that caused the destruction of tumour 
cells (Overwijk et al. 1999). These data collectively confirm the conclusion that the 
delivery of self-antigen by a recombinant virus has the ability to overcome immune 
tolerance and induce an immune response. 
A T cell response in the ovary was detected in only one of four rabbits in both the 
day 5 and the day 15 groups. At this stage, it is not possible to prove that these T cells 
actually reacted with ZPB. Since a B cell response, as measured by antibody 
production, was mounted to ZPB but then quickly waned, it seems that a good B 
memory cell response was not obtained. This lack of a good memory response could be 
explained by tolerance at the level of T cell help. 
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This raises the question of how a B cell response to ZPB was initially generated. One 
hypothesis is that B cells bind to viral proteins complexed with ZPB via a ZPB antibody 
on the B cell surface. The antigen complex is internalised and processed. This can 
provide two sets of peptides, one derived from viral proteins, the other from ZPB, to 
interact with T cells. Viral proteins can activate a T cell response and stimulate B cell 
responses to both the viral antigen and ZPB, probably by cell-cell interaction and 
producing T cell cytokines in the micro-environment. However, ZPB peptides did not 
activate T cell responses including T memory cells to ZPB. In the absence of T cell 
help, B cell response to ZPB was short-lived. APC could also fail to activate T cell 
responses to self-antigen (Roitt, 1997) or only activate a weak T cell response to ZPB 
but could stimulate a strong T cell response to the viral antigen. In the absence of T 
helper cells, this would result in lower and shorter-lived IgG responses to ZPB. Another 
possibility is that B cell tolerance to ZPB is maintained by self-antigen eliminating or 
inactivating some self-reactive B cells (Goodnow, 1992). The fact that the overall 
antibody response to ZPB was lower than that to HA might indicate that fewer B cells 
were involved in the response. 
5.4.2 Follicle loss and infertility 
5. 4. 2.1 A potential mechanism for JgG-mediated tertiary or secondary follicle 
disruption 
Reduction in follicle numbers following ZP immunisation has frequently been 
reported (Sacco, 1987; Henderson et al. 1988; Skinner et al. 1996), possibly reducing 
the ability of the ovary to produce both oocytes and ovarian hormones (Skinner et al. 
1984). Significant loss of follicles at the pre-ovulatory or tertiary stage was also 
observed in the current study after MV-ZPB infection. This follicle loss could be 
attributable to a combination of specific factors such as antibody or specific T cell 
responses and non-specific factors such as fever resulting from the virus infection. 
Infection with MV-ZPB caused mild myxomatosis and fever (Kerr et al, 1999). Mild 
myxomatosis was also seen in the current study. This clinical disease might have 
physically affected the development or maintenance of ovarian follicles. This was 
suggested by the significant ovarian weight loss in infected rabbits at both 15 and 30 
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days post-infection and the presence of more degenerate follicles in ovaries of infected 
rabbits compared to uninfected controls. 
However, viral infection with MV-HA did not cause significant follicle reduction at 
either 15 or 30 days post-infection. Histological examination also indicated that ovarian 
pathology in MV-HA infected rabbits was not as severe as that in MV-ZPB infected 
rabbits especially in the day 30 group with less accumulation of LPC in the cortex area. 
Furthermore, a previous study showed that infection with the parent strain of MV-ZPB 
(strain Uriarra) showed no effect on fertility (Kerr et al. 1999). This suggests that the 
viral infection has only a limited effect on ovarian function and fertility. 
Because rabbit IgG cannot fix complement (Mage, 1998) and IgG was the dominant 
antibody class bound to the ZP in the ovary, it does not appear likely that IgG induced 
complement damage in the ovary. As mentioned above, only one of four infected 
rabbits showed a T cell response in the ovary whereas reduced numbers of both pre-
ovulatory and tertiary follicles were observed in all four rabbits in the MV-ZPB D30 
group. This result suggests that T cell responses may not play a major role in follicle 
loss. However, T cells were present in one of the four infected rabbits where they may 
damage follicles by producing cytokines or other factors. 
After excluding viral infection and T cell responses, IgG to ZPB remains as the main 
factor responsible for follicle loss (Skinner et al. 1984; Kerr et al, 1999). This was 
supported by the fact that IgG binding was to secondary and tertiary follicles which 
were also the follicles that were undergoing degeneration or reduction in number 
compared with control ovaries. This is also consistent with the development of rabbit 
ZP, in which ZP proteins first appear at the primary follicle stage (but may not be 
detectable by immunofluorescent staining) and are much more developed in secondary 
and tertiary follicle stages (Skinner, 1996). IgG was also suggested to play a major role 
in follicle loss and ovarian dysfunction in rabbits immunised with porcine ZP (Skinner 
et al. 1984) and antibody titer to ZPB was correlated to infertility in rabbits immunised 
with ZPB protein (Kerr et al, 1999). 
How could IgG antibody cause follicle disruption? One explanation suggested by 
Dunbar ( 1989) is that antibody binding to ZP might block communication between 
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oocytes and granulosa cells. Consequently, the oocytes would not exchange essential 
signals with the microenvironment, which might result in oocyte degeneration. Equally, 
granulosa cells would also lack signals from oocytes and therefore undergo 
degeneration or luteinization. This combined failure of signalling between follicle and 
oocyte would lead to fo Ilic le disruption. Eppig et al. ( 1997) have shown that oocytes 
can control the differentiation of granulosa cells by secreting paracrine-signalling 
factors which confirms communication between oocyte and granulosa cells and 
supports the signal disruption hypothesis. Nevertheless, this hypothesis remains to be 
tested. Another possible explanation is that antibody could combine with newly formed 
ZP and change ZP structure thus affecting oocyte development that would result in 
granulosa cell and follicle disruption. 
5.4.2.2 Is there a relationship between follicle loss and infertility 
In the current study, the number of pre-ovulatory and tertiary follicles for the four 
rabbits in the MV-ZPB D30 group was significantly reduced. However, in the previous 
study, only 3 out of 12 (25%) MV-ZPB infected rabbits were infertile when they were 
mated at 34 days post-infection (Kerr et al. 1999). This suggests that the significant loss 
of pre-ovulatory and tertiary follicles may not necessarily correlate to infertility. Kerr et 
al. (1999) showed previously that if the female rabbits infected with MV-ZPB were 
boosted twice with recombinant ZPB protein, the infertility rate increased to 80% (Kerr 
et al. 1999). Similar immunological and histological changes to those in the MV-ZPB 
D30 group were seen in ovaries from a group of rabbits boosted in the same way as 
Kerr et al. (1999). However, compared with the MV-ZPB D30 group the boosted group 
had significantly fewer primary and primordial follicles, consistent with the lower 
fertility reported by Kerr et al. ( 1999). These studies suggest that a high infertility rate 
may require loss of primordial or primary follicles as well as pre-ovulatory or tertiary 
follicles. Significant primary and primordial follicle reductions and high infertility rates 
were reported by previous studies in rabbits immunised with porcine ZPC (Skinner et 
al. 1984; Jones et al. 1992). These data support this conclusion. 
How is the reduction of primary and primordial follicle reduction linked to a higher 
infertility rate? One obvious possibility is that once the follicles at early developmental 
stages are disrupted in the ovary, the entire follicular pool is depleted and the ovary 
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therefore cannot produce oocytes or normal secretion of hormones and this leads to 
infertility. In contrast, in the case of the MV-ZPB D30 group, primary and primordial 
follicles remained basically normal so although there would be an initial level of 
infertility following the loss of secondary and tertiary follicles, subsequent development 
of primary follicles would result in the infertility being transient. However, in the 
current study IgG staining was not detected in primary and primordial follicles in the 
ovarian sections from either MV-ZPB infected or boosted groups and primary or 
primordial follicle reduction did not correlate with tertiary follicle reduction. This result 
supports the idea that primary and primordial follicle reduction is more likely to be a 
result of longer-term ovarian pathology or dysfunction including LPC accumulation and 
possible endocrine changes (see also following section 5.4.3) rather than a direct 
antibody reaction. From this point of view, the reduction of early stage follicles should 
occur after tertiary or secondary follicle reduction at later time points after infection. 
5.4.3 Accumulation of LPC in infected ovaries 
As well as a reduction in secondary and tertiary follicles, another obvious 
histological change in ovaries from MV-ZPB infected rabbits was the accumulation of 
LPC in both cortex and medulla. This was more obvious at later stages of MV-ZPB 
infection (the day 30 group) and in the boosted rabbits. Ovaries showing substantial 
LPC accumulation also showed extensive follicle loss. However, the reasons for LPC 
accumulation, their effects and the relation between LPC accumulation and follicle 
reduction or infertility are unknown. 
Two cell-types, granulosa lutein cells (Leeson and Leeson, 1970) and expanded 
interstitial cells (Hammond and Marshall, 1925; Leeson and Leeson, 1970) are similar 
in description to LPC. The formation of LPC from granulosa cells is consistent with 
their origin close to degenerating follicles and with the possibility that antibody binding 
to the ZP results in an interruption of signalling between oocyte and granulosa cells. 
This latter might well result in atresia of the oocyte and aberrant development of the 
granulosa cells. However, careful examination of granulosa lutein cells (Figure 5-16) 
suggested that they had different cytological characteristics from LPC (Figure 5-13 and 
5-16). The possibility that LPC could be expanded interstitial cells is supported by the 
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observation that LPC are first seen at sites where small follicles have degenerated. In 
humans, expanded interstitial cells can be seen in normal ovaries as a result of follicle 
degeneration but massive accumulation of interstitial cells is thought to result only from 
extensive follicle disruption (Leeson and Leeso~ 1970). In rabbits, massive 
accumulation of LPC could also follow extensive follicle disruption by antibody. 
Further investigation will be necessary before any decision between these two 
alternatives, or indeed whether either is correct, can be made. 
LPC have also reported in other studies in rabbits (Kerr et al. 1999) and mice 
(Jackson et al. 1998) where they have been described as luteinised cells. Further study 
is needed to understand LPC, especially in the endocrinological aspects. 
5.4.4 Summary 
Although recombinant myxoma virus has the ability to overcome self-tolerance to 
delivered antigens immune tolerance still existed to some extent compared to foreign 
antigens delivered by the same virus. The follicle disruption and ovarian pathology in 
the ovary following MV-ZPB infection is more likely to relate to IgG-mediated follicle 
degeneration than to a T cell response. High and long lasting levels of serum antibody 
(IgG) are needed to disrupt the primary and primordial follicles, which seem more 
important to higher infertility rate than disruption of secondary and tertiary follicles. 
From this point of view, the antigenicity of ZPB needs to be enhanced to achieve a 
higher infertility rate if ZPB is to be delivered by a recombinant myxoma virus. 
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CHAPTER 6: FINAL DISCUSSION 
6.1 Introduction 
As a critical step in developing a viral vectored immunocontraceptive vaccine for 
rabbit fertility control, this program focused on understanding the immune response in 
the female rabbit reproductive tract to antigens delivered by recombinant myxoma 
viruses. Recombinant myxoma vfrus did not induce high IgG and IgA responses to a 
model antigen (HA) in the mucosal compartments of the reproductive tract. However, 
strong IgG responses to HA were always induced in serum and the antibody could 
transfer freely from serum into the ovarian follicular fluids. If antibody is critical for 
immunocontraception, the fact that only low levels of antibodies were induced in the 
mucosal part of the reproductive tract whereas high levels of antibodies were induced in 
the ovarian follicles indicated that the ovary was a more appropriate target for 
immunocontraception if the antigen was to be delivered by recombinant MV. 
Infection of female rabbits with MV-ZPB overcame self-tolerance to ZPB and 
induced an IgG response to ZPB. The antibody bound to the zona pellucida of oocytes 
in the ovary and this was associated with a significant reduction in the number of pre-
ovulatory or tertiary follicles and other ovarian pathology including extensive 
accumulation of large pale-staining cells (LPC). This result, together with the low 
antibody response to MV-HA infection in the reproductive tract confirms that the ovary 
is a better target for immunocontraception delivered by a recombinant myxoma virus 
than is the mucosa! compartment of the reproductive tract. However, although here all 
rabbits showed a similar loss of pre-ovulatory or tertiary follicles (Chapter 5), in a 
previous study immunisation with MV-ZPB led to only 25% infertility (Kerr et al, 
1999). But boosting with ZPB protein was followed by a loss of primary or primordial 
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follicles that was correlated with high infertility (Kerr et al, 1999). Following boosting 
in the current study, there was also a loss of primary and primordial follicles. In this 
chapter, the implication of these results and the possible mechanisms behind them will 
be discussed. Some possible future experiments will also be outlined. 
6.2 The Immune response 
recombinant MV and 
to antigens delivered by a 
the selection of immuno-
contraceptive target antigens 
6.2.1 IgA antibody response 
It has been demonstrated in rabbits that, following immunisation with semen or 
sperm proteins, IgG and IgA to sperm antigens in the reproductive tract fluids were the 
main contributors to blocking fertilisation (Menge and Lieberman, 1974). Consequently, 
it has been the prevailing view that induction of effective IgG and IgA responses in the 
reproductive tract by the recombinant MV would be essential for developing viral 
vectored immunocontraception targeted at sperm antigens. However, studies with the 
model antigen delivery system MV-HA, or with the self-antigen expressing MV-ZPB 
have proved that MV is not an effective vector for inducing IgA antibody responses in 
rabbits. 
Infection of female rabbits with MV-HA by intradermal inoculation (the natural 
infection route of the virus) was inefficient at inducing specific IgA responses in serum 
or reproductive tract fluids (Kerr and Jackson, 1995; Chapter 4). Infection of female 
rabbits with MV-ZPB confirmed this (Chapter 5). These results suggest that by its 
natural route of infection the virus is not effective at inducing an IgA response. 
Infection of female rabbits with MV-HA through a common mucosa! inductive site 
(intranasal) also failed to induce an IgA response in serum or a high IgA response in the 
reproductive tract fluids and nasal washings (Chapter 4). An earlier study in rabbits 
showed that intra-tracheal immunisation with either live or inactivated influenza virus 
induced an IgA antibody response to HA in both serum and respiratory secretions 
(Kasturi and Hannoun, 1977). However, HA encoded by the recombinant MV did not 
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induce IgA suggesting that delivery by recombinant myxoma virus may interfere with 
generation of IgA responses. In the mouse, however, intranasal infection with a 
recombinant adenovirus expressing HSV-1 was effective at inducing IgA responses to 
the antigen in serum and vaginal secretions and B cell homing to the reproductive tract 
was also induced ( Gallichan et al. 1993; Gallichan and Rosenthal, 1995; Gallichan and 
Rosenthal, 1998). Clearly, recombinant myxoma virus is less effective at inducing an 
IgA response in the rabbit than the recombinant adenovirus is in the mouse. 
Based on the numbers of potential antigen-presenting MHC-II positive cells present, 
the rabbit vagina has more potential than other regions of the reproductive tract to 
present antigens and induce a local immune response (Chapter 3), probably through 
antigen presenting cells migrating to local draining lymph nodes (McGhee et al. 1994; 
1999). Intra-vaginal immunisation of rabbits with DNA vaccines induced IgA antibody 
responses in vaginal washings (Schreckenberger et al. 2000). However, intra-vaginal 
infection with MV-HA did not induce an IgA response to either MV or HA in either the 
circulation or local mucosa even though this infection led to the replication of the virus 
in vaginal MHC-II+ cells and a strong IgG antibody response in the circulation (Chapter 
4). Collectively, these data suggest that MV is not an effective vector for inducing an 
IgA antibody response in rabbits. This effect was not limited only to the vectored 
antigen; IgA antibody to MV was also not detected in either the circulation or 
reproductive tract fluids following mucosa! infections with MV-HA (Chapter 4). 
However, rabbits are capable of mounting an IgA response to various antigens (Menge 
and Lieberman, 1974; Winchell et al. 1997; 1998; Schreckenberger et al. 2000) 
including HA (Kasturi and Hannoun, 1977), confirming that the absence of an IgA 
response in the present study is probably attributable to the mode of delivery as a 
recombinant MV and not any intrinsic lack of ability to mount an IgA response in the 
rabbit. 
Compared with other species like mice and human, that have only one or two IgA 
isotypes, rabbits have 13 IgA heavy constant a-chain genes and 11 of which are 
expressed in rabbit tissues (Spieker-Polet et al. 1993; Spieker-Polet et al. 2002). 
Furthermore, in rabbits, different tissues express different isotypes with variable 
expression levels (Spieker-Polet et al. 1993; Spieker-Po let et al. 2002). It is not known 
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which isotypes are expressed in the reproductive tract fluids or at what levels they are 
expressed. It is also not known which of the 11 expressed rabbit isotypes of IgA are 
recognised by the anti-rabbit IgA polyclonal antibody used in the present study 
However, this antibody detected IgA in the reproductive tract fluids by ELISA and in 
the tissues by immunofluorescence. Furthermore, high titers of IgA were detected in the 
serum by immunodiffusion assay. It is possible that some IgA isotypes in the 
reproductive tract were not detected by this antibody. This would require further 
investigation. 
6.2.2 IgG antibody response and transfer of IgG into the lumen of the 
reproductive tract 
Recombinant MV is also not an effective delivery system for inducing a high IgG 
antibody titer in the reproductive tract fluids of rabbits. This was shown by the finding 
that only low levels of HA-IgG antibody were induced in the tract fluids and by 
comparison of the titers of IgG to HA in the serum and in the reproductive tract fluids 
following infections with MV-HA (Chapter 4). However, the recombinant MV 
consistently induced a high and lasting serum IgG antibody titer to HA (Chapter 4, Kerr 
and Jackson, 1995). In contrast to immunisation with recombinant adenovirus in the 
mouse, where intra-vaginal immunisation induced only low levels of serum IgG to 
HSV-I (Gallichan and Rosenthal, 1995), the recombinant MV was also effective at 
inducing a strong IgG response to HA in serum following intra-vaginal infection 
( Chapter 4). 
The IgG present in female reproductive tract fluids is considered to be mainly 
derived from serum (Parr and Parr, 1996). For example, in mice the IgG titer in 
reproductive tract fluids was more than 10% of the IgG titer in serum (Gallichan and 
Rosenthal, 1995; Johansson et al. 1998). However, in the present study only about 1 % 
of the serum IgG level was present in the luminal fluids after MV-HA infection 
(Chapter 4). In previous studies in rabbits IgG antibody was either not detected in the 
reproductive tract fluids (Edwards, 1960; Shapiro, 1971) or was detected at only 4 % of 
the levels in serum (Oliphant et al. 1977). Thus compared with the mouse, the rabbit is 
less efficient at transferring IgG into the reproductive tract. The oestrogen dominance in 
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the female rabbit reproductive tract before mating could account for the low IgG 
transfer efficiency; in rats, IgG levels in reproductive tract fluids were low at stages of 
the oestrous cycle when oestrogen concentration are high (Wira and Sandoe, 1980, 
Chapter 1 section 1.5.3). However,_induction of ovulation in rabbits did not significantly 
alter IgG levels in the luminal fluids (Chapter 4). These data indicate that IgG transfer 
into the female rabbit reproductive tract is not influenced by oestrogen and progesterone 
in the same way as in rodents, in which the fall in oestrogen concentration and rise in 
progesterone concentration following ovulation is accompanied by an increase in 
antibody levels (Chapter 1 section 1.5.3). The finding that recombinant MV did not 
induce a high level of IgA and IgG in the female rabbit reproductive tract fluids and that 
serum IgG did not effectively transfer into the luminal fluids indicate that the virus is 
unlikely to be a suitable vector to deliver antigens such as sperm proteins for 
immunocontraception. 
In contrast to the mucosal part of the reproductive tract, IgG and IgM in serum can 
freely transfer into the ovarian follicular fluids of rabbits (Chapter 4; Symons and 
Herbert, 1971; Kille and Goldberg, 1979). In addition, IgG antibody to ZPB induced by 
MV-ZPB infection was shown to enter ovarian follicular fluids and bind to oocytes 
(Chapter 5). These results suggest that, unlike the epithelial cells in the tract, there is no 
barrier between ovarian follicular fluids and serum, at least for IgG transfer. The fact 
that recombinant MV is effective at inducing a strong systemic IgG antibody response, 
and that this antibody could freely enter the ovarian follicles and react to oocytes, 
indicates that the ovary may be a more appropriate target for immunocontraception. 
6.2.3 A model of the immune response to recombinant MV 
The antibody response to myxoma virus infection is generally considered to be T 
cell-dependent. Both IgM and IgG antibodies to HA and MV were produced following 
infections with MV-HA (Chapter 4). This indicates that both HA and MV protein 
peptides have been presented by professional APC to CD4+ T cells and that intact 
antigens have been recognised by B cells. The role of T cell help is indicated by the 
switching from IgM to IgG production by B cells that has occurred (Figure 6-1 ). MV-
HA is highly attenuated allowing the infection to be rapidly cleared, which in other 
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Figure 6-1. A model of antigen presentation and immune response to a strong 
antigen HA delivered by a recombinant myxoma virus (MV-HA) in the female 
rabbit. After infection of female rabbits with MV-HA, the APC at the inoculation sites (DC or 
LC in the skin; M cells in NALT and perhaps MHC-II + cells in the reproductive tract) take in and 
process the recombinant virus. Antigen peptides of both MV and HA are then presented complexed 
with MHC class II molecules at the APC cell surface (mv and ha). CD4+ T cells (possibly mainly 
Thl) recognise the peptide-MI-IC-II complex by T cell receptor (TCR) and are activated. Thl 
cytokines (such as INF-y, IL-2) are produced. In contrast, Th2 cell activation and Th2 cytokine 
production may be disturbed probably by an unclear mechanism. B cells can also bind the 
recombinant viral or HA antigen through cell surface antibody. The activated T cells (both MV and 
HA specific) and Thl cytokines could help in stimulating strong HA and MV B cell responses 
including lg isotype switch from lgM producing cells to lgG producing cells. The T and B memory 
(T.m and B.m) cells are also produced which ensure lasting antibody responses to MV and HA. The 
lack or absence of Th2 cytokines (such as lL-4, IL-5 and lL-6) would affect the lg isotype switch 
from lgG producing cells to IgA producing cells and B cell homing to mucosal sites. 
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poxvirus infections requires an effective CD4+ and CD8+ T cell response as well as 
antibodies (Karupiah et al., 1996; Karupiah, 1998). Viral clearance implies that there 
was an effective T and B cell response to the infection. Based on the low levels of IgA 
to HA or MV, lg isotype switching from IgG to IgA did not occur. It is known that Th2 
cytokines such as IL-4, IL-5 and IL-6 are crucial in IgA isotype-switching and IgA 
production (Husband et al. 1994; Strober and Ehrhardt, 1994; Husband, et al. 1999). 
The weak IgA response could be due to a dominant Thl response producing INF-y and 
IL-2 rather than the Th2 cytokines, IL-4, IL-5 and IL-6. A strong Thl response, together 
with production of IgG driven by a Thl immune response, could explain the highly 
attenuated phenotypes of the recombinant virus and the low IgA to HA. Rabbits only 
produce one subtype of IgG (Knight, 1992) so further definition of the IgG subclass, as 
can be done for mice and humans, is not possible. Myxoma virus is postulated to inhibit 
Thl responses (Best and Kerr, 2000) and down-regulates the rabbit inflammatory 
response (Nash, 1999) but this is probably not occurring efficiently with the highly 
attenuated MV-HA. 
According to this model, recombinant myxoma virus is an effective vector to deliver 
an antigen to rabbits and induce a strong and lasting serum IgG response. However, it is 
not effective at inducing an IgA response. If this failure of the virus to induce a good 
IgA antibody response was due to the lack of Th2 cytokines, then co-expression of the 
foreign antigen with Th2 cytokines such IL-5 and IL-6 might enhance the IgA response. 
This is worth further investigation because it may have implications for developing 
immunocontraception targeted at sperm antigens. 
6.3 Antigen presentation and immune response to ZPB, a 
self-antigen 
6.3.1 Overcoming self-tolerance to ZPB 
Female rabbits are normally immunologically tolerant to recombinant rabbit ZPB . 
This was demonstrated by a direct immunisation experiment where female rabbits 
needed 2-3 injections of ZPB protein in adjuvant to develop high titers of antibodies to 
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ZPB (Kerr et al. 1999). On the other hand, male rabbits, where ZPB is not a self-
antigen, had a strong antibody response to ZPB following a single protein injection 
(Kerr et al. 1999). In contrast, infection of female rabbits with MV-ZPB induced 
antibodies to ZPB (Kerr et al. 1999; Chapter 5), which were similar in titer and kinetics 
to those of male rabbits infected with MV-ZPB (Kerr et al. 1999). The IgG was shown 
to bind to the ZP of rabbit oocytes and this was associated with follicle loss (Chapter 5). 
This raises the question of how the recombinant virus is overcoming immune tolerance 
in female rabbits. 
One possible explanation is that tolerance is due to suppression or deletion of ZPB 
reactive T cells. However, if a viral protein-ZPB complex could bind to B cells through 
surface lg specific for MV or ZPB, these cells could then present both ZPB and MV 
peptides on MHC-Il molecules following internalisation and processing of the antigen 
complex. MV specific T cells, probably activated by APC cells, could activate these B 
cells. This model was proposed by Jackson et al. (1998) to explain how recombinant 
ectromelia virus expressing mouse ZPC could overcome immune tolerance and induce 
antibodies to ZPC. Another possible explanation is that viral infection creates an 
inflammatory micro-environment ( enriched with proinflammatory molecules such as 
cytokines and other immune factors) which non-specifically increases the 
responsiveness of auto-reactive T and B cells to self-antigen. 
Mouse ZPC delivered by a recombinant mouse poxv1rus induced an antibody 
response to this antigen and infertility in female mice (Jackson et al. 1998). Similarly, 
recombinant murine cytomegalovirus expressing mouse ZPC is able to induce antibody 
responses and infertility in infected mice (Chambers et al., 1999). Recombinant vaccinia 
virus, which delivered a mouse tumour antigen, overcame self-tolerance and induced an 
autoimmune response that caused the destruction of tumour cells (Overwijk et al. 1999). 
Taken together, these data suggest that the immune response induced by a recombinant 
virus to a self-antigen may be quite different to that induced by conventional 
immunisation. 
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6.3.2 A possible model for the short-lived antibody response to ZPB 
induced when rabbits were immunised with MV-ZPB 
Although self-antigens delivered by recombinant viruses could overcome tolerance 
as described above, some level of immune-tolerance to the antigen still existed. This 
was suggested by the observation that only a short-lived antibody response and a weak 
inflammatory response in the ovary were induced in female rabbits infected with MV -
ZPB (Chapter 5). These responses led to significant losses of pre-ovulatory or tertiary 
follicles associated with a low and transient infertility in some rabbits. Both antibody 
levels and infertility were enhanced by boosts of recombinant ZPB protein (Kerr et al. 
1999); boosting was also associated with a partial depletion of primordial and primary 
follicles (Chapter 5). 
The relatively transient antibody response to ZPB induced after MV-ZPB infection 
. compared with immunisation with MV-HA (Kerr et al. 1999; Chapter 5), is postulated 
to be due to the lack of T memory cells. It is known that activated T cells play important 
roles in B cell differentiation and antibody production (Roitt, 1997) for example through 
CD40 and CD40 ligand interaction (Kooten and Banchereau, 2000). Without T memory 
cells, the B cell response and antibody production may not be long-lasting (Roitt, 1997). 
If we postulate that the poorly sustained antibody response to ZPB is due to a lack of 
memory T cells, then this may reflect T cell tolerance to ZPB during CD4+ T cell 
activation. One explanation for this is that ZPB-reactive T cells are anergic through the 
mechanism of peripheral tolerance (Lo, 1992; Roitt, 1997). Another possibility, as 
suggested by de St Groth (1998), is that the lymphoid dendritic cells (LDC) could 
distinguish a self-antigen (ZPB) from a foreign antigen (MV) and so lead to self-
tolerance. The finding that CD4+ T cells were crucial for the antibody response to a 
self-tumor antigen delivered by recombinant vaccinia virus (Overwijk et al. 1999) 
supports the view that Th memory cells are important to a sustained immune response to 
a self-antigen. Therefore, overcoming T cell tolerance by enhancing the 
immunogenicity of ZP antigens and antigen presentation to CD4+ T cells could be 
important for inducing a high and lasting antibody response to ZP antigens. 
Another explanation for the short-lived antibody response to ZPB is that since the 
recombinant MV was rapidly cleared from the host, viral-ZPB antigen complexes or 
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ZPB protein were no longer available to bind to B cells. The B cells for ZPB antibodies 
then could not be activated by MV specific T cells, which would result in a short-lived 
antibody response. From this point of view, keeping the recombinant virus longer in the 
host, and thus a sustained production of ZPB, might lead to a sustained antibody 
response to ZPB. If ZPB is persisting but the immune response is not sustained, this 
would suggest that regulatory mechanisms are acting to suppress the autoimmune 
response and this contrasts strongly with the high titer and sustained antibody responses 
to HA. Further experiments are needed to determine whether tolerance is mediated at 
the level of B or T cells before a detailed explanation can be developed. 
6.4 A hypothesis for the relationship between follicle losses 
and infertility induced by MV-ZPB infection 
A reduction in the number of follicles in the ovary is considered to be one important 
factor contributing to infertility in rabbits immunised with ZP antigens (Skinner et al. 
1984; Jones et al. 1992; Kerr et al, 1999). But significant reduction of only pre-
ovulatory or tertiary follicles with retention of normal primary or primordial follicles 
produced low rates of infertility (Kerr et al, 1999, Chapter 5). However, significant 
reduction of primary or primordial follicles as well as pre-ovulatory or tertiary follicles 
may result in significant and sustained infertility. In addition, although IgG to ZPB was 
postulated to be the main factor responsible for follicle loss in rabbits (Chapter 5, 
Skinner et al. 1984), it did not seem to directly disrupt primary and primordial follicles. 
This was suggested by the observation that primary and primordial follicles remained 
basically normal at 15 and 30 days post-infection with MV-ZPB, whereas tertiary 
follicles were significantly disrupted in the same infected rabbits (Chapter 5). From the 
time course of ovarian pathology, it appeared that primary or primordial follicle 
reduction happened at a later stage of ovarian pathology and needed a persistent, high-
titered antibody response (Chapter 5). Based on these observations, a two-stage model 
of ovarian pathology is postulated to explain the relationship between antibody 
response, follicle reduction, and infertility. 
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Stage 1 is dominated by IgG mediated tertiary or secondary follicle degeneration and 
disruption. During this stage, an antibody response to ZPB is mounted and IgG antibody 
binds to ZP of the oocytes in the ovary. It is also possible that the binding of IgG to ZP 
could prevent sperm from attaching to the oocytes following ovulation or inhibit correct 
development of the oocyte thus resulting in a fertilisation block (Chapter 1 ). In this 
model, the binding of antibody to the ZP would initiate ovarian pathology by causing 
tertiary or secondary follicle degeneration and disruption (Chapter 5). Because most 
primary and secondary follicles are unaffected at this stage (Chapter 5), the infertility 
rate may not be heavily influenced by ovarian pathology such as follicle losses and 
ovarian dysfunction but may be more influenced by failure of fertilisation following 
binding of antibody to the ZP. If the immune response ceased at this stage, follicle 
development and fertility may be easily recoverable. 
Stage 2 is dominated by primary and primordial follicle disruption and ovarian 
dysfunction. As the disruption of tertiary or secondary follicles in stage I continues, the 
ovary develops severe pathology (such as accumulation and expansion of LPC), 
presumably accompanied by endocrine dysfunction. Most primary and primordial 
follicles are lost. This could be due to ovarian pathology and endocrine dysfunction that 
makes the transformation of primordial to primary follicles and the subsequent 
development of primary follicles impossible. Alternatively, primordial and primary 
follicles may be recruited into the developing follicle pool where they are disrupted by 
IgG antibody at such a rate that primordial follicle depletion was observed. This means 
that for sustained infertility long-lasting IgG antibody and continuous depletion of 
newly formed tertiary or secondary follicles would be important. Because of the 
sparcity or absence of tertiary or secondary follicles in the ovary in this stage, direct 
antibody blocking of fertilisation would be less important. This makes the ovarian and 
endocrine dysfunction that caused the ovary to fail to produce oocytes the main cause of 
infertility. This stage could take much longer to develop ( 6-7 weeks) according to the 
current results (Chapter 5) and previous studies with porcine ZP immunisations (Wood 
et al. 1981; Skinner et al. 1984; Jones et al. 1992). Recovery from this stage could be 
prolonged or impossible. 
According to this model, IgG antibody and primordial and primary follicle atresia are 
both important for inducing a high infertility rate. A high titer of IgG antibody may be 
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more important for directly blocking fertilisation by binding to the ZP at stage 1 but 
follicle disruption may be more important for infertility during stage 2. A long-lasting 
antibody response is crucial for sustaining the ovarian pathology. MV-ZPB infection 
induces only a low and short-lived antibody response and ovarian pathology stayed at 
stage 1. This would explain the low infertility rates in female rabbits after MV-ZPB 
infection (Kerr et al. 1999). Boosting of the MV-ZPB infected rabbits with recombinant 
ZPB protein induced a sustained antibody response, led the ovary into stage 2 of the 
pathogenesis and resulted in the higher infertility rate in boosted rabbits (Kerr et al. 
1999). Although the induction of infertility has been divided into two stages in this 
model, the two stages may not be critically divided. For example, loss of primary 
follicles was seen in some individuals in the day 15 and 30 groups ofMV-ZPB infection 
(Chapter 5, Table 5-4). But, in general, the tertiary follicles were disrupted before 
primary or primordial follicle reduction at the level of antibody induced by MV-ZPB 
infection. Because T cells were only seen in ovaries from one rabbit at day 5 and one 
rabbit at day 15 following infection, the role of T cells in follicle disruption is unclear 
and has not been developed in this model. 
6.5 Future studies 
6.5.1 Enhancing immunogenicity of ZP to induce a stronger antibody 
response 
MV-ZPB showed the potential to be an immunocontraceptive vaccine (Kerr et al , 
1999; Chapter 5). However, tolerance needs to be more fully overcome to induce a 
stronger and lasting IgG antibody response to ZPB for a higher infertility rate. Further 
studies could include co-expressing adjuvant cytokines such as IL-2 with ZPB in the 
virus to enhance the T cell response to ZPB. As an alternative strategy, using 
heterologous ZP antigens such as porcine ZPC instead of rabbit ZPB to increase the 
immunogenicity of ZP antigens may overcome self-tolerance. In the monkey, 
immunisation with recombinant rabbit ZPA (75-Kd ZP) protein showed interference 
with ovarian follicular development and function whereas immunisation with rabbit 
ZPB protein showed an antibody response but no effects on follicular development and 
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ovanan function (VandeVoort et al. 1995). For the rabbit, selecting other ovanan 
antigens such as rabbit ZPA, ZPC or co-expressing these antigens with ZPB might be 
able to enhance the immunogenicity of ZP antigen and achieve a better sterilisation 
effect or fertilisation block. In addition, for the long-term, identifying other 
immunocontraceptive ovarian antigens such as antigens from granulosa cells would also 
be worthwhile. 
6.5.2 Understanding LPC and their effect on follicle development and 
ovarian function 
It was shown that LP_C were associated with follicle loss and ovarian pathology 
(Chapter 5). Whether these LPC are the result of pathology or are capable of causing 
further ovarian dysfunction is wholly unknown. It would therefore be worthwhile to 
investigate how LPC are induced, what kind of hormones, if any, they produce, and 
which hormones, if any, regulate these cells. Measurement of oestradiol, progesterone, 
FSH and LH levels in serum may facilitate the understanding of ovarian dysfunction 
and the mechanisms underlying the infertility that follows ovarian pathology. 
6.5.3 Passive immunisation experiments with anti-ZPB IgG 
Comparison of MV-ZPB and MV-HA infections showed that infections with 
myxoma virus itself caused some follicle degeneration (Chapter 5). To investigate the 
role of IgG to ZPB in ovarian pathology, in the absence of the virus and to understand 
the role of IgG in the time course of ovarian pathology, an IgG antibody passive 
immunisation experiment would be necessary. Anti-ZPB IgG can be purified and 
injected into female rabbits. Considerable preliminary study would be needed to 
establish the injection does and regime necessary to maintain high serum antibody 
levels for the duration of the experiment. Immunological and histological changes in the 
ovary and infertility rates would then be monitored over a longer time period (at least 7 
weeks) to observe the changes in tertiary (stage 1) and primary or primordial (stage 2) 
follicle numbers as well as other ovarian pathology, for example the development of 
LPC. This study is relatively simple in concept but purification of the large amounts of 
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ZPB antibodies needed and the development of an appropriate regime for their delivery 
would be demanding. 
6.5.4 Further studies of mucosa! immunity in the female reproductive 
tract 
The presence of IgG and IgA in uterine epithelial cells showed that both antibodies 
are able to transfer from tissue to epithelial cells (Chapter 3 and 4). Detection of 
secretory component on epithelial cells or conducting a passive lg transfer assay could 
provide more information about antibody transfer into these cells and to the mucus and 
lumen of the reproductive tract. IgG and IgA was highly concentrated within the cells of 
the epithelial surface of the reproductive tract, especially the uterus. This was shown 
both immunohistochemically and by the low levels of IgA in washings from the 
reproductive tract. Further characterisation of IgA isotypes and their potential functions 
is important for understanding mucosal antibody responses in the reproductive tract. 
At the T cell level, investigating and characterising the IEL might enable an 
understanding of their functional roles. The number of KEN-5+ T cells, IL-2 m.RNA 
expression and MHC-II+ cells increased dramatically in the uterus after ovulation. 
Understanding their relationship to mucosal immunity or reproduction will increase our 
knowledge of reproductive immunology of rabbits. 
6.6 Conclusion 
This study classified the basic immune cells in the female rabbit reproductive tract 
and investigated the immune response in the tract to a model antigen HA and an ovarian 
antigen ZPB delivered by recombinant myxoma viruses. The recombinant virus was an 
effective vector at inducing antibody responses within the ovary but not within the 
mucosal part of the reproductive tract for immunocontraception. MV-ZPB has the 
potential to be an immunocontraceptive vaccine but a high and lasting IgG response to 
ZPB is needed to achieve higher infertility rates. 
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